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Communicable diseases and public health
Public health has been defined as the science and art of  disease prevention, pro-
longing life, and promoting health and well-being through organized community 
effort for the sanitation of  the environment, the control of  communicable infec-
tions, the organization of  medical and nursing services for the early diagnosis 
and prevention of  disease, the education of  the individual in personal health 
and the development of  the social machinery to assure everyone a standard of  
living adequate for the maintenance or improvement of  health.1
In the era of  the eradication of  smallpox in the sixties and seventies of  the last 
century the world was optimistic about a future world with controlled com-
municable diseases. The eradication of  smallpox inspired the world to eradicate 
poliomyelitis as well. This optimism was in vain. The poliomyelitis eradication 
experienced drawbacks, resulting in an all or nothing battle.2 Also old infectious 
diseases like Influenza, Dengue and Tuberculosis have revived and Legionella, 
HIV and SARS and the development of  antibiotic resistance in the form of  
MRSA and multi-drug resistance of  Mycobacterium tuberculosis are new examples 
of  emerging communicable diseases.3
Microbial agents that cause communicable diseases have proven to be very dynamic, 
resilient, and well adapted to exploit opportunities for change, development and 
emergence of  new species and for spread. In the “global village” the increase of  
travelling of  humans and animals and the enormous increase in meat industry and 
its antibiotic use, have created new opportunities for sexually transmitted diseases, 
zoonoses, antibiotic resistance and emerging diseases.
The yearly world wide mortality due to communicable diseases is 14 million 
death.4 The major part of  this mortality occurs in the developing world, where 
nearly half  of  all deaths are due to communicable diseases. Of  this mortality, 
90% is due to acute diarrhoeal and respiratory infections of  children, AIDS, 
tuberculosis, malaria, and measles. In developing countries millions are also 
still suffering from disabling diseases, such as poliomyelitis, leprosy, lymphatic 
filariasis, and onchocerciasis. In many of  these countries communicable diseases 
overwhelm the capacity of  health systems. 
In the developed world serious challenges to the health system are likely to occur 
as well when the next inevitable influenza pandemic occurs, or after the deliberate 
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release of  pathogens by bio-terrorists, or when any other major outbreak occurs. 
China’s public health system required major upgrading to counter a threat such 
as SARS.5 The public health significance of  communicable diseases in terms of  
human suffering, deaths, and disability, public fear and fear among health care 
workers for emerging diseases like Ebola and SARS, is aggravated by their nega-
tive consequences on economic growth and development.
The control of  several communicable diseases has been problematic due to lack 
of  effective vaccines, lack of  therapeutic drugs and drugs becoming ineffective 
due to antimicrobial resistance. However, new initiatives such as the Global Fund 
to Fight AIDS, Tuberculosis and Malaria, and the Global Alliance for Vaccines 
and Immunization (GAVI) offer new perspectives for improvement. 
Recently, the occurrence of  emerging and re-emerging communicable diseases, 
and critics such as the journalist Laurie Garrett in her book ’Betrayal of  Trust’ 
have inspired countries to improve their public health infrastructures for com-
municable disease control. Laurie Garrett wrote: “Were a naturally arising epidemic 
or a biological attack to occur, the public would only have one viable direction in which to place 
its trust: with its local, national, and global public health infrastructure”.6
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Motivation for this thesis
The first ideas for this thesis arose during the investigation of  an outbreak of  
coughing in a primary school in 1986 in Heel, a village of  around 3000 inhabitants 
in the province of  Limburg.7 The reason to study this outbreak was the concern 
of  a general practitioner and a school physician about an epidemic of  coughing 
of  unknown cause, which had lasted several weeks already. The coughing chil-
dren seriously disturbed the lessons and several of  the children were exhausted 
due to nightly coughing and vomiting after cough attacks. The two doctors did 
not consider the diagnosis pertussis because of  the high vaccination coverage 
of  the children (99%). The type of  coughing was, however, very similar to the 
typical pertussis coughing which can be observed in the tropics. A retrospective 
cohort study was therefore started of  the population at risk, including the school 
children (n=147), the teaching staff  (n=11), and household members (n=100) 
of  children and teaching staff  with and without pertussis, in order to reveal the 
cause of  the disease and the extent of  the epidemic. Structured questionnaires 
were used to study the extent of  the epidemic and the nature of  the complaints, 
and nasopharyngeal samples were taken for culture and blood samples for sero-
logical investigation.
At first the high serological antibody titres were interpreted as laboratory mistakes 
by the laboratory which executed the serological tests (the RIVM in Bilthoven). 
A mistake was ruled out with a repetition of  all serological tests by the same 
laboratory. In the end, the outcome of  the tests supported the hypothesis that 
it was indeed a pertussis epidemic in a group of  well-vaccinated children.
The study did not only reveal the diagnosis pertussis (pertussis was confirmed 
by 10 positive cultures of  Bordetella pertussis, the causative agent of  pertussis), 
but also several other dimensions of  knowledge concerning the agent, transmis-
sion and the host were obtained. This study revealed that a pertussis epidemic 
occurred among well-vaccinated primary school children and their teachers and 
families, and that a vaccination coverage of  99% did not provide sufficient herd 
immunity to stop transmission of  Bordetella pertussis in this group. The secondary 
attack rate was significantly higher in families of  teachers and school children 
with pertussis, compared to those without pertussis. The incidence of  pertussis 
increased with age in the age group 6-13 years, probably because the immunity 
against pertussis decreased with increasing duration since the vaccination in 
the first year of  life. The incidence of  pertussis in children vaccinated with 16 
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Opacity Units per doses vaccine was higher than in children vaccinated with 10 
Opacity Units. 
At the level of  diagnosis the sensitivity and specificity of  single IgA and IgG 
antibody titres were evaluated in relation to the outcome of  clinical symptoms. 
This led to the formulation of  questions regarding the course and sensitivity and 
specificity of  IgA and IgG antibodies for the diagnosis of  pertussis.
The study was the first description in the Netherlands of  the re-emergence of  
pertussis in a population with excellent vaccine coverage. It generated knowledge 
about pertussis at the level of  determinants of  pertussis and interventions against 
the disease. It was therefore advised to reintroduce pertussis vaccination at the 
age of  four, which was established as of  1998. 
The study was performed at the time of  a flourishing discussion about the mean-
ing of  the increase of  reported pertussis since 1980 by the national surveillance 
system in the Netherlands.
On the one hand, this increase was hypothesized to be a true increase of  the 
incidence of  pertussis. This true increase was attributed to “infection pressure” 
from neighbouring countries with a less successful national vaccination program 
or no program at all (England, Belgium, Germany, Sweden)8,9 and to a lowering 
of  the Opacity Units between 1976 and 1984 from 16 to 10 Units.9
On the other hand the increase of  reported pertussis was hypothesized to be 
no true increase of  the incidence of  pertussis because the pertussis vaccine 
had remained effective in spite of  lowering the Opacity Units between 1976 
and 1984.10 The increase of  reported pertussis was attributed to the increased 
interest of  doctors in pertussis because of  the serious epidemic in England in 
the periods 1978-1979 and 1981-1982,11 and the availability of  a new diagnostic 
single serological IgA and IgG test for pertussis since 1981.10-16
In 1986-1987 the number of  reported pertussis increased sharply.17-20
In 1987 it was hypothesized, based on the interpretation of  surveillance data 
of  reported pertussis, that the 1986-1987 increase was no true increase in the 
incidence of  pertussis and was attributed to the introduction of  the single IgA 
and IgG test10 and lack of  clinical, laboratory and epidemiological criteria for 
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the diagnosis pertussis. It was argued that due to the lack of  such criteria not 
only “serious cases of  pertussis” were reported, but also atypical cases.21 This 
dominant hypothesis led to the decision in 1987 to change the sensitivity and 
application of  the diagnostic criteria for pertussis, through defining strict clinical 
criteria for pertussis and requiring a paired instead of  a single serological test for 
confirmation of  pertussis infection.21-24 
This decision was followed by a sharp decrease of  the reported pertussis cases 
in 1988.20
This 1986 study7 supported the hypothesis of  a true increase in the pertussis 
incidence, which in the meantime has been accepted.25,26 The study also rejected 
the 10-16 Opacity Unit hypothesis as an explanation for this true increase.
The experiences gained in this epidemiological study of  a pertussis outbreak, 
together with those gained in studies of  some other outbreaks,27-29 suggested 
that communicable disease outbreaks can be seen as natural experiments. These 
experiments may not only generate specific knowledge for the containment of  
the outbreak as such, but may also generate more general scientific knowledge 
about determinants and interventions of  a communicable disease. This idea is 
the central theme of  this thesis, which attempts to illustrate the relevance of  
epidemiological studies of  outbreaks of  communicable diseases for gaining more 
general knowledge.
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Determinants and interventions of  communicable   
diseases
A communicable disease is a clinically manifest disease of  humans or animals due 
to a specific infectious agent or its toxic products, that arises through transmis-
sion of  that agent or its products from an infected person, animal or inanimate 
source to a susceptible host; either directly or indirectly through an intermediate 
plant or animal host, vector or the inanimate environment.3
The three basic determinants of  communicable diseases are (1) the infectious 
agent and its sources, (2) transmission of  the agent to the host and the environ-
ment in which transmission takes place, and (3) the host, or a group of  hosts 
including the routes of  entry into the host, and the reaction of  a host or a group 
of  hosts to the infection with an agent.3,30,31
Interventions to control communicable diseases control are directed towards 
these three determinants of  communicable diseases:
•	 The elimination or containment of  the sources of  infectious agents or of  the 
infectious agent as such. This is the field of  environmental control such as 
provision of  clean air, water, milk and food and the proper management of  
sewage and garbage.
•	 The interruption of  the chain of  transmission, such as the control of  insects 
and vectors of  disease, but also technical hygiene like masks and protecting 
clothing and avoiding contact between hosts and groups of  hosts, (e.g. closing 
schools, avoiding crowding, quarantine and isolation). Also avoiding infection 
with micro organisms as in case of  sexually transmitted diseases is considered 
as an interruption of  the chain of  transmission.
•	 The protection of  the hosts against infection or disease or both. This can 
be reached through passive and active immunization (vaccination), antibiotic 
and antiviral prophylaxis and therapy.31 The maintenance of  good health of  
hosts and populations of  hosts, undergoing first and natural re-infections 
can also be considered as a form of  protecting hosts against communicable 
diseases.
Interventions in communicable disease control are divided as well in primary and 
secondary prevention at individual and population level. The most successful 
form of  primary prevention is the national vaccination programme resulting in 
immunity at individual level and population level (herd immunity). In addition, 
Chapter 1
17
education programmes towards avoiding infection with sexually transmitted 
diseases like HIV are successful forms of  primary prevention, especially in 
democratic countries with an open and taboo free atmosphere among parents, 
teachers and children for sexual education. Secondary prevention at individual 
level is given in the health care system and at population level in screening pro-
grammes and outbreak management.
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Scientific knowledge and public health practice to  
control communicable diseases
Communicable disease control is based on both scientific knowledge about the 
determinants and interventions of  communicable diseases and on public health 
practice.
Public health practice includes (1) the application of  scientific knowledge of  
determinants and interventions in order to control communicable diseases, (2) 
surveillance in order to guard the control of  communicable diseases through 
monitoring the occurrence of  communicable diseases and through detecting 
outbreaks of  communicable diseases, and (3) the management of  outbreaks.
The application of  scientific knowledge about determinants and interventions 
of  communicable diseases may result in a successful control of  communicable 
diseases. Surveillance is used to guard this success.
Surveillance
The term surveillance, derived from the French word meaning “to watch over,” 
may be defined as a system of  close observation of  all aspects of  the occurrence 
and distribution of  a given disease through the systematic collection, tabulation, 
analysis, and dissemination of  all relevant data pertaining to that disease. Although 
the methodology of  surveillance is basically descriptive, its function has been 
considered as of  far greater importance than merely collective and archival: 
“Surveillance must be dynamic, current, and is purposeful and fundamental to 
prompt and effective control and prevention of  disease”.32 
In communicable disease control surveillance has been defined as the permanent 
process of  systematic collection, orderly consolidation, analysis, interpretation 
and evaluation of  pertinent data with prompt dissemination of  the results and 
processed information to those who need to know, particularly those who are 
in a position to take action.3,31 
There is a prolonged concern about the quality of  surveillance in communicable 
disease control. Traditional methods of  surveillance in communicable disease 
control are based on cases of  clinical disease, reported by physicians or identified 
by some survey technique. The adequacy of  surveillance based on such clinical 
cases requires the occurrence of  clinical illness, sufficient severity to seek medi-
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cal care, availability of  medical care, capability of  physicians to diagnose illness, 
laboratory support of  diagnosis, reporting of  disease and collection and analysis 
of  data by health departments.
In many countries, however, reported cases of  communicable diseases still form 
the backbone of  input of  their national surveillance system for communicable 
disease control. Therefore, high-quality data are needed if  surveillance and assess-
ment information are to be relied upon in public health decision-making. This 
implies that attention must be given to the quality of  data in designing, imple-
menting, and evaluating surveillance systems and analytic and evaluative studies. 
Analysis and interpretation of  surveillance data are only as good as the quality of  
the data collected, (the “garbage in, garbage out” principle).33 Following this under-
standing, attention has been given to improve reporting in communicable disease 
surveillance. This included the motivation of  reporters other than those related 
to disease reporting laws, by emphasizing, for example, professional gain and 
by summarizing surveillance data, improving the ease of  reporting and defining 
specific case definitions for accurate reporting. Active reporting was added to 
the original passive reporting. In active surveillance, the reporter is contacted 
at regular intervals and specifically asked about the occurrence of  the disease(s) 
under surveillance. Thus, there is an active attempt by public health officials 
to obtain disease occurrence information from the reporter. Also reporting 
by sentinel physicians, laboratory reporting and serological surveillance were 
introduced to compensate for the drawbacks of  surveillance.32 
In the past decades concern about communicable disease surveillance has been 
growing internationally, especially about surveillance as a method to obtain valid 
data.34-40 Therefore it was suggested that data sources and surveillance methods 
must be carefully selected to match the specified goals of  surveillance and to 
maximize the attributes (timeliness, sensitivity, positive predictive value, simplicity, 
flexibility) of  greatest importance at each level of  the public health system for 
each health event or determinant.41 However the requirements for surveillance 
to obtain valid data may be missing or inadequate, and even in highly developed 
countries the reporting of  communicable diseases is less than satisfactory and 
involves much variability.42
Core activities of  communicable disease surveillance systems remain collection, 
analysis, and dissemination of  information about health events under surveil-
lance. Doing these well requires attention to the mechanics of  surveillance, 
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such as making the health department accessible at all times to receive reports 
from the health care system and provide consultation, and maintaining current 
directories of  persons for dissemination of  surveillance data, alerts, and recom-
mendations. Although rapid access to electronic representations of  health events 
(e.g., laboratory reports, patient records, or health care claims) may provide 
great opportunities for more timely and complete surveillance, some important 
information (e.g., exposures, contacts) will still need to be collected directly from 
affected persons, through the health care system.43 So even this modern technol-
ogy may not be able to compensate for the basic drawbacks of  communicable 
disease surveillance, because principally modern information technology remains 
dependant on the quality of  reporting in the health service systems. 
In modern times determinants of  the outcome of  surveillance in communicable 
disease remain multi-factorial and therefore surveillance data might be used to 
monitor health events and determinants, and to formulate hypotheses, but not 
to test hypotheses. So surveillance should lead to, but not be confused with, 
research.33 Indeed, there is a still increasing realisation that the quality improve-
ment of  surveillance in communicable disease control due to modern information 
technology is less in providing knowledge for control of  communicable disease 
and adequate information for containment of  individual outbreaks and more 
in early warning of  cases of  infectious diseases, outbreaks, and emerging and 
re-emerging diseases.44-46 
Outbreak management
Unsuccessful control of  communicable diseases and re-emerging and emerging 
of  these diseases may result in outbreaks of  communicable diseases in a host 
or in a group of  hosts. An outbreak or epidemic is the occurrence, in a defined 
community or region, of  cases of  an illness with a frequency clearly in excess 
of  normal expectancy, the background incidence. Epidemicity is thus relative 
to usual frequency of  a disease in a specified population in a specified area in a 
specified time and does not depend on the absolute number of  cases. A single 
case of  a new communicable disease in a population can be considered as an 
epidemic and two new cases as evidence of  transmission. Endemicity refers to 
a habitual presence of  a disease or infectious agent within a given geographic 
area or a population group. It may also refer to the usual prevalence of  a given 
disease within such an area. Hyperendemicity expresses a habitual presence at 
all ages at a high level of  incidence.3
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The steps in surveillance to detect outbreaks are (1) detecting signals of  a com-
municable disease outbreak, and (2) combining signals to suspect an outbreak. 
Outbreaks of  communicable diseases may require outbreak management. 
Important to outbreak management is a coordinated investigation and response 
involving health workers including clinicians, epidemiologists, microbiologists, 
health educators and the public health authorities. The best way to ensure coor-
dination is usually to establish an outbreak containment committee early in the 
outbreak. The goal of  outbreak management is containment of  the specific 
outbreak through the principles of  communicable disease control: interrup-
tion of  the transmission of  the infectious agent and management of  infected 
hosts.3,31,47 
In order to establish an etiological diagnosis and to reach the goal of  containment 
of  an outbreak, the possible steps in an outbreak response should be systematic 
and based on epidemiological evidence, despite the fact that public and political 
reaction, urgency and the local situation may make this difficult.3,31,47
Epidemiology and proof  of  causation
In communicable disease control, epidemiology is used to obtain evidence about 
determinants and interventions. 
Epidemiology is the study of  distribution of  health and disease in populations 
and of  its determinants.48 Regarding communicable diseases, it is a quantitative 
science concerned with the circumstances under which infectious disease proc-
esses occur, the factors that affect their incidence and spread, and the use of  this 
knowledge for prevention and control.49 
Serological epidemiology is the systematic testing of  blood samples from a 
defined sample of  a population for the presence of  antibodies, antigens, genetic 
markers, specific cell-mediated immunity, and other biological characteristics. 
It constitutes an important epidemiological tool. Serological techniques can (1) 
identify the past and current prevalence of  an infectious agent in a community; (2) 
identify the incidence of  infection by sero-conversion or a rise in titre in samples 
obtained at two different times; (3) reveal the ratio of  sub-clinical to clinical 
infections, when combined with clinical data; and (4) estimate the need for 
immunization programmes and estimate their effectiveness as to the presence, 
level, and quality of  antibody produced; its duration; and the degree of  protec-
tion against disease. 
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New developments in the study of  communicable disease control are molecular 
epidemiology and mathematical modelling of  transmission dynamics of  infec-
tious diseases.
Epidemiological methods can be divided into descriptive, analytical and experi-
mental.31 Epidemiological methods are used to compare the effectiveness of  
new antibiotics or of  new therapies in treatment or prophylaxis, to delineate the 
etiological importance of  a new micro-organism, to establish normal laboratory 
values, to assess risk factors that affect infection, disease, and prognosis, and in 
many other clinical and laboratory settings.
With descriptive epidemiology, the circumstances under which infection and 
disease occur in a population are described. This includes data on prevalence 
and incidence, epidemic behaviour, and the spatial and temporal distribution of  
infection and disease, as well as the characteristics of  the host such as age, sex, 
race, occupation, familial or other setting, socio-economic level, nutritional status, 
and genetic background. Analytical epidemiology is a pre-planned manner to 
weigh the importance of  factors involved in infection or disease and to evaluate 
a hypothesis of  causation, or to measure the effectiveness of  an immunization 
or control programme. The major analytic methods used are the retro- and 
prospective cohort study and the retrospective case-control and cross-sectional 
study. Most efforts of  this type represent special studies in specific population 
groups. Experimental epidemiology represents planned experiments designed to 
control the influence of  extraneous factors, among those exposed or not exposed 
to an etiological factor, preventive measure, or environmental manipulation by 
the investigator. An example is the planned introduction of  vaccine or infec-
tious agent in a controlled fashion into a population of  volunteers or animals 
and the analysis of  the spread of  infection and disease within these groups as 
compared to a non-exposed group. Such studies offer the most scientifically 
controlled method of  epidemiological study. Natural experimental studies make 
use of  existing natural circumstances, which give the opportunity to study clues 
for infectious disease control. 
The information obtained from epidemiological studies can be utilised in several 
ways. It may help elucidate the aetiology of  a specific disease or group of  diseases 
by combining epidemiological data with information from other disciplines such 
as genetics, biochemistry and microbiology. The information can also be used 
to evaluate the consistency of  epidemiological data with etiological hypotheses 
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developed either clinically or through (natural) experiments. Finally, it may pro-
vide the basis for developing and evaluating preventive procedures and public 
health practices.
Evidence for a causal relationship between a factor and a disease is provided in 
the most direct way through experimentation and through the determination 
of  biological mechanisms. Epidemiological studies usually provide very strong 
support for hypotheses of  either a causal or indirect association. However, infer-
ences from such studies are not made in isolation; they must take into account all 
relevant biological information. Epidemiology and other evidence can accumulate 
to the point where a causal hypothesis becomes highly probable. Unfortunately, 
it is not yet possible to quantify the degree of  probability achieved by all the 
evidence for a specific hypothesis about the cause of  a disease, so an element of  
subjectivity remains. Nevertheless, a causal hypothesis can be sufficiently probable 
to provide a reasonable basis for preventive and public health action.
Following the principles of  proving causation,50-52 a unified concept of  causation 
that parallels the Henle Koch postulates has been developed, which is generally 
applicable to both communicable and non-communicable diseases:53
•	 Prevalence of  the disease should be significantly higher in those exposed to the 
hypothesized cause than in controls not so exposed, because the cause may be 
present in the external environment or as a defect in host responses.
•	 When all other risk factors are held constant, exposure to the hypothesized 
cause should be more frequent among those with the disease than in controls 
without the disease.
•	 Incidence of  the disease should be significantly higher in those exposed to 
the cause than in those not so exposed, as shown by prospective studies.
•	 Temporally, the disease should follow exposure to the hypothesized causa-
tive agent with a distribution of  incubation periods on a log-normal-shaped 
curve.
•	 A spectrum of  host responses should follow exposure to the hypothesized 
agent along a logical biologic gradient from mild to severe.
•	 A measurable host response following exposure to the hypothesized cause 
should have a high probability of  appearing in those lacking this before 
exposure or should increase in magnitude if  present before exposure; this 
response pattern should occur infrequently in persons not so exposed.
•	 Experimental reproduction of  the disease should occur more frequently in 
animals or man appropriately exposed to the hypothesized cause than in those 
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not so exposed; this exposure may be deliberate in volunteers, experimentally 
induced in the laboratory, or demonstrated in a controlled regulation of  natural 
exposure, the natural experiment.
•	 Elimination or modification of  the hypothesized cause or of  the vector car-
rying it should decrease the incidence of  the disease (e.g., control of  polluted 
water, removal of  tar from cigarettes).
•	 Prevention or modification of  the host's response on exposure to the hypoth-
esized cause should decrease or eliminate the disease (e.g., immunization, 
drugs to lower cholesterol, specific lymphocyte transfer factor in cancer).
•	 All of  the relationships and findings should make biologic and epidemiologi-
cal sense.
A systematic approach of  outbreaks for generating knowledge
In order to reach the goal of  containment of  an outbreak, I suggest 22 steps, 
which sometimes are taken concurrently, as shown in Table 1.3,31,47 My argument 
for this systematic procedure is that it integrates surveillance, epidemiological 
methods and outbreak management. This systematic and integrative approach 
creates the opportunity to generate knowledge to contain the outbreak of  the 
communicable disease at hand, and to generate knowledge of  a more general 
nature, included the testing of  hypotheses generated through surveillance, about 
the communicable disease.
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Table 1. Steps to contain an outbreak.
A. Confirmation of  an outbreak and establishment of  its aetiology
1 Verify the diagnosis
2 Confirm the existence of  an outbreak through comparing with previous surveillance data 
on the disease
3 Establish an etiological diagnosis if  possible and go to C
4 If  an etiological diagnosis cannot be established, go to B
B. Epidemiological investigation of  an outbreak
5 Define the condition epidemiologically and clinically
6 Collect material for isolation and culture and for serological tests
7 Investigate the extent of  the outbreak by a quick survey of  hospitals, physicians and 
other sources, in order to identify the infected and possible affected persons and their 
characteristics
8 Record case histories and if  possible identify additional cases
9 Investigate the basic epidemiological characteristics in terms of  time, place and person 
(age, sex, occupation, ethnic groups), possible routes of  transmission, methods of  spread 
and ports of  entry, and the spectrum of  clinical illness
10 Prepare, if  necessary, a spot map of  cases
11 Draw an epidemic curve
12 Seek a common denominator and define the population at risk
13 Formulate a hypothesis about the nature of  the agent causing the outbreak, its source, its 
way of  transmission and its port of  entry, and possible ways of  control, and about the 
susceptibility of  the host, or the groups of  hosts, and the population at risk
14 Test the hypothesis by determining infections and illness rates in persons exposed and not 
exposed to putative source(s) by questionnaires, interviews, and laboratory tests. Try to 
isolate the agent from the putative sources(s)
15 Extend epidemiological and laboratory studies to other possible cases or to persons 
exposed, but not ill
16 Analyse the data and consider possible interpretations
17 On the basis of  the analysis formulate short and long term control measures
C. Containment of  the outbreak
18 Contain the outbreak through control measures to prevent transmission and through 
protection of  infected hosts against infection
19 Consider conducting ongoing disease surveillance in the acute phase of  an outbreak in 
order to control the outbreak initially. This can be reached through keeping persons at risk 
(e.g. contacts of  infectious hosts, the sources) under surveillance for disease onset. This 
form of  surveillance is known as “source and contact tracing”
20 Consider continuation of  community surveillance after the outbreak has initially been 
controlled, in order to identify additional cases and to complete containment
21 Prepare interval reports during and after the containment, in order to inform the general 
public and the public health authorities about the nature of  the outbreak and what is 
required to contain the outbreak
D. Publish the outbreak management
22 Prepare a scientific report of  the management of  the outbreak for publication in a 
medical journal or epidemiological bulletin, in order to learn from the way the outbreak 
was managed and if  applicable to present knowledge of  more general nature about the 
communicable disease at hand
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A model of  communicable disease control
In the previous paragraphs we have introduced the three basic determinants of  
communicable diseases (infectious agent, transmission and host) and explained 
how knowledge about these determinants will lead to the development of  suc-
cessful preventive interventions. Research of  the determinants of  communicable 
diseases and the development of  interventions is the domain of  science. The 
implementation of  interventions (control) is in the domain of  public health 
practice. Unsuccessful control may lead to outbreaks of  communicable diseases. 
These outbreaks are usually detected through surveillance systems. We estab-
lished the need for an etiologic diagnosis to reach the goal of  containment of  
an outbreak, argued that epidemiological evidence is necessary, and described 
the systematic steps in an outbreak response to be followed to reach this goal. 
Finally, we introduced surveillance as a tool in the control of  communicable 
diseases. We stated that surveillance data may be used to monitor health events 
and determinants, and to formulate hypotheses, but not to test hypotheses. So 
surveillance should lead to, but not be confused with research. Figure 2 depicts 
Figure 2. A model of  communicable disease control.
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the various aspects of  communicable disease control and how the domains of  
science and public health practice interrelate.
Research questions
This thesis focuses on outbreak management, the domain of  public health prac-
tice, as an opportunity for obtaining knowledge, basically the domain of  science, 
in communicable disease control.
The research questions are:
1. Are epidemiological studies during outbreak management able to generate 
specific knowledge for the containment of  the communicable disease at 
hand?
2. Are epidemiological studies during outbreaks management able to generate 
knowledge of  a more general nature than necessary for the immediate con-
tainment of  the communicable disease at hand?
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Outline in this thesis
In chapter 2 to 8 we give examples of  epidemiological studies of  communica-
ble disease outbreaks and of  studies arising from these outbreak studies. In the 
studies, knowledge is generated for communicable disease control.
Chapter 2 describes a study of  an epidemic of  pertussis among elderly people in 
a religious institution in the Netherlands. Chapter 3 describes a study about the age-
specific long-term course of  IgG antibodies to pertussis toxin after symptomatic 
infection with Bordetella pertussis. Chapter 4 describes the sensitivity and specificity 
of  single IgA and IgG antibodies for early diagnosis of  pertussis in adults as tools 
for outbreak management in public health practice. Chapter 5 describes a study 
in which the pertussis outbreak, described in Chapter 2, is associated with social 
isolation among elderly nuns in the convent.
Chapter 6 describes an epidemic of  Salmonella typhimurium associated with tra-
ditional salted, smoked, and dried ham. Chapter 7 describes a gastroenteritis 
epidemic caused by a Norwalk-like virus after two weddings in a restaurant and 
provides a plea for integral microbiological investigation. 
Chapter 8 describes the risk of  introduction of  poliovirus into a Cape Verdian 
community in the Netherlands during an outbreak of  poliovirus in Cape Verde 
in 2000.
Finally, in chapter 9, the general discussion, the research questions are answered 
and recommendations are provided. 
The work reported on in this thesis is summarized in chapter 10.
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Abstract
An epidemic of  pertussis is described among elderly people in a religious institu-
tion in the Netherlands in 1992. 
Subjects were evaluated for their vaccination status and for history and presence 
of  respiratory symptoms. Specimens were collected for culture, polymerase chain 
reaction, and serological evaluation.
None of  the 75 residents and 19 of  24 non-resident personnel had been vac-
cinated against pertussis. The overall attack rate of  clinical pertussis, defined as 
persistent cough lasting at least 2 weeks, was 49%. In five subjects with clinical 
pertussis, either culture or polymerase chain reaction or both were positive for 
Bordetella pertussis. A significant (at least 4-fold) change in specific antibody titre 
was observed in 85% (41/48) and 20% (10/49) of  subjects with and without 
clinical pertussis, respectively (P < 0.0001, chi-square 41.1). The attack rate of  
laboratory-confirmed pertussis was 42% (41/98). This rate was 5% (1/19), 
20% (1/5), and 53% (39/74) in vaccinated personnel, unvaccinated personnel, 
and unvaccinated residents, respectively (not significant). Among residents aged 
between 55–74 years and 75–94 years, the attack rates were 47% (17/36) and 
58% (22/38), respectively (relative risk = 0.8; 95% confidence interval 0.5–1.3). 
Four of  75 residents (5%) died from intracranial bleeding, while they were 
symptomatic for pertussis.
It is concluded that the attack rate of  pertussis was high among unvaccinated 
elderly and that pertussis tended to increase with age. There may be a consider-
able risk of  mortality from pertussis in this population. Physicians should be 
alert to the diagnosis of  pertussis in the elderly with nocturnal and prolonged 
periods of  coughing.
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Introduction
Bordetella pertussis is an important pathogen of  the upper respiratory tract par-
ticularly in children. Worldwide, the pathogen represents a significant part of  
childhood morbidity, characterized by a persistent vigorous paroxysmal cough. 
This entity is recognized as whooping cough. Especially in developing countries, 
the disease is a major threat to health in childhood, complicated by wasting and 
brain damage. 
Most developed countries vaccinate to prevent pertussis. In the Netherlands, 
96% of  the children complete the vaccination program 3, 4, 5, and 11 months 
after birth. Because the national vaccination program in the Netherlands was 
introduced in 1952, subjects born before that year have not been vaccinated. 
In spite of  the high degree of  vaccination, whooping cough is reported at a rate 
of  1–4.2 cases per 100,000 people each year.1 These rates are maximal for non- or 
incompletely vaccinated children at 1–4 years of  age, amounting to 95.3 cases 
per 100,000 per year during the period 1989–1994. During that period, reports 
of  cases in adults over 20 years of  age were rare.2 However, there is increasing 
evidence that adults are at risk of  pertussis and play a role in transmission of  
the disease in the community.2–8
In this report, we describe an epidemic of  pertussis among unvaccinated elderly 
and partly vaccinated personnel from a religious community in the Netherlands. 
We studied the symptoms, duration, and spread of  the disease, and calculated 
demographic and clinical scores. From nasopharyngeal swabs, a routine culture 
for Bordetella pertussis and a polymerase chain reaction (PCR) designed to detect 
Bordetella pertussis was performed. 
In addition, the changes of  immunoglobulin (Ig)A and IgG class-specific antibody 
titres were determined in two or three consecutive samples.
Materials and methods
Subjects and procedures 
All 99 subjects who resided or were employed in the convent, i.e. 75 resident nuns 
and 24 non-resident personnel, were evaluated for the presence of  persistent 
coughing. All subjects were informed about the purpose of  the study and all 
consented to participate. 
Due to late reporting, the study started in week 9 of  the epidemic. At that time 
trained interviewers, assisted by a nurse from the institution, collected information 
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about clinical manifestations suggestive of  pertussis while blind to laboratory 
data. They asked retrospectively about the presence of  prolonged illness with 
paroxysmal productive cough, data of  disease onset, cough at night, inspiratory 
wheezing, whooping, and post-tussive emesis.9 In addition, the emergence and 
duration of  the same clinical manifestations were prospectively monitored; first 
on a daily basis and, later (when new cases no longer emerged), weekly until 
symptoms had subsided in all subjects. They asked for the subject’s vaccination 
status and for a history of  prior diseases, with particular emphasis on respiratory 
symptoms.
Laboratory evaluation
From each individual, two nasopharyngeal swabs were obtained at weeks 9 and 
13 of  the epidemic. 
For each individual, one nasopharyngeal swab was immediately placed in transport 
medium containing charcoal agar, Oxoid CM119 agar (Oxoid, Unipath, The 
Netherlands), sodium-citrate-diluted sheep blood, cephalexin 40 mg/l (Oxoid, 
Unipath), and amphotericin B (Bristol-Myers Squibb BV, The Netherlands). 
Within 12 h after collection, the specimens were transported to the microbiology 
laboratory of  the hospital at Heerlen, The Netherlands. Subsequently, specimens 
were inoculated immediately on prewarmed Bordet-Gengou agar plates (Oxoid 
CM 267, Unipath), supplemented with defibrinated sheep blood (12%) and 
amphotericin B (1.7 mg/ml). After inoculation, the agar plates were incubated 
in 5% CO2 at saturation and at 37 °C for 7 days. The plates were evaluated daily 
for the presence of  colonies with typical morphological characteristics. Isolated 
strains were identified as Bordetella pertussis if  they passed the criteria for gram-
negative, oxidase- and catalase-positive microorganisms, and if  they specifically 
reacted with the antiserum against Bordetella pertussis (Wellcome 2.M.10, supplied 
by the National Institute for Public Health and the Environment, Bilthoven, 
The Netherlands). 
For each individual, another dry swab was immediately sent to the National 
Institute for PCR analysis. The procedure of  sample processing, PCR, and the 
analysis of  PCR products were performed as described previously.10 The primer 
recognition of  repeated DNA elements specific for Bordetella pertussis and Bordetella 
parapertussis has also been described previously.11 
In addition, at weeks 9, 13, and 60 of  the epidemic, serum samples were obtained 
to evaluate the presence of  antibodies against Bordetella pertussis and other res-
piratory pathogens. For measurement of  Bordetella pertussis antibodies, enzyme 
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immunoassay procedures were used according to described methods.12,13 For 
IgG-class antibody detection, purified pertussis toxin was used. For IgA-class 
antibody detection, a crude cell-wall preparation of  Bordetella pertussis was used.13 
Antibody-binding activities were quantitatively expressed as units per millilitre 
as described elsewhere.12,13 
In addition, the antibody response to influenza A and B viruses, parainfluenza 1, 2, 
and 3 viruses, respiratory syncytial virus, adenovirus, Chlamydia psittaci, Mycoplasma 
pneumoniae, and Coxiella burnetii were evaluated by routine enzyme immunoassays 
(National Institute for Public Health and the Environment). 
The presence of  active pulmonary tuberculosis was evaluated by means of  a 
chest radiograph. In addition, repetitive sputum samples were evaluated for the 
presence of  Mycobacterium tuberculosis by means of  routine acid-fast staining and 
culture in the hospital at Heerlen, The Netherlands.
Definitions
Clinical pertussis was defined as the presence of  a persistent cough for at least 
14 days, which started during the epidemic of  coughing.9 Laboratory-confirmed 
pertussis was defined as clinical pertussis, combined with one of  the following 
laboratory findings: (i) a Bordetella pertussis strain isolated from the nasopharynx; 
(ii) a reactive PCR or; (iii) a significant (at least 4-fold) increase or decrease of  
IgA and/or IgG antibody titres among serum samples obtained at weeks 9, 13, 
and 60 of  the epidemic.
Statistical analysis
Clinical and laboratory data were collected in a database management system. For 
the statistical analyses, the Statistical Package for Social Sciences (SPSS, USA) was 
used. The analyses of  frequency tables were performed with Pearson’s chi-square 
test and by comparing risks.14
Results
Study population
The study was performed in a religious community (n = 99) consisting of  75 
residents (all nuns) and 24 non-resident personnel (3 males, 21 females) with 
a mean age of  75 years (range 55–94 years) and 27 years (range 21–46 years), 
respectively. They all (100%) participated in the study. The residents and staff  
A pertussis epidemic in a religious institution
40
members participated in daily common social and religious activities and shared 
meals in the dining room. Residents with severe complaints of  upper respiratory 
tract infections were nursed in a separate care room in the institution.
Clinical characteristics.
In retrospect, the first case, a resident nun, experienced her onset of  disease 
on 3 June 1992, designated as week 1. Overall, the crude attack rate of  cough 
was 52% during the epidemic (52/99). The epidemic reached its peak at week 6 
(median at day 34), as expressed in an epidemic curve (Figure 1). The last patient 
started coughing in week 12 of  the epidemic. Coughing persisted for a mean 
period of  69 days (range 7–268 days). Retrospective evaluation of  the epidemic’s 
first 9-week period revealed 46 cases of  recent or actual coughing illness. All but 
two of  these 46 cases (95.7%) met the criteria for clinical pertussis. Prospective 
evaluation revealed six cases of  cough. The overall attack rate of  clinical pertussis 
was 49% (49/99). 
Among residents and personnel, the distribution of  cases showing symptoms of  
cough and clinical pertussis was assessed according to vaccination status and age 
category (Table 1). Among personnel and residents, the rate of  clinical pertussis 
was 12% (3/24) and 61% (46/75), respectively. Among vaccinated and unvac-
Table 1. Morbidity, mortality and laboratory results by status of  vaccination and age (years) in the 
study population.
Variables All participants Personnel Residents (non-vaccinated)
age 21-94
(n=99)
All
age 21-46
(n=24)
Vaccinated
age 21-43
(n=19)
Non-vaccinated
age 21-46
(n=5)
All
age 55-94
(n=75)
< 75 years
age 55-74
(n=37)
³ 75 years
age 75-94
(n=38)
Subjects with a cough 52/99 5/24 2/19 3/5 47/75 22/37 25/38
Subjects with clinical pertussis 49/99 3/24 1/19 2/5 46/75 22/37 24/38
Subjects with isolation of  
Bordetella pertussis or reactive PCR
5/99 1/24 1/19 0/5 4/75 3/37 1/38
Subjects with significant change 
in antibody titres
51/97a 4/24 3/19 1/5 47/73 20/36 27/37
Laboratory confirmed pertussis 41/98b 2/24 1/19 1/5 39/74 17/36 22/38
Mortality 6/99c 0/24 0/19 0/5 6/75 1/37 5/38
Pertussis-associated mortality 4/99 0/24 0/19 0/5 4/75 1/37 3/38
a From one subject with and one without clinical pertussis only one serum sample was obtained
b The subject without clinical pertussis from whom only one serum sample was obtained is added 
in the denominator
c The subject with clinical pertussis from whom only one serum sample was obtained is added in 
the denominator
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cinated personnel, the rate was 1/19 (5%) and 2/5 (40%), respectively [relative 
risk (RR) = 0.8, 95% confidence interval (CI) 0.3–1.5]. The rate was 59% (22/37) 
and 66% (25/38) for the unvaccinated residents from the age categories 55–74 
years and 75–94 years, respectively (RR = 0.9, 95% CI 0.7–1.3)
Laboratory evaluation
At weeks 9 and 13 of  the epidemic, 
respectively, from 93 and 96 subjects 
a nasopharyngeal specimen was 
obtained for culture of  Bordetella 
pertussis, and from 91 and 95 subjects 
a nasopharyngeal specimen was 
obtained for PCR. Bordetella pertus-
sis was isolated in four of  93 (4%) 
subjects and PCR was reactive in two 
of  91 (2%) subjects. One case revealed 
both isolation of  Bordetella pertussis 
and a reactive PCR. Bordetella pertus-
sis isolates and reactive PCR results 
were only found in samples obtained 
during week 9 from subjects who met 
the criteria for clinical pertussis.
Table 1. Morbidity, mortality and laboratory results by status of  vaccination and age (years) in the 
study population.
Variables All participants Personnel Residents (non-vaccinated)
age 21-94
(n=99)
All
age 21-46
(n=24)
Vaccinated
age 21-43
(n=19)
Non-vaccinated
age 21-46
(n=5)
All
age 55-94
(n=75)
< 75 years
age 55-74
(n=37)
³ 75 years
age 75-94
(n=38)
Subjects with a cough 52/99 5/24 2/19 3/5 47/75 22/37 25/38
Subjects with clinical pertussis 49/99 3/24 1/19 2/5 46/75 22/37 24/38
Subjects with isolation of  
Bordetella pertussis or reactive PCR
5/99 1/24 1/19 0/5 4/75 3/37 1/38
Subjects with significant change 
in antibody titres
51/97a 4/24 3/19 1/5 47/73 20/36 27/37
Laboratory confirmed pertussis 41/98b 2/24 1/19 1/5 39/74 17/36 22/38
Mortality 6/99c 0/24 0/19 0/5 6/75 1/37 5/38
Pertussis-associated mortality 4/99 0/24 0/19 0/5 4/75 1/37 3/38
a From one subject with and one without clinical pertussis only one serum sample was obtained
b The subject without clinical pertussis from whom only one serum sample was obtained is added 
in the denominator
c The subject with clinical pertussis from whom only one serum sample was obtained is added in 
the denominator
Figure 1. The epidemic curve of  cases with persistent cough among 99 subjects in a closed religious 
institution. The first case was reported on 1 June 1992 (week 1) and the study was started at week 
9 as indicated by an arrow. Grey bars present the cumulative case reports of  clinical pertussis, the 
closed bars present newly reported cases of  clinical pertussis. The first case was reported to the 
physician of  the institution.
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At weeks 9, 13, and 60 of  the epidemic, 94, 97, and 85 serum samples were 
obtained for measurement of  IgA and IgG antibody titres, respectively. At these 
times, the mean levels of  IgA titres were 304, 313, and 124 U/ml in subjects 
with clinical pertussis, compared with 39, 36, and 19 U/ml, respectively, in the 
group of  subjects that did not meet the criteria of  clinical pertussis (P < 0.0001). 
Corresponding IgG titres were 1012, 743, and 82 U/ml in subjects who met the 
criteria for clinical pertussis, compared with 49, 30, and 15 U/ml, respectively, 
in subjects who did not meet the criteria of  clinical pertussis (P < 0.005).
In order to detect significant changes between IgG and IgA antibody titres, three 
consecutive serum samples were collected from 80 subjects at weeks 9, 13, and 
60 of  the epidemic. 
Two serum samples were obtained from 17 subjects. 
From one resident with and from one resident without clinical pertussis, only 
one single serum sample was obtained. Therefore, these two subjects were not 
further evaluated for changes in antibody titres. 
The 97 subjects from whom at least two serum samples were obtained were 
further evaluated for changes in antibody titres. Four (4%) subjects showed 
a significant (at least 4-fold) increase in IgA or IgG antibody titres. In seven 
(7%) subjects, both a significant increase and decrease in antibody titres were 
observed. Forty (40%) subjects showed a significant (at least 4-fold) decrease in 
antibody titres. Forty-six (47%) subjects showed no significant change in IgG 
or IgA antibody titres. 
Forty-eight of  97 subjects from whom at least two serum samples could be 
obtained met the criteria for clinical pertussis; 49 subjects did not. Forty-one of  
48 (85%) subjects with clinical pertussis and ten of  49 (20%) subjects without 
clinical pertussis showed a significant change in antibody titres against Bordetella 
pertussis (P < 0.0001, chi-square = 41.1).
Two of  five subjects with a positive culture of  Bordetella pertussis or a reactive PCR 
showed a significant increase of  antibody titres. Three of  these five subjects con-
secutively showed both a significant increase and a decrease of  antibody titres. 
The attack rate of  laboratory-confirmed pertussis could be evaluated in 98 
subjects, consisting of  the 97 subjects described above and the subject without 
clinical pertussis from whom only one serum sample could be obtained. The 
attack rate of  laboratory-confirmed pertussis was 42% (41/98) (Table 1). Among 
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personnel and residents, this rate was 8% (2/24) and 53% (39/74), respectively. 
Among the (unvaccinated) residents, the attack rate of  laboratory-confirmed 
pertussis was 47% (17/36) and 58% (22/38) for the categories 55–74 years and 
75–94 years of  age, respectively (RR = 0.8, 95% CI 0.5–1.3). Among vaccinated 
and unvaccinated personnel, this rate was 5% (1/19) and 20% (1/5), respectively 
(RR = 3.8, 95% CI 0.3–50.7). 
As determined by enzyme immunoassay, no serological evidence was present 
for infection with influenza A and viruses, parainfluenza 1, 2, and 3 viruses, 
respiratory syncytial virus, adenovirus, Chlamydia psittaci, Mycoplasma pneumoniae, 
or Coxiella burnetii. 
The presence of  pulmonary tuberculosis was excluded in ten symptomatic 
residents with the greatest clinical suspicion of  tuberculosis.
Severity of  laboratory-confirmed pertussis
Among personnel, laboratory-confirmed pertussis was observed in only two 
subjects and it did not run a severe course. They coughed for a period of  16 
Table 2. Clinical variables of  non-vaccinated elderly residents with laboratory-confirmed pertussis 
by age.
Variables Age group
55-74 years
(n=17)
75-94 years
(n=22)
All
(n=39)
Duration of  cough (days)a
- mean 65 67 66
- median 45 57 52
- range 14-268 14-159 14-268
- standard deviation 62 41 50
Duration of  cough (days)b
- 14-20 3 2 5 (13%)
- 21-41 5 4 9 (23%)
- 42-55 1 5 6 (15%)
- 56-69 4 3 7 (18%)
³ 70 4 8 12 (31%)
Symptomsb
- nightly cough 10 14 24 (61%)
- productive cough 2 1 3 (8%)
- inspiratory cough 6 3 9 (23%)
- whooping 5 2 7 (18%)
- posttussive emesis 2 3 5 (13%0
a Results given in days
b Results given in number of  patients
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days and 108 days, and accompanying clinical symptoms were not typical for 
pertussis. In contrast, among the residents with laboratory-confirmed pertussis, 
the median duration of  cough was 55 days with typical accompanying symptoms 
(Table 2). For example, the prevalence of  nightly cough was 61% (24/39) in this 
group and in 64% of  the cases the cough lasted for more than 6 weeks. The 
prevalence of  coughing lasting more than 6 weeks was 53% (9/17) and 73% 
(16/22) for the categories 55–74 years and 75–94 years of  age, respectively (RR 
= 0.7, 95% CI 0.4–1.2).
Mortality
The death rate during the study period was 6% (6/99). 
Two deaths were not associated with pertussis. One subject died of  pancreatic 
carcinoma without signs of  clinical pertussis. At weeks 9 and 13 of  the epidemic, 
the IgA antibody titres of  this subject were 55 U/ml and 29 U/ml, respectively. 
The corresponding IgG antibody titres were 56 U/ml and 46 U/ml. A second 
subject died of  breast carcinoma without signs of  clinical pertussis with an IgA 
antibody titre of  356 U/ml and an IgG titre of  224 U/ml at week 9. 
The third and fourth subjects died after developing intracranial bleeding during 
the symptomatic episode of  laboratory-confirmed pertussis. At that time, they 
had coughed for a period of  108 days and 159 days. 
The fifth subject also died as a result of  intracranial bleeding, after she had been 
symptomatic for clinical pertussis for 173 days. For this subject, the IgA antibody 
titre was 41 U/ml at week 13. The corresponding IgG antibody titre was 800 
U/ml, which was significantly higher than the mean IgG titre of  30 U/ml for 
subjects without clinical pertussis at week 13. 
The intracranial bleedings were diagnosed clinically by an experienced physician 
and based on the acute development of  dysarthria, aphasia, and hemiplegia. The 
sixth subject died after a period of  cough lasting 236 days, with IgA titres of  656 
U/ml and 1120 U/ml and IgG titres of  8000 U/ml and 5824 U/ml at weeks 9 
and 13, respectively. The antibody titres of  this subject were significantly higher 
than the mean IgA and IgG titres of  subjects who did not meet the criteria for 
clinical pertussis (mean IgA titres were 39 U/ml and 36 U/ml and mean IgG 
titres were 49 U/ml and 30 U/ml at weeks 9 and 13, respectively). 
Presuming that the deaths of  cases 3 to 6 were associated with the presence of  
pertussis, the pertussis-associated death rate was 5% (4/75) among residents. 
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Yield of  laboratory tests to confirm clinical pertussis.
Early nasopharyngeal swabs and convalescent blood samples were not obtained 
from the majority of  subjects. As a result, the yield of  a positive test to confirm 
clinical pertussis was low, e.g. the yields were 4%, 8%, and 16% for a reactive PCR, 
a positive culture, and a significantly increasing antibody titre, respectively. In 
addition, among the subjects with clinical pertussis, concordant results of  reactive 
PCR and positive culture were observed in only 20% of  the cases. Concordant 
results between positive culture and a significant increase in antibody titre were 
observed in 50% of  the cases. In contrast, the yield of  a significant decrease in 
titres among subjects with clinical pertussis was 79% (38/48).
Discussion
In this report, we describe an epidemic of  pertussis in a religious community 
of  75 unvaccinated elderly residents, and 19 vaccinated and five unvaccinated 
personnel. 
The attack rates of  clinical pertussis and laboratory-confirmed pertussis were 
as high as 49% and 42%, respectively. Unvaccinated subjects were more at risk 
of  pertussis than those vaccinated. The rates, the duration, and the severity of  
laboratory confirmed pertussis tended to increase with age. The observed pertus-
sis-associated mortality was 5% (4/75) in the unvaccinated elderly residents.
One hundred percent of  the population (n = 99) participated in the study. The 
epidemic was reported late to the public health department because the clinicians 
of  the institute did not consider pertussis to be a possible cause of  the epidemic. 
As a result, clinical symptoms had to be studied retrospectively for a 9-week 
period. However, retrospective clinical data collection over a 9-week period in 
infectious disease epidemics seems to be reliable.15
Another limitation of  the partly retrospective study is that sample collection 
occurred relatively late during the epidemic. As a result, in the majority of  subjects, 
the yield of  the golden standard tests to confirm the diagnosis of  clinical pertussis 
was low (PCR, culture, significant increase in antibody titre). Previously, it has 
been described that the percentage of  positive culture can be as low as 1–2% three 
weeks after the onset of  cough. At that time, the recovery by means of  PCR is 
below 10%.10 In addition, among the subjects with clinical pertussis, concordant 
results between a reactive PCR, a positive culture, and a significant increase in 
antibody titres occurred infrequently. The low yield of  these tests is a generally 
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accepted problem in the diagnosis of  pertussis. In contrast, retrospective analysis 
by a significant decrease in titres among subjects with clinical pertussis was as 
high as 79% when using a third serum sample at week 60 of  the epidemic. 
Prolonged cough and cough at night were the most common clinical symptoms 
among the unvaccinated elderly with laboratory-confirmed pertussis. Previously, 
Keitel and Adwards16 described that, in adults, the most common manifestation 
of  pertussis is prolonged cough. 
In the early years of  the 20th century, it was observed that only 2.3% of  cases 
during epidemics of  pertussis occurred in persons older than 15 years and that 
children could be infected by adult household contacts.17,18 In more recent years, 
the number of  cases with pertussis among older children and adults increased, and 
the proportion of  reported cases among persons older than 10 years increased 
from 15.1% in 1977 to 27% in 1993.19 Among adults, a high prevalence of  
pertussis is described in recent reports6,7 although, compared with this study, 
the prevalence in elderly was found to be relatively low.4
Three of  the four pertussis-associated deaths developed symptoms of  intrac-
ranial bleeding during the coughing period, possibly as a result of  increased 
intracranial pressure. This complication of  pertussis has been described previ-
ously.20,21 Intracranial bleeding could possibly be a significant cause of  death in 
elderly persons with pertussis during a prolonged period of  coughing. To our 
knowledge, this is the first time that such a high pertussis-associated mortality 
rate has been reported among the elderly. In the USA, in 1992 and 1993, only 23 
pertussis-related deaths were reported. They all occurred in children, who most 
frequently died as a result of  pneumonia.22 Thirteen percent of  these children 
demonstrated signs of  encephalopathy. 
In conclusion, an epidemic of  pertussis among unvaccinated adults is described, 
with attack rates tending to increase with age. Among the elderly, an unexpectedly 
high attack rate of  pertussis was observed. Four of  six deaths are thought to be 
associated with pertussis. Therefore, physicians should be alert to the diagnosis 
of  pertussis in unvaccinated elderly with prolonged and nightly cough. 
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Summary
To investigate the possible dependence on age of  the rate of  decline of  IgG 
antibodies to pertussis toxin (IgG-PT) after natural infection with Bordetella per-
tussis, we measured IgG-PT in follow-up sera of  121 patients (age 0–94 years) 
obtained after 123 episodes of  Bordetella pertussis infection. 
For analysis we applied a dynamic model for the inactivation of  Bordetella pertussis 
by the immune system. 
There were no significant differences in rise, peak and decline of  IgG-PT between 
different age groups, although there was a tendency for a more rapid increase, a 
higher peak and a faster decline with increasing age. 
The IgG-PT cut-off  of  100 U/ml for serodiagnosis of  pertussis appeared valid 
in all age groups. 
A decline of  IgG-PT to <10 U/ml was associated with increased risk of  re-
infection with Bordetella pertussis.
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Introduction
Neither vaccination against pertussis nor natural infection with Bordetella pertussis 
affords lifelong immunity.1–12 However, the rate of  waning of  immunity and 
possible differences after both vaccination and natural infection are difficult to 
establish, because no method exists to unequivocally measure (non)-susceptibility 
for pertussis for each individual. A simple single correlate of  protection has not 
been found; both humoral and cellular immunity play a role.13,14 However, a rela-
tionship between protection and levels of  IgG antibodies against the virulence 
factors pertussis toxin, pertactin and fimbriae has been demonstrated.2,13,15–17 
In accordance with the concept of  waning immunity, it has been observed that 
elevated levels of  these IgG antibodies, whether induced by vaccination or natu-
ral infection quite rapidly decrease again.9,13,18,19 However, the rate of  decline 
and its possible age dependency have not been established. Also the question 
of  whether or not after infection, IgG antibodies to pertussis toxin (IgG-PT) 
eventually persist at some level or completely disappear, remains unanswered.
Of  the mentioned virulence factors pertussis toxin is of  special interest; when 
used as a single component in an acellular vaccine, it induces considerable 
protection and is the only virulence factor which is present in each of  the 
newly developed acellular pertussis vaccines.20 Furthermore, IgG-PT is also an 
important parameter for serodiagnosis of  pertussis, because cross-reactivity of  
pertussis toxin with antibodies induced by heterologous proteins has never been 
established, and most individuals produce high levels of  IgG-PT in response to 
infection with Bordetella pertussis.19,21,22
In our first study of  the longitudinal course of  IgG-PT after typical symptomatic 
infection with Bordetella pertussis, practically all 57 participating pertussis patients 
were young children and an established model for assessing the rate of  decline of  
IgG-PT antibodies was lacking.19 For assessment of  the possible age dependence 
of  the rate of  IgG-PT decline after natural infection, we extended our studies 
to a larger group of  pertussis patients of  various ages for whom follow-up sera 
were available, and to a group of  elderly adult patients with pertussis for whom a 
follow-up serum sample had been drawn 1 year after infection with Bordetella pertus-
sis.23 For analysis we applied an adapted version of  a recently described dynamic 
model for the inactivation of  Bordetella pertussis by the immune system.24
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Materials and Methods
Patients and sera
The first group of  pertussis patients studied (A) consisted of  87 subjects (80 
children and adolescents between 0 and 18 years and seven adults between 30 
and 42 years), who suffered from clinically typical whooping cough (paroxysmal 
coughing for >2 weeks) between 1989 and 1999, confirmed by positive IgG-PT 
serology (for criteria see below). These patients were from the paediatric prac-
tice of  one of  the authors (F.G.A.V.) in Gouda, The Netherlands, and, after the 
pertussis episode (diagnosed by F.G.A.V.), remained as a patient in that practice, 
often because of  asthma or other respiratory problems. At the time of  the pertus-
sis episode, these patients or their parents gave informed consent to use future 
sera, which might be obtained for various reasons at irregular control visits or 
at consultations with new complaints, for measurement of  IgG antibodies to 
pertussis toxin. The adults in this group were parents of  participating children 
who had pertussis at the same time as their child and who had volunteered to 
participate in this study. Only patients for whom at least one follow-up serum 
sample, obtained > 6 months after onset of  disease, was available were included 
in this analysis. The Medical Ethical Committee of  the Groene Hart Hospital 
approved the study.
The second group (B) of  pertussis patients studied consisted of  34 people from 
a convent in the southern part of  The Netherlands, 33 nuns (aged between 59 
and 94 years) and one employee (aged 26 years). All of  them had clinically typi-
cal pertussis during an outbreak of  pertussis in this convent in 1992, which was 
confirmed by positive IgG-PT serology (for criteria see below). This pertussis 
outbreak was described in detail previously.23 Approximately 1 year after the 
outbreak one follow-up serum sample had been obtained from all patients. All 
patients gave informed consent.
Laboratory evaluation
In both patient groups the clinical diagnosis of  pertussis had been confirmed 
by the finding, in sera obtained within 3 months after onset of  disease, of  a sig-
nificant (i.e. > fourfold) increase of  IgG-PT in paired sera to a level of  at least 
20 U/ml, or by the finding of  a high IgG-PT concentration in a single serum 
sample, i.e. above a defined diagnostic cut-off  of  100 U/ml as measured in an 
in-house IgG-PT ELISA of  the National Institute of  Public Health and the 
Environment, Bilthoven, The Netherlands.19 Previously, it was shown that the 
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sensitivity of  these criteria for diagnosis of  actual or very recent infection with 
Bordetella pertussis was 90% in paired sera of  two groups of  patients with culture- or 
PCR-confirmed pertussis, studied several years apart (respectively n = 89 and n 
= 56).19,25 The specificity of  these criteria in paired sera of  control patients with 
respiratory infection of  other aetiology (n = 58) was 96%.25 The specificity of  the 
>100 U/ml criterion for single sera was 99% when assessed in population sera (n 
= 7756), and was independent of  age.19 This ELISA, in which purified pertus-
sis toxin is coated after pre-coating with fetuine, was developed and described 
at the start of  the 1980s,26 and has been in use since then for serodiagnosis of  
pertussis for the whole country. For long-term consistency of  potency expres-
sion in U/ml a serially diluted nationally standardized reference serum is applied 
on each ELISA plate. Routinely, two dilutions (1:100 and 1:400) of  patient sera 
are used, and depending on the magnitude of  optical densities (OD) of  those 
dilutions, the OD of  one is used to calculate the IgG-PT concentration of  the 
patient serum sample relative to the defined potency of  the reference serum. 
Although the minimal quantisation in this assay is 1 U/ml, the coefficient of  
variation being ~20% in the 5–500 U/ml range, is >30% in sera with values < 5 
U/ml.27 Therefore, the detection level of  the assay is considered to be 5 U/ml. 
Due to the limited number of  dilutions of  patient sera used in the assay there 
is an upper limit of  quantitative differentiation of  500 U/ml. However, the sera 
of  patients from group B with IgG-PT > 500 U/ml were subsequently retested 
in higher dilutions (1:800, 1:1600 and 1:3200) to obtain an exact value.
Recently, the IgG-PT ELISA used here19,26 has been compared to an interna-
tionally standardized IgG-PT ELISA which was recommended by the United 
States’ Food and Drug Administration (FDA) for use in clinical trials of  pertussis 
vaccines, and in which the ‘lot 3 pertussis serum’ of  the FDA, with a predefined 
content of  IgG-PT in IU/ml, is used as reference serum.27–29 It was shown by 
Giammanco et al.29 that there was a good correlation between both assays and 
that the relation between IU/ml in the internationally standardized ELISA and 
U/ml in our ELISA as calculated through linear regression of  log-transformed 
concentrations with the formula log10(U/ml) = 0.2174 + 0.8475log10(IU/ml). 
This results in 5 U/ml (detection level) = 3.7 IU/ml and 100 U/ml (diagnostic 
cut-off) = 125 IU/ml. 29
Data analysis 
IgG-PT responses show considerable variation among individual patients, as 
is clear in Figure 1. Therefore we analyse these responses with a hierarchical 
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model, allowing for variations between individual patients. For any individual 
patient the amount of  information is limited: only a few measurements at best. 
For that reason we have described longitudinal responses with a model of  the 
interaction between bacteria and the immune system. The model assumes that 
during infection bacteria are growing exponentially in the host. At the same 
time, bacteria are inactivated (killed) by antibodies (or by some action associated 
with the antibody response) according to a mass-action mechanism: inactivation 
depends on the product of  the concentrations of  bacteria and antibodies (or 
antibody-producing cells). Conversely, antibody production is controlled by the 
probability of  antibodies (or antibody-producing cells) encountering bacteria (or 
being presented with antigens derived from these pathogens). Antibody removal 
is considered an autonomous first-order process. This is the simplest possible 
model for the interaction between host and pathogen, and it is well known in 
population biology as a Lotka–Volterra model.30 The model can be formulated 
as a system of  ordinary differential equations (see Appendix).
This set of  equations can be solved numerically and the solution is used for fit-
ting to the patient data. Rather than fitting the model to data from any patient 
Fig. 1. Measured IgG-PT levels against time from infection [log10 (IgG-PT) against log10 (time)]. 
Different age groups are in separate panels; data from individual patients are connected.
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at any sampling time, individual records are fitted separately, producing a set 
of  parameters for each of  the patients. We further use population distributions 
to describe the variation of  these parameters among all the patients in an age 
group, thereby generalizing the set of  responses from individual patients to the 
age-group level. Sampling from these population distributions then allows us to 
construct generalized immune responses typical for the whole age group, instead 
of  individual patients in that group. All our conclusions are based on these pre-
dicted responses. The model is fitted by means of  a Markov Chain Monte Carlo 
(MCMC) algorithm31 that allows efficient sampling of  the parameter space for 
such complex multilevel problems. Some details are given in the Appendix.
Results
Descriptive analysis.
The age distribution of  the 87 patients in group A is given in Figure 2. Pertus-
sis-vaccination in The Netherlands at the time of  the study consisted of  four 
immunizations in the first year of  life, with a nationally produced whole-cell 
pertussis vaccine. Fifteen of  the 19 patients aged <1 year were not vaccinated at 
onset of  pertussis or were incompletely vaccinated (fewer than three immuniza-
tions). In only one of  those 15 was it documented that the patient had received 
immunizations against Bordetella pertussis after the pertussis episode [note: at the 
time of  the study it was normal practice to abandon (further) vaccination against 
Bordetella pertussis in infants who already had pertussis]. In the other 68 patients 
five were not vaccinated. For two subjects the vaccination status was unknown 
(aged 30.2 and 35.6 years).
Fig. 2. Age distribution of  pertus-
sis cases from the two studies (note 
that these are 2-year categories, dif-
ferent from the age categories used 
for analysis). Patients<18 years are 
from group A (□), those >65 years 
from group B (■). Adults (18–65 
years) are either parents of  children 
in group A, or from group B.
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In three of  the 87 patients in group A during serological follow-up after per-
tussis a second infection with Bordetella pertussis was serologically documented, 
respectively 3.4, 5.8 and 6.6 years after the first (see below for details). In those 
three patients the follow-up of  the first infection with Bordetella pertussis was 
considered to have ended with the last serum sample obtained before onset of  
the second infection with Bordetella pertussis. The serological follow-up of  the 
second episode in two of  these three patients was > 6 months and inclusion of  
the follow-up of  these two second episodes therefore resulted in a follow-up in 
group A of  89 episodes of  infection with Bordetella pertussis in 87 patients. From 
the 89 follow-up periods in group A, 403 sera were available. The distribution 
of  those sera over time since the onset of  pertussis is shown in Table 1. The 
mean number of  sera for each follow-up period was 4.5 (range of  2–12). As 
shown in Figure 3 the time between onset of  infection with Bordetella pertussis 
and obtaining the last follow-up serum sample ranged from 6 months to 10.7 
years, with a median of  3.1 years. 
The age distribution of  the 34 patients of  group B is also given in Figure 2. Since 
the national vaccination programme in The Netherlands against pertussis started 
in 1952, the 33 patients of  group B who were born before 1952 (i.e. all the nuns) 
had not been vaccinated. The one patient born after 1952 (the employee) had 
been completely vaccinated. From the 34 pertussis episodes of  the 34 patients 
of  group B 99 sera were available, with 64 sera in the first 6 months after onset, 
six sera from six patients in the second half  year, and 29 sera from 29 patients 
in the second year (Table 1). The mean number of  sera per patient/episode was 
2.97 (range of  2–3). The time between onset of  pertussis and obtaining the last 
follow-up serum sample ranged from a minimum of  11.1 months to a maximum 
of  13.6 months, with a median of  12.6 months.
Categorization of  IgG-PT values (< 5, 5–20, 20–100, 100–400 and > 400 U/ml) 
and of  time elapsed since onset of  pertussis (0–6 months, 6–12 months,1–2 
years, 2–4 years, 4–6 years, 6–11 years) yielded the results shown in Table 1. All 
89 episodes followed in group A were associated with an IgG-PT of  > 100 U/ml 
at some time-point in the first 6 months after pertussis, while in the second half  
year and in the second year after pertussis the IgG-PT in >70% of  cases had 
fallen below the level of  100 U/ml and in some cases had already fallen below 
the detection level of  5 U/ml. Six to 11 years after pertussis the IgG-PT had 
declined to < 5 U/ml in five out of  eight cases (62%); in the other three IgG-PT 
had declined to a level between 5 and 20 U/ml (Table 1).
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Of  the patients of  group B 95% had an IgG-PT value of  > 100 U/ml at some 
point in the first 6 months after pertussis (Table 1). In the two patients with IgG-
PT< 100 U/ml in the first 6 months, a more than fourfold increase of  IgG-PT 
in paired sera to a value between 50 and 100 U/ml had been found during the 
pertussis episode. In the second half  year and in the second year after onset of  
pertussis > 70% of  the patients of  whom sera of  that period were available had 
an IgG-PT of  < 100 U/ml and in one patient a value < 5 U/ml was found in 
the second year after infection. 
The distribution of  IgG-PT categories in groups A and B in the first 6 months 
after infection (for each individual the highest value in that period is taken) and 
in the second year after infection (also highest value) are remarkably similar sug-
gesting that the rate of  decline over time in both groups was similar (Table 1).
Table 1. Percentages of  pertussis episodes with indicated category of  IgG-PT serum-concentra-
tion within the indicated time category.
Time after onset of  disease
0-6 mo. > 6-12 mo. > 1-2 yr > 2-4 yr > 4-6 yr > 6-11 yr
Group A
No. Episodes (no. Sera) 89 (180) 39 (49) 32 (44) 48 (75) 30 (40) 8 (15)
IgG-PT concentration (U/ml)
> 400 57 5 0 0 0 0
> 100 to ≤ 400 43 18 19 0 0 0
> 20 to ≤ 100 0 51 41 42 27 0
> 5 to ≤ 20 0 26 28 48 46 38
≤ 5 0 0 12 10 27 62
Group B
No. Episodes (no. Sera) 34 (64) 6 (6) 29 (29)
IgG-PT concentration (U/ml)
> 400 74 0 7
> 100 to ≤ 400 21 17 14
> 20 to ≤ 100 5 83 48
> 5 to ≤ 20 0 0 24
≤ 5 0 0 7
Separate data for group A (89 episodes in 87 patients) and group B (34 episodes in 34 patients). 
Times in months (mo.) or years (yr). In case of  availability of  multiple sera from one episode within 
one time category, the serum with the highest value has been used. Apart from the numbers of  
episodes with at least one serum available in the indicated time category (no. episodes) also the total 
numbers of  sera available from those episodes in that time category (no. sera) is indicated
Re-infections 
In the three patients in group A with re-infection after 3.4, 5.8 and 6.6 years, 
the maximum IgG-PT titre in the first months after the first typically sympto-
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matic infection was > 500, > 500 and 248 U/ml respectively, the high titres had 
declined in sera obtained after 2.8, 2.9 and 3.1 years respectively (i.e. the last 
serum sample before onset of  the second episode of  infection), to 10, 8 and 6 
U/ml respectively. The maximum IgG-PT titre reached in the first months after 
onset of  the second episode was 492, 156 and 270 U/ml respectively. The patient 
with re-infection after 3.4 years (first infection at age 4.2 years) had had a very 
mild cough, lasting 1 week, 4 weeks before sampling of  the serum in which a 
high IgG-PT, diagnostic of  very recent infection, was found. At the same time 
a sibling had serologically confirmed pertussis. The patient with re-infection 
after 5.8 years (first infection at age 0.4 years) was discovered when blood was 
sampled at that time for other reasons; the parents recalled no recent coughing 
illness. The patient with re-infection after 6.6 years (first infection at age 2.7 
years) suffered from mild coughing during 3 weeks; besides the finding of  a high 
IgG-PT concentration diagnostic for very recent infection, this patient was also 
pertussis-PCR positive.
In Figure 3 the times (after first infection) of  occurrence of  the three re-infec-
tions have been indicated. It can be seen that the one re-infection after 3.4 years 
was among 40 patients with a follow-up of  3.4 years or more (2.5%), the one 
re-infection after 5.8 years was among nine patients with a follow-up of  5.8 years 
or more (11%) and the one re-infection after 6.6 years was among four patients 
with a follow-up of  6.6 years or more (25%).
Fig. 3. Number of  times 
patients of  group A have 
been in the study; numbers of  
patients as a function of  the 
time between onset of  disease 
and last serum sample. The 
arrows denote time points of  
confirmed re-infections (one 
at each time point).
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Analysis in the dynamic model
For analysis in the dynamic model, all patients of  group A and B were divided 
into seven age groups: (a) < 1 year (n = 19), (b) 1–4 years (n = 19), (c) 4–7 years 
(n = 21), (d) 7–18 years (n = 23), (e) 18–65 years (n = 14; seven from group A, 
seven from group B), (f) 65–80 years (n = 11), and (g) > 80 years (n = 16).
Figure 1 shows the individual responses of  IgG-PT to infection with Bordetella 
pertussis in the seven different age groups. In age groups (a)–(d) and part of  
group (e) (i.e. the 7 patients derived from group A) the IgG-PT concentrations 
are censored at an upper level of  500 U/ml (see “Laboratory evaluation” section 
above). In part of  group (e) (i.e. the 7 patients derived from group B) and in 
groups (f)–(g) the non-censored IgG-PT concentrations are given. The regression 
model allows for censoring of  IgG-PT data from group A (as reported previ-
ously24), making groups A and B comparable. Note that in Figure 1, both, IgG-PT 
concentrations and time elapsed since onset of  pertussis, are logtransformed. In 
this manner both the rapidly increasing as well as the slowly decreasing phase of  
the immunoresponse can be shown in a single graph.
In Figure 4 the estimated variation in individual IgG-PT responses in the differ-
ent age groups, as calculated in the dynamic model, is shown as the median (50th 
percentile) and the 5th and 95th percentiles of  simulated responses for each age 
group. In all groups there is considerable variation. The older groups (e)–(g) tend 
to have a higher median peak response, also with a wide range. The time to reach 
peak levels seems inversely correlated with age (Table 2). Group (b) (1–4 years) 
seems to have the lowest predicted peak level (Table 3) and the longest time to 
reach peak levels (Table 2). However, the response range in the 1–4 years age group 
was wide and overlapped the corresponding ranges in the other age groups. The 
Table 2. Predicted times (in months post onset of  symptoms), to reach peak levels of  the IgG-PT 
response, and (during the declining phase of  the IgG-PT response) to reach 100 U/ml and times 
to reach 5 U/ml: Q0.05–0.50–0.95=5th, 50th (median) and 95th percentiles.
Age (years)
Time to peak Time to 100 U/ml Time to 5 U/ml
Q0.05 Q0.50 Q0.95 Q0.05 Q0.50 Q0.95 Q0.05 Q0.50 Q0.95
0-1 0.55 1.18 2.94 1.34 8.28 38.90 15.11 36.48 104.36
1-4 0.47 1.45 2.72 1.48 5.30 97.83 4.63 26.27 257.39
4-7 0.41 0.96 1.86 1.80 14.06 34.40 21.74 62.06 159.55
7-18 0.38 0.77 1.63 3.12 12.25 29.09 20.11 47.93 113.90
18-65 0.09 0.31 1.34 2.29 8.73 25.23 4.56 23.16 100.32
65-80 0.14 0.45 1.20 2.73 10.63 24.61 8.63 25.48 75.67
³ 80 0.15 0.40 1.52 2.08 6.61 19.44 3.75 17.13 68.55
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Fig. 4. Predicted IgG-PT antibody responses to infection in each of  the age groups, on a log10 
(IgG-PT)-log10 (time) scale to show both initial rise and final decline of  the responses. Intervals 
show (95%) range of  variation in response among individual patients. Circles indicate observed 
IgG-PT titres. Also indicated are 3 weeks and 1 year past onset of  symptoms (vertical lines), and 
IgG levels (horizontal lines) of  5 U/ml (detection level), and 100 U/ml (diagnostic cut-off).
Table 3. Predicted peak levels (U/ml) of  the IgG-PT response : Q0.05–0.50–0.95 = 5th, 50th (median) 
and 95th percentiles.
Peak titre (U/ml)
Age (years) Q0.05 Q0.50 Q0.95
0-1 85.9 244.3 624.7
1-4 46.2 136.2 575.1
4-7 100.3 213.0 621.6
7-18 124.3 303.0 653.7
18-65 138.7 695.2 2631.6
65-80 188.2 792.6 2384.6
> 80 162.1 720.5 2503.3
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median time-periods in the different age groups for IgG-PT to reach the peak 
level, and to decline to levels of  respectively < 100 U/ml (the diagnostic cut-off) 
and < 5 U/ml (detection level) are given in Table 2. These data also indicate 
that there might be an age-dependent tendency for older people to have a faster 
decline. Eventually, the median time for Ig-PT to decrease below the detection 
level of  5 U/ml varied by age group from 1.4 to 5.2 years, with wide inter-indi-
vidual variations (Table 2).
The estimated variation in the older groups (e)–(g) is higher than in groups (a)–(d). 
While it cannot be excluded that this is also – in part – caused by the influence of  
censoring, it should also be noted that the records of  older patients (of  group B) 
consist of  fewer measurements (two or three) than those of  the juvenile patients 
(of  group A). We checked the influence of  censoring by recalculation after arti-
Fig. 5. Age profiles of  (log10) IgG-PT responses : predicted antibody levels against age (category) 
at various times from infection. As in Figure 4 the intervals show (95%) range of  variation in 
response among individual patients.
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ficially censoring the data from group B, finding similar results, confirming that 
correction for censoring of  the data from group A in the dynamic model was 
appropriate (data not shown).
In Figure 5 the predicted age profile of  IgG-PT responses at different time-points 
after onset of  pertussis is given (10, 20, 50, 100, 200, 365 and 730 days). At 10 
and 20 days there is large variation in response in all age groups, possibly partly 
due to large variations in the rapidity of  the increasing phase of  the IgG-PT 
response to infection, and possibly partly due to inaccurate reports of  the first 
day of  the disease. However, at both time-points the IgG-PT concentrations 
in the three adult subgroups tended to be higher, suggesting that the IgG-PT 
response to infection in adults may be somewhat more rapid. At 50 and 100 
days all predicted median IgG-PT levels are >100 U/ml and the variation of  
responses is small, without substantial differences among age groups, although 
peak responses in the oldest two subgroups appeared to be somewhat higher. 
At 200 days antibody decay has started in all age groups.
In the older patients (65 to < 80 and > 80 years) there seemed to be a tendency 
towards a more rapid decline of  IgG-PT after 365 and 730 days than in younger 
patients. The second youngest age group (1–4 years) appears to show a response, 
which is slightly different from the other age groups (slower increase, lower mag-
nitude). As already stated, data in this group show markedly high dispersion, as 
may also be appreciated by comparing error bars (illustrating variation) in Figure 
5 (see also Fig. 4 and Tables 2 and 3).
Discussion
This study of  121 pertussis patients aged 0–94 years shows that elevated levels 
of  IgG-PT induced by infection with Bordetella pertussis consistently decline again 
to below detection levels within several years, unless this course is interrupted by 
re-infection with Bordetella pertussis, which was observed in three cases. In each of  
the different age groups there was wide variation in rapidity, intensity and rate 
of  decay of  IgG-PT and between groups there was a wide overlap of  the ranges 
of  these variables. Although the pattern of  IgG-PT response is not significantly 
age dependent, there was a tendency for the IgG-PT response after infection to 
be faster and stronger and the decay to be more rapid with increasing age. The 
pattern in the 1–4 years age group was different from all other age groups in that 
the IgG-PT response tended to be slower mounting and smaller in amplitude 
and in most cases decayed rapidly. 
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Our study is unique with respect to the high number of  participating patients, the 
wide age range of  the patients, the long follow-up times in part of  the patients, 
and also the method of  analysis, using a hierarchical model for induction and 
decay of  antibodies after infection. The few studies of  the course of  IgG-PT 
after infection with Bordetella pertussis that have been published all show decline 
over time, but assessment of  possible differences in children and adults is lack-
ing and follow-up times are relatively short. In the studies of  Hodder et al.9 
and Heininger et al.32 the course of  IgG-PT over a period of  20 months after 
pertussis in 48 adults aged > 65 years9 and over a period of  28 months in 11 
adults32 was remarkably similar to the pattern over the same time span in adults 
in our study. In those studies the internationally standardized IgG-PT ELISA, 
recommended by the FDA was used, of  which the relationship with our ELISA 
is known (see Materials and Methods section.29). For instance, the geometric 
mean IgG-PT titre of  11 adult pertussis patients was 242 IU/ml at 2 months 
after onset of  infection and 45 IU/ml at 28 months after onset.32 However, in 
none of  those patients did IgG-PT decline below detection levels, which may 
be related to the limited follow-up time. Two other studies, one comprising both 
adults and children2 and one comprising young children,33 also showed a signifi-
cant decline of  geometric mean IgG-PT titre 1 year after pertussis. The study 
with the longest follow- up time was from Tomoda et al. who measured IgG-PT 
during an outbreak of  pertussis in a semi-closed adult community and again 5 
years later.34 He showed that in the large majority of  21 pertussis patients in that 
outbreak (37.5 + 12.1 years) IgG-PT was > 50 U/ml several weeks after onset 
of  pertussis; 5 years later the IgG-PT in all patients had declined to < 10 U/ml 
and in most to undetectable levels. These findings support our conclusion that 
in the majority of  cases or perhaps in all cases of  pertussis, the subsequent decay 
of  infection-induced IgG-PT does not level off  well above detection thresholds 
but progresses to undetectability.
The relatively short persistence in all age categories of  infection-induced peak 
levels of  IgG-PT, supports our previous finding that a diagnostic cut-off  of  
100 U/ml (equivalent to 125 IU/ml) for serodiagnosis of  actual or very recent 
infection with Bordetella pertussis is valid for all ages.19 Although vaccination can 
induce IgG-PT levels > 100 U/ml, interference with serodiagnosis of  pertussis 
is minimal because IgG-PT induced by vaccination with wholecell pertussis vac-
cines or acellular pertussis vaccines also declines quite rapidly. Multiple studies 
show a decrease after primary and booster vaccination to very low or undetect-
Age-specific IgG course after symptomatic Bordetella pertussis infection
64
able levels within 1–8 years.13,35–38 For instance, Taranger et al.39 followed 813 
children after pertussis vaccination with a monovalent pertussis toxoid vaccine. 
There was a strong IgG-PT response to a geometric mean of  143 IU/ml at 1–2 
months after vaccination and a rapid decrease to a geometric mean of  8 IU/ml 
at 21–32 months after vaccination.
One explanation for our finding of  a relatively slow and low IgG-PT response 
in the 1–4 years age group, the large majority of  whom had been (recently) vac-
cinated, might be, that children who suffer from Bordetella pertussis infection shortly 
after vaccination, are a separate category, i.e. are children with a relatively poor 
immunoresponse to pertussis antigens. Indeed, Taranger et al.39 showed that 
previously vaccinated children who within 33 months of  completing vaccination 
developed pertussis upon exposure in their household had had a significantly 
lower IgG-PT response 1–2 months after the third vaccination with a mono-
component (PT) acellular vaccine (mean peak response 79 U/ml) than children 
who did not develop pertussis upon household exposure within that time-frame 
(mean peak response after vaccination 212 U/ml). 
The tendency of  the IgG-PT response to be more rapid and strong with increas-
ing age may indicate the involvement of  specific memory immunity through 
encounters with Bordetella pertussis antigens earlier in life. Also Granström et al.40 
have shown that adults have a faster peak response than children after a natural 
infection. The intuition that such rapid and strong responses would persist evi-
dently longer, is not true. The rapid decay of  IgG-PT after a rapid and strong 
response may be explained by a faster eradication of  the pathogen and shorter 
duration of  antigenic stimulation of  the immune system. The phenomenon 
as such has been noted before: Blennow & Granström41 showed that children 
receiving a booster vaccination with an acellular vaccine, containing pertussis 
toxin and filamentous haemagglutinin, showed a more rapid decay of  neutral-
izing antibodies to pertussis toxin in the Chinese hamster ovary cells (CHO) 
assay, than after the primary vaccination, despite the fact that after the booster 
vaccination the median of  the neutralizing antibody titres was higher than after 
the primary vaccination.
The three re-infections documented in this study were in children whose IgG-PT 
at the time of  the second infection had declined to < 10 U/ml. Although the 
number of  re-infections was small, their timing and incidence was compatible 
with the statement that natural infection initially induces protection against 
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re-infection but that susceptibility to (re)-infection re-emerges when IgG-PT 
concentrations have fallen to < 10 U/ml and that subsequently, susceptibility 
for disease in association with infection increases over time. In a previous paper, 
we have described two other patients who had infection with Bordetella pertussis 
12 years after the first episode. In contrast to the three re-infections 3.4, 5.8 
and 6.6 years after the first in this study, the re-infections after 12 years were 
associated with typical symptoms, i.e. long-lasting paroxysmal cough.12
In conclusion this study shows that the high IgG-PT concentrations induced by 
infection with Bordetella pertussis consistently decline to low or undetectable levels 
within 5–6 years, this decline is associated with emergence of  susceptibility for 
re-infection and disease. Although the pattern of  decline is largely independent 
of  age, there is a tendency for older people to have a more rapid increase, higher 
peak and faster decline. This study also shows that a diagnostic cut-off  of  100 
U/ml is not only valid in children,19 but is true for all ages.
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Appendix
The predator–prey model of  the interaction between the immune system and 
invading bacteria can be formulated as:
Where:
x(t) = pathogen concentration
y(t) = antibodies
a = pathogen growth rate
b = antibody-dependent pathogen inactivation
c = antibody decay rate
d = pathogen-dependent antibody production rate
Numerical solutions to these equations (a simple analytical solution does not exist) 
can be fitted to the longitudinal antibody data, treating the unknown pathogen 
concentration as a nuisance variable. 
Measurement errors were assumed lognormal: both data and model function 
were log-transformed (TBS: transform both sides) so that we could use a nor-
mal likelihood function. This also allows treatment of  censoring as previously 
reported.24 Variation between individual patients is considerable, we therefore 
used a hierarchical Bayesian model. 
For statistical analysis, parameters were transformed:
u = √ac  w = √bd 
v = √a/c  z = √b/d 
and these new parameters were log-transformed, to restrict them to positive 
values. Parameters u and v were assumed equal in all patients, w and z vary among 
individuals. Parameter estimation for the hierarchical model was performed using 
a MCMC method, employing the Metropolis–Hastings algorithm.31
Posterior predictive intervals for the longitudinal response to pertussis were 
constructed by applying the longitudinal model to a parameter sample from the 
MCMC output (by addition of  a subject with missing data only, for convenient 
sampling from the population parameter distributions).
x′(t)=ax(t)-bx(t)y(t)           x(0)=x0 
y′(t)=-cy(t)+dx(t)y(t)          y(0)=y0,
{ {
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Abstract
Background. An accurate, practical laboratory test is needed to confirm clinical 
diagnosis of  pertussis in adults during the first 3 symptomatic weeks, when treat-
ment is effective and transmission can be interrupted.
Methods. The sensitivity and specificity of  single IgA and IgG levels were assessed 
in a cohort study of  a pertussis epidemic in 99 adults in a closed community. 
Sensitivities were assessed in the sera of  46 laboratory confirmed clinical pertussis 
cases during the first 3 weeks. Specificities were calculated in sera of  35 asymp-
tomatic controls without clinical symptoms or laboratory confirmed infections 
from the same community (internal controls). We compared these specificities 
with the specificities of  single IgA and IgG levels in 4275 external controls from 
a cross-section of  the general Dutch population aged 21-79 years who had not 
coughed for more than 2 weeks in the past year, and without pertussis diagnoses. 
The study was done in the Netherlands when whole-cell pertussis vaccine was 
used in the national vaccination programme.
Results. Levels of  24 U/ml for IgA and 27 U/ml for IgG gave sensitivities of  
100% and 75%, respectively, in the first 2 weeks, 100% in the third week, and 
97% after the fourth week. The levels were reached within 2 days after onset 
of  increase, and remained above these levels for roughly 7.2 and 5.1 months, 
respectively. Specificity was 82% for IgA and 89% for IgG in the internal controls 
and 90% in the external controls, respectively.
Conclusions. We suggest levels of  24 U/ml for IgA and 27 U/ml (= 27 Interna-
tional Units (IU)/ml) for IgG as sensitive, specific, and practical for laboratory 
confirmation of  clinical pertussis in adults in the first 3 weeks of  outbreak 
management.
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Background
Pertussis is a bacterial infection caused by Bordetella pertussis. Despite the intro-
duction of  mass vaccinations in the Netherlands in 1952 and other countries, 
pertussis is still an endemic disease with regular epidemic outbreaks.1-5 In unvac-
cinated populations, pertussis morbidity and mortality occur predominantly in 
those 15 years or younger.6 In vaccinated populations, pertussis is more likely 
to be found in older children and adults.7-13 Circulation of  Bordetella pertussis in 
vaccinated children, adolescents, and adults plays an important role in the con-
tinuing transmission of  the pathogen to infants too young to be vaccinated, in 
whom the disease is the most severe and sometimes fatal.14-19
Pertussis is most infectious in its prodromic and early clinical stages. Effective 
management in unvaccinated infants and during outbreaks requires early diagnosis 
and treatment of  cases, accompanied by antibiotic prophylaxis of  contacts.20,21 
There is no evidence of  benefit from chemoprophylaxis given more than 21 days 
after the onset of  the primary case.22,23 Therefore, antibiotic management of  
pertussis should be initiated promptly to minimize secondary spread.24 For the 
improvement of  clinical diagnosis and pertussis surveillance, rapid, easily acces-
sible, highly sensitive and specific laboratory methods are needed to diagnose 
pertussis in the first 3 weeks.25 
The validity of  methods for pertussis diagnosis depends on the time of  initiation. 
Early in the disease, culture and Polymerase Chain Reaction (PCR) can be used. 
Culture of  Bordetella pertussis is highly specific, but laborious and insensitive.26 
The yield progressively decreases during disease27 and is low after 2 weeks and 
antibiotic use.28 The sensitivity of  PCR is superior, but rapidly decreases with 
increasing duration of  the disease and patient age.29,30 Serology is a good alter-
native.29,31,32 In this study, we assessed the sensitivity and specificity of  single 
IgA and IgG antibody levels for laboratory confirmation of  clinical pertussis in 
adults during the first 3 weeks of  symptoms. The study was done in The Neth-
erlands when whole-cell pertussis vaccine was used in the national vaccination 
programme.
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Methods
Study population
The clinical and laboratory outcomes of  a pertussis epidemic in a religious con-
vent, which has been described previously, was used as a sample population to 
evaluate single IgA and IgG levels after other causes for an outbreak of  coughing 
were excluded.12 
In short, the epidemic was reported to the Municipal Public Health Service 
(MPHS) in its 9th week for outbreak management, at which time the study began. 
The convent was a nursing home for 75 elderly resident nuns supported by 24 
non-resident personnel. The personnel consisted of  3 males and 21 females. The 
mean age was 75 years (range 55-94 years) for the nuns and 27 years (range 21-
46 years) for the personnel. All of  the nuns and 5 of  24 non-resident personnel 
had never been vaccinated against pertussis. The nuns and staff  shared common 
social and religious activities, and shared meals in the dining room. Pertussis cases 
were cared for in the convent by nuns and personnel. Retrospective interviews 
based on structured questionnaires were conducted to obtain information about 
the onset of  characteristic clinical symptoms in first 9 weeks of  the epidemic. 
The emergence and duration of  the clinical manifestations were prospectively 
monitored daily from week 9 up to week 13, the period that the epidemic persisted 
with new cases. After week 13, cases were monitored weekly until symptoms 
subsided. 
Two nasopharyngeal swabs were obtained from each individual at weeks 9 and 
13 of  the epidemic, one for culture and one for PCR. 
At weeks 9, 13, and 60 serum samples were obtained to determine IgA and IgG 
antibody levels. 
Definitions
Laboratory confirmed Bordetella pertussis infection was defined as one of  the laboratory 
findings: 1) Bordetella pertussis strain isolated from the nasopharynx; 2) reactive 
PCR; 3) significant (at least 4-fold) increases or decreases33,34 of  IgA or IgG 
antibody levels between at least one pair of  serum samples obtained at weeks 9, 
13, and 60 of  the epidemic; and 4) IgG level ≥ 100 U/ml at weeks 9 or 13 of  
the epidemic35 (equivalent to 125 International Units (IU)/ml).12 
We defined clinical pertussis as a persistent cough and its duration was divided in 
“7-13 days” and “at least 14 days”.36 
Pertussis cases had both laboratory confirmed Bordetella pertussis infection and 
clinical pertussis. 
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The index case was the first pertussis case in the epidemic. 
Pre-epidemic cough was defined as a cough that occurred before the emergence of  
the index case. 
Internal controls had no laboratory confirmed Bordetella pertussis infection and were 
asymptomatic residents or non-resident personnel, i.e. they had no pre-epidemic 
cough nor clinical pertussis.
Sensitivities of  different IgA and IgG levels were calculated as the proportion of  
serum samples with a positive test result. The calculations were done in samples 
obtained from pertussis cases who had coughed for at least one day during their 
period of  clinical pertussis. 
Specificities of  different IgA and IgG levels were calculated as the proportion 
of  serum samples with a negative test result. These calculations were done in 
samples obtained from the internal controls. 
Specificities were also calculated in 4275 external controls from a cross-section of  
the general Dutch population in the same age group (21-79 years) as the convent 
population. Control subjects reported in a structured questionnaire to have not 
coughed for more than 2 weeks in the past year, nor to have had a physician-
diagnosed pertussis.35,37 From the external controls, specificities of  different IgA 
and IgG levels were calculated as the proportion of  the 4275 serum samples 
with a negative test result. 
The duration of  waxing and waning of  IgA and IgG concentrations
To estimate the time period after which single IgA and IgG concentrations can 
be reused as a diagnostic test for a subsequent pertussis infection, we assessed 
the duration (in days) of  waxing and waning of  IgA and IgG concentrations after 
a Bordetella pertussis infection. Therefore we first calculated the geometrical mean 
concentration (GMC, U/ml) over the highest IgA and IgG levels obtained in week 
9 and 13 of  the epidemic for all subjects with a significant increase or decrease 
of  antibody level. In these subjects we then calculated the mean rate of  increase 
(expressed as U/ml/day) towards the GMC and the mean rate of  decrease from 
the GMC downwards. This was done for IgA and IgG separately.
Laboratory methods
In the two populations, the serological laboratory investigation of  pertussis spe-
cific IgA and IgG antibodies was performed by enzyme-linked immunosorbent 
assay (ELISA) at the National Institute for Public Health and the Environment 
(RIVM), the Netherlands, as described previously.12,31,35,38 For IgA class antibody 
detection, a crude cell-wall preparation of  Bordetella pertussis was used. For IgG 
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class antibody detection, purified pertussis toxin was used. Antibody binding 
activities were quantitatively expressed in ‘local’ units per millilitre (U/ml). IgG 
can be converted to Food and Drug Administration (FDA) international units 
(IU) non-linearly by the formula log10(U/ml) = 0.2174 + 0.8475log10(IU/ml).
39,40 
The detection limit of  the assays was 5 U/ml.35 
In our evaluation of  sensitivities and specificities of  single IgA and IgG levels, 
we focused on levels at least 4 times the detection limit. 
Culture and PCR were processed as described previously.12,30,41
Results
Convent population
The convent population consisted of  75 nuns and 24 personnel. All 99 individu-
als participated in the study. The pertussis epidemic started in week 1 with the 
emergence of  the first case with laboratory confirmed pertussis infection. The last 
case was detected in week 13. During the study, 6 residents died resulting in 99, 
99, and 93 study subjects in weeks 9, 13, and 60 of  the epidemic, respectively.
Clinical outcome
Retrospective evaluation of  weeks 1-9 of  the epidemic revealed 2 subjects with 
a pre-epidemic cough, 3 subjects with clinical pertussis of  7-13 days duration, 
and 41 with clinical pertussis coughing 14 days or more. Prospective evaluation 
in weeks 9-13 of  the epidemic revealed another 6 subjects with clinical pertus-
sis coughing 14 days or more and 47 with no cough (Table 1). Clinical pertussis 
persisted for a mean period of  69 days (range: 7-268 days).  
Laboratory outcome
At weeks 9, 13, and 60 of  the epidemic 94, 97, and 85 serum samples, respec-
tively, were obtained. Three samples were collected from 80 subjects, and 2 from 
17 subjects. One serum sample was obtained from one resident with, and one 
resident without clinical pertussis. Of  the 99 subjects, 51 showed a significant 
increase or decrease in IgA or IgG between week 9, 13 and 60 of  the epidemic, 5 
of  whom also had either a positive PCR or culture. Additionally, 7 subjects had a 
single IgG level of  ≥ 100 U/ml at week 9 or 13 of  the epidemic, with no further 
significant increase or decrease of  IgA or IgG. This resulted in 58 subjects with, 
and 41 without laboratory confirmed pertussis infection (Table 1).
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Pertussis cases for sensitivity and internal controls for specificity 
calculations
Table 1 shows the source data for the sensitivity calculations, the 46 pertussis cases 
(45 cases with clinical pertussis coughing 14 days or more and 1 case coughing 
11 days, all with laboratory confirmed pertussis infection) and the 35 internal 
controls who had no cough and no laboratory confirmed pertussis infection. 
The mean age of  the cases and internal controls was 77 years (range: 21-86 years) 
and 56 years (range: 22-91 years), respectively.
The levels of  IgA and IgG obtained from the 46 pertussis cases and the 35 inter-
nal controls are shown in Table 2. The GMC of  IgA and IgG in the 46 pertussis 
cases was significantly higher (p < 0.001) in all sampling weeks compared to the 
35 internal and 4275 external controls.
Table 1. Outcome of  clinical and laboratory investigations in absolute numbers in the convent 
population (N=99).
Outcome of  laboratory tests for pertussis 
infection
Clinical Outcome Total
Clinical 
pertussis
coughing 
> 14 days 
Clinical 
pertussis
coughing 
7-13 days
Pre-
epidemic 
cough
No 
cough
(n=47)c (n=3)c (n=2) (n=47)e (N=99)
Laboratory confirmed pertussis infection 45b 1b 0 12f 58
IgA or IgG 4-fold increase or decrease between 
week 9, 13 and 60 of  the epidemic
41 1 0 9 51
IgG ≥ 100 U/ml at week 9 or 13 of  the 
epidemic, no IgA or IgG 4-fold increase or 
decrease
4 0 0 3 7
Details of  laboratory confirmed pertussis findings
- IgG ≥ 100 U/ml 41 0 0 6 47
- IgA 4-fold increase 8 1 0 2 11
- IgA 4-fold increase or decrease 22 1 0 5 28
- IgG 4-fold increase 6 1 0 2 9
- IgG 4-fold increase or decrease 39 1 0 9 49
- PCR or culture positivea 5 0 0 0 5
No laboratory confirmed pertussis infection 2 2 2 35d 41
a All culture and PCR positive subjects had a significant increase of  IgA or IgG as well
b Pertussis cases for sensitivity calculation
c Subjects for calculations of  spectrum bias in sensitivity
d Internal controls for specificity calculation
e Subjects with no cough for calculations of  spectrum bias in specificity
f  Subjects with asymptomatic pertussis infection
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Figure 1a and 1b. The course of  IgA and IgG. The course of  IgA (Figure 1a) and IgG (Figure 
1b) levels obtained in all 89 serum samples from the 46 pertussis cases obtained in week 9 and 
13 of  the pertussis epidemic in the convent population (n=99). Pertussis cases had a laboratory 
confirmed Bordetella pertussis infection and a clinical pertussis (see methods).
The levels are related to the first day of  cough of  the pertussis cases. Six serum samples were 
obtained from cases before they started coughing and 83 samples were obtained from cases who 
had been coughing for between 1 and 87 days. Lines connect samples obtained from one subject.
Dotted lines are from the 5 subjects with a positive culture or PCR.
a
b
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Course in time of  IgA and IgG in pertussis cases
Figure 1 shows the longitudinal courses of  the 89 IgA and IgG concentrations 
obtained from the 46 pertussis cases in weeks 9 and 13 of  the epidemic, as 
related to the onset (day 0) of  the clinical period (coughing). Six pre-clinical and 
83 clinical serum samples were obtained from the 46 pertussis cases. The earli-
est serum sample was obtained 19 days before, and the latest one 87 days after 
the onset of  cough. 
The general pattern of  IgA (Figure 1a) shows a more consistent increasing and 
decreasing pattern compared to IgG (Figure 1b). IgG concentrations reached 
higher levels than IgA concentrations and tended to decrease more rapidly to 
relatively lower levels earlier in the clinical period compared with IgA. From 3 of  
the 5 PCR or culture positive cases (dotted lines in the figures), the first serum 
samples were obtained before the onset of  the cough. These 3 cases showed at 
least 4-fold increases of  IgA and IgG levels, starting from below 5 U/ml.
Sensitivity and specificity of  single IgA and IgG levels for estimating 
optimal cut-off  values
Figure 2 shows the sensitivities of  single IgA and IgG levels calculated in the 83 
serum samples obtained in week 9 and 13 of  the epidemic from the 46 pertussis 
cases who had been coughing for at least one day during their period of  clinical 
pertussis.
Sensitivities of  different levels of  IgA (24-74 U/ml) and IgG (27 - 90 U/ml) ranged 
from 98% to 75% and 95% to 81%, respectively. The sensitivity of  IgG was 80% 
Table 2. The Geometrical Mean Concentration (GMC), with 95% CI, of  serum samples from 
pertussis cases and from internal controls at week 9, 13 and 60 of  the epidemic, and of  the 
serum samples from the external controls (n=4275).
Subjects and time of  sampling 
during the pertussis epidemic
Number
of  samples
IgA IgG
GMC 95% CI GMC 95% CI
Cases (n=46)
- week 9
- week 13
- week 60
43
46
40
123
172
60
75 – 202
121 – 244
40 – 89
252
355
34
119 - 535
235 - 537
22 – 53
Internal controls (n=35) 
- week 9
- week 13
- week 60
- week 9, 13 and 60 combined
34
34
29
97
9.4
7.8
6.6
7.9
6.4 - 13.7
5.2 – 11.6
4.4 – 9.9
6.3 – 9.9
6.0
3.8
2.8
4.1
3.9 – 9.3
2.4 – 6.1
1.8 – 4.2
3.1 – 5.3
External controls (n=4275) 4275 8.5 7.9 – 9.1 7.4 6.7 – 8.3
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Figure 2. Sensitivity and specificity of  different IgA (Figure 2a) and IgG (Figure 2b) antibody 
levels (U/ml). To estimate optimal cut-off  levels, antibody levels against Bordetella pertussis from 
the convent population during the pertussis epidemic are used.
Sensitivities (-□-) are calculated in the 83 serum samples obtained in week 9 and 13 of  the epidemic, 
from the pertussis cases (n=46) who had been coughing for between 1 and 87 days of  their total 
period of  clinical pertussis. Pertussis cases had a laboratory confirmed Bordetella pertussis infec-
tion and a clinical pertussis (see methods). 
Specificities (-о-) are calculated in the 68 serum samples obtained in week 9 and 13 of  the epidemic 
from the internal controls (n=35). 
Specificities (s) of  IgA and IgG (levels calculated in the sera (n = 4275) of  external controls (n 
= 4275) are indicated as well. 
The sensitivity  mark (-■-) of  the IgA level of  24 U/ml, 24 and the IgG level of  27 U/ml, 27 in 
pertussis cases and the corresponding marks with 90% specificity in the external controls (▲) are 
indicated as well.
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at 100 U/ml and 71% at 200 U/ml (not shown in Figure 2). Compared to IgG, 
sensitivities of  IgA started higher but decreased faster with increasing levels. 
To probe spectrum bias42 in the sensitivities obtained in our 46 pertussis cases, 
we also calculated sensitivities in the 91 IgA and 91 IgG levels obtained in weeks 
9 and 13 of  the epidemic of  all 50 subjects with clinical pertussis, after they had 
coughed for at least 1 day during their period of  clinical pertussis (Table 1). This 
resulted in lower sensitivities of  IgA levels (24-74 U/ml) and IgG levels (27-90 
U/ml) ranging from 90% to 69% and from 87% to 73%, respectively, while the 
sensitivity of  IgG of  100 U/ml decreased from 80% to 72%. The lower sensi-
tivities can be explained by the addition of  concentrations from three subjects 
with clinical pertussis who had been coughing for 7, 11, and 21 days, respectively, 
and with IgA and IgG levels of  at most 14 U/ml and 4 U/ml, respectively, sug-
gesting that these three subjects did not have pertussis infection. The addition 
of  a fourth subject increased the sensitivities. Indeed, this was most probably a 
missed pertussis case with 255 days clinical pertussis and highest obtained IgA 
and IgG levels of  116 and 80 U/ml, and a 3.6-fold decrease of  IgG, while we 
Table 3. Specificities in external controls (n = 4275) and sensitivities in time intervals (in days) in 
reference to the onset of  cough in pertussis cases (n = 46) of  single IgA and IgG concentrations 
(see Figure 2). Geometrical Mean Concentrations (GMC) and number of  samples are indicated.
Level (U/ml)a Specificity 
external 
controls
Sensitivity (%) in time intervals with reference to the onset of  cough
-21 to 0 d 1 to 14 d 15 to 21 d 22 to 87 d 1 to 87 d
IgA
24 90.0% 33 100 100 97 98
40 95.0% 33 63 82 95 90
52 97.5% 17 63 82 92 88
74 99.0% 17 63 64 78 75
GMC (U/ml) 11 60 136 212 177
IgG
27 90.0% 33 75 100 97 95
41 95.0% 33 75 91 95 93
65 97.5% 33 50 82 94 87
90 99.0% 33 38 82 86 81
100b 99-100% 33 38 82 84 80
GMC (U/ml) 8 48 390 506 391
No. samples 6 8 11 64 83
a Levels are obtained from the estimation of  optimal cut-off  values in Figure 2
b Used by the National Institute for Public Health and the Environment in The Netherlands for 
surveillance
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used a 4-fold change in our case definition. A 3-fold change has been accepted 
as significant in a sufficiently precise assay.43
The specificities calculated in the 68 concentrations in serum samples obtained 
from the 35 internal controls in the convent population at weeks 9 and 13 of  the 
epidemic are shown in Figure 2. Specificities of  different levels of  IgA (24-74 
U/ml) and IgG (27-90 U/ml) levels ranged from 82% to 94% and 89% to 99%, 
respectively. The specificity of  IgG was 100% at 100 U/ml. 
The specificities of  different levels of  IgA (24-74 U/ml) and IgG (27-90 U/ml) 
from 4275 sera samples from the 4275 external controls ranged from 90 to 99% 
(Figure 2). In the external controls IgA levels showed higher specificities than 
similar IgG levels. 
Table 4. Estimated waxing and waning of  IgA and IgG levels between diagnostic parameters.
Variable IgA IgG
Laboratory detection limit 5 U/ml 5 U/ml
100% sensitivity level in the 46 pertussis cases 24 U/ml 27 U/ml
90% specificity level in 4275 external controls 24 U/ml 27 U/ml
99% specificity level in 4275 external controls 74 U/ml 90 U/ml
GMC of  the highest level obtained in week 9 and 
13 of  pertussis cases with at least 4-fold increase or 
decrease between week 9, 13 and 60 of  the epidemic 
229 U/ml
(n = 28 levels)
406 U/ml
(n = 49 levels)
Average speed of  significant increase 16.0 U/ml/day
(n = 11 level pairs)
14.7 U/ml/day
(n = 9 level pairs)
Average speed of  significant decrease 1.0 U/ml/day 
(n = 18 level pairs)
2.9 U/ml/day 
(n = 46 level pairs)
Mean time to increase from detection limit to 100% 
sensitivity level
1.2 days 1.5 days
Mean time to increase from detection limit to 99% 
specificity level
4.3 days 5.8 days
Mean time to increase from detection limit to  GMC 14.0 days 27.3 days
Mean time to increase from 99% specificity level to 
GMC
9.8 days 21.5 days
Mean time to decrease from GMC  to 99% 
specificity level
156.0 days 109.0 days
Mean time spent above 99% specificity level 165.8 days
(5.5 month)
130.5 days
(4.3 month)
Mean time to decrease from 99% specificity level to 
100% sensitivity level
50.0 days 21.7 days
Total time spent going up and down between 
detection limit and GMC 
238.0 days 165.6 days
Total time spent going up and down between 100% 
sensitivity level and GMC
217.8 days
(7.2 months)
156.5 days
(5.1 months)
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To probe spectrum bias in the specificities obtained in our 35 internal controls, 
we calculated specificities as well in the 90 IgA and IgG concentrations obtained 
in weeks 9 and 13 of  the epidemic of  all 47 subjects with no cough (Table 1). 
This resulted in lower specificities of  different levels of  IgA (24-74 U/ml) and 
IgG (27-90 U/ml) ranging from 71% to 85% and 72% to 90%, respectively. The 
specificity of  100 U/ml IgG decreased from 100% to 92%. The lower observed 
IgA specificities were due to the high levels from the 12 added subjects with a 
laboratory confirmed pertussis infection and without a pre-epidemic cough or 
a clinical pertussis. Indeed, 15 of  the 22 IgA levels from these 12 subjects were 
at least 24 U/ml, and of  the IgG levels, 18 of  22 were at least 27 U/ml, and 8 
were at least 100 U/ml. So the added 12 subjects were not a true control group 
of  unexposed and uninfected subjects. 
Sensitivities at different time intervals
Table 3 shows the sensitivities of  IgA (24-74 U/ml) and IgG (27-90 U/ml) levels 
calculated from the 46 pertussis cases (see Figure 2) at different time intervals 
in reference to the first day of  coughing. In the first two weeks after the onset 
of  clinical pertussis, cut-off  levels of  24 U/ml for IgA and 27 U/ml for IgG 
showed sensitivities of  100% and 75%, respectively. In the third week of  infec-
tion, a sensitivity of  100% was calculated for both parameters. From the fourth 
week onwards, the sensitivity remained at 97%.
Waxing and waning of  IgA and IgG between diagnostic parameters
It was estimated that IgA reached the 100% sensitivity and 99% specificity levels 
earlier than IgG. IgG waned more quickly back towards pre-infection levels. IgA 
and IgG remained above their 100% sensitivity level during 7.2 and 5.1 months, 
respectively and above their 99%-specificity level during 5.5 and 4.3 months, 
respectively (Table 4). The rate of  increase of  IgA and IgG levels indicates that 
the paired samples should be collected within 4 and 7 days, respectively, after they 
begin to increase in order to observe the fourfold rise towards their GMC.
Discussion
Early diagnosis of  pertussis in adults for outbreak management requires low cut-
off  levels for single IgA and IgG serological tests. We found that cut-offs of  24 
U/ml for IgA and 27 U/ml for IgG led to a specificity of  90% and a sensitivity 
of  100% and 75%, respectively, during the first 2 weeks of  pertussis. In the third 
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week, the sensitivity was 100% for both tests. The sensitivity decreased slightly 
to 98% for IgA, and 95% for IgG during the first 87 days of  clinical pertussis. 
After acute onset of  pertussis, IgA remained above 24 U/ml for a mean dura-
tion of  7.2 months, and IgG remained above 27 U/ml for a mean duration of  
5.1 months.  
Although this study is limited by the relatively small number of  subjects, the results 
are based on a pertussis epidemic in a defined community, with 100% participa-
tion. We are not aware of  another study in which sensitivities of  single IgA and 
IgG were evaluated in both the pre-clinical and clinical phases of  pertussis. 
The definition of  pertussis was partly based on single IgA and IgG levels, which 
were also evaluated as diagnostic marker. This may have caused some incorpo-
ration bias.42,44 However, 42 of  the 46 pertussis cases were based on at least 
4-fold changing IgA or IgG levels in paired samples (Table 1). The lowest IgG 
level of  the 4 cases identified with a single IgG sample was 376 U/ml and they 
had coughed between 44-263 days. From 3 of  these 4 cases we were not able 
to obtain a third serum sample in week 60 (2 subjects died earlier with pertus-
sis), in order to detect significant change. The fourth subject showed a 3.6-fold 
changing IgG level. In addition, we did not find other causes of  this epidemic 
of  cough12 in the ideal epidemic circumstances of  a convent population with 
positive cultures for Bordetella pertussis. 
In our evaluation of  spectrum bias in sensitivity and specificity, we showed that 
our choice of  pertussis cases and controls was sound. Arguably, the use of  our 
35 internal controls may have led to underestimation of  the specificity of  sin-
gle low IgA and IgG levels. Indeed 7 of  the 35 internal controls had high IgA 
levels ranging from 24–74 U/ml and 2 internal controls had IgA levels above 
74 U/ml. Six internal controls had IgG levels ranging from 27–90 U/ml and 
one internal control above 90 U/ml. We argue that IgA levels above 24 U/ml 
and IgG levels above 27 U/ml decreased the specificities obtained in the inter-
nal controls, compared with the specificities obtained in the external controls 
(Figure 2). Among all 47 subjects with no cough (Table 1), 21 (45%) had high 
single IgA and/or IgG levels. Because these 21 subjects with high single IgA 
and/or IgG levels had a serological indication of  infection (antibody boosting) 
without symptoms, we consider the external control group, with GMC of  IgA 
and IgG levels significantly lower than in the 46 pertussis cases, the better choice 
for calculating specificities. 
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The retrospective part of  the study may have resulted in recall bias regarding onset 
of  cough. The study however, was supported by a nun who was responsible for 
looking after all the nuns with pertussis during the epidemic. This registered nurse 
kept reliable clinical records including the history of  coughing before and after the 
start of  the study. We are therefore fairly confident that recall bias is limited.
IgA antibodies to Bordetella pertussis antigens in whole-cell sonicate is known to 
lack specificity compared to IgA antibodies to pertussis toxin.30 Indeed single 
high values of  IgA and IgG antibodies to pertussis toxin indicate infections in 
adults, and IgA is more indicative of  a recent antibody response, although less 
consistent than IgG.30 However, we excluded causes of  the epidemic other than 
pertussis and used culture, PCR, and IgG against pertussis toxin to positively 
identify pertussis cases. 
In our external control group, the levels of  IgA against whole cell sonicate showed 
higher specificities than similar IgG levels. In the original Dutch study of  IgA 
antibodies, it was stated that IgA antibodies, which are not induced by vaccina-
tion, can be used as a reliable indicator of  natural infection with Bordetella pertussis 
in adults within one week of  infection,38 especially if  interpreted in connection 
with clinical findings.46 On the other hand it has been postulated that because 
of  the prolonged antibody response, IgA is not such a useful marker for recent 
infection.38 We estimated however, that IgA reaches 100% sensitivity and 99% 
specificity level sooner than IgG, and that IgA and IgG remain above the 99% 
specificity level for a mean duration of  5.5 and 4.3 months, respectively, after 
the onset of  pertussis. 
IgG antibodies against the virulence factors pertussis toxin, pertactin, and fim-
briae increase and decrease after both natural infection and vaccination.31,47-49 
In bacteriologically proven pertussis cases, IgG antibodies declined more rapidly 
than IgA.31 This was confirmed in our study. 
IgG levels of  at least 25 IU/ml were associated with Bordetella pertussis infection 
in a previous study.31 In our study, a cut-off  level of  27 U/ml for IgG resulted 
in a sensitivity of  100% the third week after the onset of  pertussis symptoms, 
and remained at 97% up to the 13th week with a specificity of  90%.
We determined a sensitivity of  90% for 50 U/ml IgG and of  80% for 100 U/ml, 
which is comparable to a previous evaluation that determined a sensitivity of  
89% for IgG levels above 50 U/ml and 76% for IgG levels of  > 100 U/ml.35 
Also, our specificity of  99% for an IgG level of  90 U/ml is comparable to that 
found in the prior study35 which concluded that, independent of  age, a cut-off  
level of  100 U/ml IgG showed a specificity of  99-100%. In the prior study, most 
patients reached IgG levels of  100 U/ml within 4 weeks of  disease onset which 
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persisted for 4.5 months. These findings are in line with our estimates that the 
IgG level increases from the detection limit (5 U/ml) to 100 U/ml in 6.7 days 
and persists at this level for 4.2 months. 
The rate of  IgA and IgG increase underlines the importance of  obtaining acute 
phase samples early in the disease in order to detect a significant increase, and 
consequently the importance of  significantly decreasing levels for ultimately 
diagnosing pertussis if  the first sample is not obtained early in the disease.33,34 
Our outcomes are also in line with a study in which a cut-off  point of  94 IU/
ml for IgG pertussis toxin, with a sensitivity of  80% and a specificity of  93%, 
has been proposed.50 This 94 IU/ml is comparable with 76 U/ml in our study 
and considerable lower then the 125 IU/ml (=100 U/ml) officially used in the 
Netherlands. In our study 94 IU IgG pertussis toxin had a sensitivity of  83% 
and a specificity of  98%. 
Our findings for low IgA and IgG levels to diagnose pertussis in outbreak manage-
ment are supported by findings from a pertussis outbreak in a boarding school in 
Australia, where IgA against whole-cell sonicate, and IgG against pertussis toxin 
proved useful for early diagnosis and outbreak management. In that study, it was 
concluded that the IgG level of  125 IU/ml (100 U/ml) was not sensitive enough 
to identify pertussis cases in their early stages for outbreak management.51 
Because IgA is not induced by vaccination against pertussis, it may be preferred 
over IgG in recently vaccinated subjects, as IgG is induced by vaccination with 
whole-cell vaccines against pertussis used in the Netherlands.31 Other vaccines 
may induce even higher IgG-pertussis toxin levels, since the response to pertussis 
toxin varies between different whole-cell vaccines and acellular vaccines. These 
IgG-pertussis toxin levels can reach levels higher than 100 U/ml.48,52-54 
Conclusions 
High sensitivity and specificity are required to track and exclude pertussis in 
vaccine efficacy trials43 if  another serious disease is suspected, and in passive 
surveillance systems used to estimate vaccine efficacy. In clinical practice and 
outbreak situations, diagnosis of  Bordetella pertussis illness must be immediate 
to allow for prompt therapeutic intervention to reduce disease severity and 
spread. Therefore, diagnostic criteria should be sensitive, even if  specificity is 
compromised.55 Pertussis has recognizable characteristic clinical symptoms to a 
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physician.56 A clinical case definition can be used in clinical practice and outbreak 
management,57,58 and for antibiotic management.59 
We conclude that after infection with Bordetella pertussis IgA and IgG concentra-
tions start to increase from low levels upwards, and that low cut-off  levels of  24 
U/ml for IgA antibodies and 27 U/ml (equivalent to 27 IU/ml) for IgG antibod-
ies could be considered as practical tools for laboratory confirmation of  clinical 
pertussis in adults during the first 3 weeks of  disease outbreak for public health 
practice, e.g. outbreak management. We suggest a more extensive study of  the 
value of  IgA antibodies to pertussis toxin for the early diagnosis of  pertussis.
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Abstract
The pertussis incidence during an outbreak in a convent in The Netherlands in 
1992 was higher among 75 retired (unvaccinated) nuns (60%) than among 24 staff  
members (8%) and was higher among 9 nuns with only a convent career (100%) 
than among 66 nuns who had a career outside of  the convent (55%). The pertussis 
incidence increased with duration of  social isolation but not with age.
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Introduction 
A decline in pertussis incidence was seen starting at the beginning of  the 20th 
century; it became more pronounced in the 1940s, when pertussis vaccine became 
available.1 Despite vaccination, pertussis resurged; the resurgence occurred first 
among children and was related to a decrease in vaccination coverage as a result 
of  opposition, in the 1970s, to the use of  whole-cell vaccine. In the 1990s, per-
tussis was increasingly seen in adults; this was related to waning vaccine-induced 
immunity in countries with high and uninterrupted vaccination coverage among 
children.2,3 The proposed explanations for this re-emergence are genetic changes 
in Bordetella pertussis that make vaccines less effective, lessened potency of  vac-
cines, waning of  vaccine-induced immunity, greater pertussis awareness, and 
general availability of  better laboratory tests.4 In addition, a decreased incidence 
of  natural immunity-boosting infections with Bordetella pertussis, as a result of  the 
high coverage of  national vaccination programs, might explain the re-emergence 
of  pertussis.5 
The importance of  natural Bordetella pertussis infections is not well understood. In 
this report, we describe an outbreak of  pertussis in a convent of  retired and unvac-
cinated nuns. Some had only limited exposure to society during their working life, 
whereas others had careers outside the convent, in The Netherlands and in the 
tropics. We aimed to study the role of  natural infection by determining the relation-
ship between incidence of  pertussis and duration of  isolation from society.
Methods
To evaluate the association between pertussis incidence and age, isolation from 
society, and a career in society, the clinical outcomes and laboratory findings of  
a previously described pertussis epidemic in a convent were used.6 The convent 
population consisted of  75 resident nuns and 24 non-resident staff  members. The 
cohort study started in week 9 of  the epidemic, when pertussis was diagnosed by 
culture, PCR, and serum IgG serological tests, and other causes of  respiratory 
tract infections (e.g., tuberculosis and influenza) were excluded. From week 10 
onward, outbreak management with antibiotics was focused on pertussis. The 
onset of  clinical symptoms, such as coughing, was established retrospectively 
through interviews. 
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Nasopharyngeal swab samples for culture and PCR in charcoal medium were 
processed as described elsewhere.7 Titers of  IgG antibody to pertussis toxin 
were determined by ELISA8 at the National Institute for Public Health and the 
Environment, Bilthoven, The Netherlands. Antibody binding activities were 
quantitatively expressed in “local” units per milliliter, which can be converted to 
US Food and Drug Administration international units.9 The detection level of  
the assay was 5 U/mL. Pertussis infection was defined as the presence of  1 of  
the following laboratory findings: (1) a Bordetella pertussis strain isolated from the 
nasopharynx; (2) a reactive PCR result; (3) a significant (at least 3-fold) increase 
or decrease in IgG antibody titers between serum samples obtained at weeks 9, 
13, and 60 of  the epidemic; or (4) a single IgG titer of  > 100 U/mL.8 Clinical 
pertussis was defined as a persistent cough for at least 10 days, starting after the 
appearance of  the first case of  laboratory confirmed pertussis infection. Pertussis 
was defined as pertussis infection and clinical pertussis combined.
The career files of  all 75 nuns in the convent archive and of  the 24 staff  members 
were examined, by use of  a structured questionnaire, to assess date of  entrance 
into the convent, duration of  isolation in the convent, duration of  a career in 
Dutch society or as a missionary in the tropics, and duration of  isolation after 
retirement in the convent up to the start of  the outbreak in June 1992. 
Statistical associations between pertussis incidence and age and career type were 
analyzed by use of  a Yates-corrected χ2 test. The relationship between pertussis 
incidence and age and the total duration of  isolation before and after retirement 
in the convent and after retirement only were analyzed by χ2 test for linear trend 
(Epi Info, version 6.04d; Centers for Disease Control and Prevention). Age 
adjustment was performed by logistic regression analysis (SAS, version 8.2; SAS 
Institute). The statistical association between median duration of  cough and age 
and duration of  isolation was calculated by linear regression analysis with cough 
duration as outcome (S-PLUS, version 6.0; Insightful).
Results 
Since entry into the convent (the first of  the nuns entered in 1922), all 75 nuns 
had been based in the same convent of  the congregation of  the Sisters Servants 
of  the Holy Ghost in The Netherlands. Nine of  the 75 nuns stayed in the convent 
for the rest of  their lives after entry. Nuns slept in separate rooms, shared their 
meals in the dining hall, and only seldom left the convent or received visitors. 
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The other 66 nuns interrupted their isolation in the convent; 38 had a career 
in The Netherlands as a nursery or primary school teacher or a hospital nurse, 
22 had a career as a missionary in the tropics, and 6 had a career in both The 
Netherlands and the tropics. The missionaries had worked in Asia, Africa, and 
South America. By the start of  the outbreak, the convent had become a nursing 
home for the 9 nuns who never left and for the 66 career nuns who had retired 
into the convent. The nuns had daily common social and religious activities and 
were supported by 24 staff  members living outside the convent. 
Since 1922, no other outbreak of  coughing had been reported by the nuns or in 
the convent archives. At the start of  the epidemic, the mean age of  the nuns was 
75 years (range, 59–91 years), and that of  the staff  was 26 years (range, 21–47 
years). The incidence of  pertussis was higher among the 75 nuns in the convent 
(45 of  75; 60%) than among the 24 staff  members living outside the convent 
Table 1. Relationship between pertussis incidence, age and duration of  isolation from society among 
the 75 nuns with (n=66) and without (n=9) a career outside the convent.
Group
Pertussis incidence Duration of  cough 
among nuns with 
pertussis
No. of  death 
among nuns 
with pertussis
No. with 
pertussis/
total
Percentage P for linear
 trend in 
proportions
Median 
days (range)
P for 
trend on 
rank
Age group, 
years
.31 .20
55-64 8/16a 50 41b (28-98) 1
65-74 13/21 62 67 (14-268) 0
75-84 16/27 59 51 (11-178) 0
85-94 8/11a 73 83b (28-236) 3
Duration of  
isolation from 
society,c years
.005 .72
0-6 5/15 33 55 (28-173) 1
7-13 9/17 53 38 (14-268) 0
14-20 10/16 63 88 (11-178) 1
21-34 9/12 75 45 (30-236) 1
35-70 12/15 80 53 (14-159) 1
a No significant difference between the incidence of  pertussis in the youngest and oldest age group 
(P = .21, Fisher’s exact)
b No significant difference between the median duration of  cough in the youngest and oldest age 
group (P = .10)
c Duration of  isolation of  the 9 nuns without a career outside the convent and the duration of  
isolation since retirement in the 66 nuns with a career outside the convent
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(2 of  24; 8%) (P = .0003). All 75 nuns and 5 of  the 24 staff  members were not 
vaccinated against pertussis. One vaccinated and one unvaccinated staff  member 
had pertussis. The duration of  cough among nuns with pertussis was 11–268 
days (mean duration, 55 days). Four of  the nuns had pertussis when they died. 
The pertussis incidence was higher among nuns with a lifelong career in the con-
vent (n = 9) than among nuns with a career outside the convent (n = 66) (100% 
vs. 55%, respectively; P = .007).The pertussis incidence among nuns who had 
worked in Dutch society only (n = 38) was 74%; in those who had worked in 
the tropics only (n = 22), it was 35%; and in those who had worked in both the 
Dutch society and the tropics (n = 6), it was 17% (χ2 for linear trend in propor-
tions, > 19.8; P < .0001). 
The pertussis incidence among all 75 nuns was not statistically significantly 
related to age (P = .31) (table 1). Pertussis incidence also did not increase with 
increasing total duration of  isolation (before and after a career outside the con-
vent) (P = .08), but it did increase with increasing duration of  isolation after a 
career outside the convent (P = .005) (table 1). In the logistic regression model, 
duration of  isolation after a career outside the convent remained associated 
with pertussis incidence (P = .01) after adjustment for age. Severity of  illness, 
expressed as duration of  cough, was not associated with age group or duration 
of  isolation. Three of  4 deaths among nuns with pertussis were in the oldest 
age group (85–94 years) (table 1).
Discussion 
The risk of  pertussis in nuns during the pertussis outbreak in this convent was 
associated with duration of  isolation from society and was independent of  
age. A career outside the convent protected against pertussis. A stay of  up to 
70 years in the convent—partly interrupted by careers in The Netherlands (an 
area with lower pertussis endemicity) and/or the tropics (an area with higher 
pertussis endemicity)—followed by a pertussis outbreak can be seen as a natural 
experiment. 
We assume that social isolation in the convent protected against immunity 
through natural Bordetella pertussis infection and explain the epidemic as being the 
result of  an increase in susceptibility once Bordetella pertussis was introduced into 
the convent. The nuns were never vaccinated against pertussis as children, and, 
if  they had been vaccinated, the effect of  the vaccination would have waned. 
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Indeed, the 1992 epidemic was the first reported in the history of  the convent, 
according to the well kept archive of  the convent and the long-term common 
memory of  the nuns. Moreover, the epidemic occurred after the convent had 
changed from a closed congregation into an open nursing facility for elderly 
nuns aided by civil staff. Also, the 100% pertussis incidence among the 9 nuns 
isolated since their entry into the convent and the overall pertussis incidence of  
60% (with a case-fatality rate of  9%) indicate a first epidemic. 
It could be argued that, in this epidemic, the nuns experienced the first cases of  
pertussis in their lives. This is unlikely, because the nuns entered the convent at 
18–34 years of  age when infections were prevalent and everyone experienced 
pertussis before the age of  15 years.10 It is estimated that infection-acquired 
immunity wanes after 4–20 years and that vaccine-acquired immunity wanes 
after 4–12 years.11
Some nuns developed serious pertussis with a high mortality rate, comparable 
to pertussis in very young children without completed immunization. Natural 
infection with Bordetella pertussis contracted in society effectively protected other 
nuns against pertussis. Indeed, in The Netherlands in 1995–1996, the estimated 
incidence of  infection was 6.6% per year among individuals 3–79 years of  age, 
up to 10.8% among individuals 20–24 years of  age, and higher than the incidence 
of  notified cases (.01%).12 However, both infection-acquired immunity and 
vaccine-acquired immunity wane over time. We conclude that booster doses of  
pertussis vaccines may be a valuable strategy to control pertussis in populations 
with national childhood vaccination programs.
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Abstract 
Objective. To discover the cause of  an outbreak of  gastro-enteritis after a family 
party.
Design. Retrospective cohort study.
Methods. All 109 party-goers were asked to complete a written questionnaire 
about consumed food products and demographic and clinical variables and to 
hand in a faeces sample. The data were collected at the Public Health service 
Midden-Limburg, The Netherlands. Faeces and the remaining food products 
were examined microbiologically. The attack rates and the incidence rates of  
positive faeces culture among consumers and non-consumers of  specific food 
products were calculated as well as the corresponding relative risks (RR) with 
95% confidence intervals (95% CI).
Results. The overall attack rate was 35%. Salmonella typhimurium phage type 20 was 
found in Coburger ham and statistically significantly more frequently in faeces of  
ill compared with non-ill party-goers (RR: 6.4; 95% CI: 2.5-16.1). Twenty-eight 
different food products were served. Consumption of  Coburger ham only, was 
statistically significantly related to a positive faeces culture (RR: 4.1; 95% CI: 
2.0-8.5). Only consumption of  Coburger ham and of  bone ham was statistically 
significantly related to being ill (RR: 2.4; 95% CI: 1.5-4.0 and RR: 1.4; 95% CI: 
1.1-1.9, respectively). Coburger ham and bone ham originated from the same 
batch of  raw meat and were prepared in the same manner in the same salt bath. 
The shorter duration of  salting and drying of  Coburger ham compared with 
bone ham corresponded with a higher relative risk of  becoming ill.
Conclusion. Consumption of  Coburger ham and bone ham infected with Salmonella 
typhimurium phage type 20 caused the outbreak. Traditional salting, drying and 
smoking of  raw pork meat was not antimicrobiologically effective against Salmo-
nella typhimurium. Investigation of  the antimicrobiological effect of  the traditional 
preparation of  meat and the importance of  Good Manufacturing Practices and 
quality control in all stages of  production of  pork meat, according to the prin-
ciples of  Hazard Analysis and Critical Control Points, is advised.
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Introduction
In the Netherlands, a country with a population of  15.5 million Nederland (1996), 
annually some 7 million episodes of  acute gastroenteritis occur, leading to 2.3 
million General Practitioner consultations, 3.6 million episodes of  drug treatment 
for an average of  2 weeks, and 12,000 years of  school or work absenteeism.1,2 
Essential to all efforts on collective prevention is a knowledge of  sources of  gastro-
enteritis. Thus viewed, it is advisable to track down the agent, source and mode of  
transmission of  outbreaks, so that preventive procedures can be adjusted, where 
necessary. These considerations led us to investigate the cause of  an outbreak of  
gastroenteritis. 
The immediate grounds for the investigation were a report from a nursing home 
employee to the Public Health Service (PHS) of  Midden-Limburg in March 1998, 
to the effect that of  the 109 individuals attending a family party, a large number 
was nauseated and had diarrhoea the next day.
Patients and methods
Four days after the party, the PHS instituted a retrospective cohort study among all 
109 partygoers, which included the individual who had reported the incident. Two 
meals had been served at the party: a selection of  confectioneries and a buffet. 
Symptoms and the foods consumed were tabulated until the end of  the outbreak 
with the aid of  structured personally addressed questionnaires in writing.
Ten to 14 days after the party, faecal samples were collected and cultured for Sal-
monella, Shigella, Campylobacter jejuni and Yersinia enterocolitica according to standard 
bacteriological methods (Streeklaboratorium, Atrium Medisch Centrum, Heerlen). 
Confirmation of  the culture results and sero- and phage typing was performed 
according to ‘standard operating procedure’ number M501 [Diagnostic Labora-
tory for Infectious Diseases and Screening, Special Bacterial Typing, National 
Institute for Public Health and the Environment (RIVM), Bilthoven].3,4 
Leftovers from one of  the food products consumed was used to perform 
an aerobic colony count for Bacillus cereus, Campylobacter, Clostridium perfringens, 
Enterobacteriaceae, Salmonella, Staphylococcus aureus, and yeast and moulds by the 
Inspectorate for Health Protection/Food Inspection Service (IGB/KvW), 
Maastricht. 
The food preparation process and location at which preparation took place were 
examined using standard methods (IGB/KvW), Maastricht. The results of  the 
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microbiological tests came in and were made known to the partygoers after all 
completed questionnaires had been returned.
Definitions and statistics
Partygoers were categorized as ‘ill’ if  they succumbed to nausea, vomiting, stom-
ach ache, diarrhoea, chills or fever within a week after the party. The median 
latency period time was calculated, as were the attack rates of  becoming ill and 
the incidence rates of  positive faecal specimens amongst consumers and non-
consumers of  specific food products.
The corresponding relative risks were calculated with 95% confidence intervals 
(95% CI), using the computer program SPSS (Statistical Package Social Sciences 
International BV, Gorinchem).
Results
Of  the 109 partygoers, 86 (79%) handed in a completed questionnaire. The 
average age of  this study group, consisting of  42 females and 44 males was 43 
years (range: 13-77). The overall attack rate was 35% (30/86) and the median 
incubation time 12 hours. The average age of  the ill individuals and those who 
remained healthy was respectively 41 years (13-69) and 44 years (21-77). Ill indi-
viduals reported nausea (53%), vomiting (3%) stomach ache (90%), diarrhoea 
(93%), chills (83%), and fever (63%). The average duration of  the illness was 6 
days (range: 1-21). 
Table 1 shows the attack rates and RRs with 95% CI among both consumers 
and non-consumers of  the 28 food products. A statistically significant RR for 
illness was found only for the products Coburger ham and bone ham, namely 
2.4 (1.5-4.0) and 1.4 (1.1-1.9) respectively.
Faecal specimens were collected from 78 (91%) persons from the study group. 
Of  the 30 ill individuals, 1, and of  the 56 healthy subjects, 7 did not submit a 
faecal sample (no statistically relevant difference). The culture was positive for 
Salmonella typhimurium phage type 20 in 33 (42%) individuals (table 2). Of  the 33 
subjects with a positive culture, 79% had become ill, in contrast to the 9% of  
the 45 individuals with a negative culture who fell ill; a statistically significant 
difference (RR: 6.4; 95% CI: 2.5-16.1). Shigella, Campylobacter jejuni and Yersinia 
enterocolitica were not cultured.
Chapter 6
107
Table 1. Food products consumed at a party, subsequent to which the partygoers became ill; the rela-
tive risks of  illness among 86 consumers and non-consumers of  28 food products are shown.
Food Product % Ill (number ill/total number)a Relative Risk
(95% CIb)Consumers Non-consumers
Confectioneries
- pineapple bavarois 0 (0/6) 37 (29/78) 0.6 (0.5-0.7)
- apricot special 29 (2/7) 35 (27/77) 0.9 (0.5-1.5)
- Christopher 33 (2/6) 35 (27/78) 1.0 (0.5-1.8)
- apricot 44 (4/9) 33 (25/75) 1.2 (0.6-2.2)
- apple-lemon 56 (5/9) 32 (24/75) 1.5 (0.7-3.2)
- rice with cream 56 (5/9) 32 (24/75) 1.5 (0.7-3.2)
- crumble 71 (5/7) 31 (24/77) 2.4 (0.7-7.8)
- hazelnut bavarois 71 (5/7) 31 (24/77) 2.4 (0.7-7.8)
Buffet
- sliced dried sausage 0 (0/4) 35 (27/76) 0.6 (0.5-0.8)
- cold dish 30 (20/66) 50 (10/20) 0.7 (0.4-1.1)
- beef  in sauce 30 (11/37) 36 (16/45) 0.9 (0.7-1.2)
- stuffed tomatoes 31 (9/29) 37 (21/58) 0.9 (0.7-1.2)
- mini rolls 33 (8/24) 34 (23/61) 1.0 (0.7-1.4)
- fruit 36 (10/28) 34 (19/55) 1.0 (0.7-1.4)
- Italian salad 36 (5/14) 32 (18/57) 1.1 (0.7-1.6)
- asparagus with ham 37 (19/51) 32 (11/34) 1.1 (0.8-1.5)
- pork cutlet in cream sauce 39 (11/28) 33 (19/57) 1.1 (0.8-1.6)
- devilled eggs 38 (22/58) 30 (8/27) 1.1 (0.5-2.3)
- sliced chicken ham 40 (2/5) 32 (24/74) 1.1 (0.5-2.3)
- French bread 41 (18/44) 30 (14/40) 1.2 (0.9-1.6)
- fresh fruit 43 (9/21) 30 (18/59) 1.2 (0.8-1.8)
- Leudal salad 41 (9/22) 28 (12/45) 1.2 (0.8-1.8)
- salmon 40 (19/47) 26 (9/35) 1.2 (0.9-1.7)
- chicken salad 42 (8/19) 27 (15/55) 1.3 (0.8-1.9)
- cocktail sauce 48 (14/29) 27 (14/51) 1.4 (0.9-1.2)
- roast beef  with pepper sauce 54 (6/11) 31 (22/70) 1.5 (0.8-2.9)
- bone ham 43 (23/54) 18 (5/28) 1.4 (1.1-1.9)
- Coburger ham 66 (21/32) 16 (8/51) 2.4 (1.5-4.0)
a The total of  consumers plus non-consumers per food product is not always 86 as not all ques-
tionnaires were completely filled in
b 95% CI=95% confidence interval 
The percentages of  stool cultures that were positive for Salmonella typhimurium 
phage type 20 among consumers and non-consumers of  the 28 food products 
were calculated. Only Coburger ham demonstrated a statistically significant 
relation with the Salmonella typhimurium positive stool culture (RR: 4.1; 95% CI: 
2.0-8.5). In the group of  78 individuals who submitted both a completed ques-
tionnaire and a faecal specimen, consumption of  the combination Coburger ham 
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and bone ham explained 31 of  the 33 positive faecal specimens; this combination 
yielded the greatest chance of  a positive faecal sample, compared to all other 
combinations eaten. (RR: 2.0; 95% CI: 1.5-2.6).
A remaining piece of  the batch of  Coburger ham served at the party was recov-
ered from the butcher’s, in which piece Salmonella typhimurium phage type 20 was 
detected.
No bone ham or other food products were further available for microbiologi-
cal examination. The Coburger ham and the bone ham were prepared from 
the same batch of  raw pork meat, supplied by the same slaughterhouse. They 
were prepared by the butcher, who was compliant with all hygiene and building 
requirements, in the same brine solution according to traditional methods. The 
Coburger ham and the bone ham were prepared by cooling the raw butt with 
bacon and, respectively, the entire ham (12 h at 1ºC), followed by immersion 
in brine for 3 respectively 4 weeks (24% sodium nitrite, 0.5% glucose, 0.25% 
potassium nitrate and 75.25% water; brine strength: 22-24º on the Baumé scale, 
a scale used to express the concentration of  solutions) using a ratio of  meat:
brine = 1:2, then salting outside the brine (10 days at 6ºC in the dark), rinsing (2 
h in cold running water), drying (1 h at 50ºC), cold smoking in a drying room 
(for respectively 14 days and 2 months at 15-20ºC).
Discussion
Our investigation led us to conclude that the outbreak was caused by the con-
sumption of  bone ham and Coburger ham contaminated by Salmonella typhimurium 
phage type 20.
Table 2. The distribution of  78 subjects with a positive or negative stool culture for  Salmonella 
typhimurium (phage type 20) by number of  individuals who became ill/not ill.
Culture Results Ill Not Ill Total Relative Risk (95% CIa)
Positive 26 7 33
Negative 4 41 45
Total 30 48 78 6.4 (2.5-16.1)b 
a 95% CI = 95% confidence interval
b Relative risk for illness with a positive culture result compared to a negative culture result
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In view of  the severity and duration of  the symptoms and the average low age 
of  the individuals who became ill, the infective dose was probably high. Selec-
tion distortion was considered unlikely as 79% of  the partygoers completed the 
questionnaire, of  whom 91% took part in the stool examination, in which no 
significant difference was seen in percentage of  individuals who were ill and 
those who were not. For this reason, no non-response study was conducted, all 
the more as the partygoers were informed of  the results of  the microbiological 
test after returning the questionnaires.
We also concluded that the Coburger ham and bone ham were the original 
source of  Salmonella typhimurium at the party. Cross-contamination from the other 
food products served appeared to be ruled out. After all, Salmonella typhimurium 
phage type 20 was also detected in the remaining piece of  the Coburger ham 
found at the butcher’s. Moreover, the other food products showed no statisti-
cally significant relation with either a positive faecal culture or with becoming 
ill. Furthermore, of  all the combinations of  foods eaten, consumption of  the 
combination of  Coburger ham and bone ham explained the greatest number 
of  positive stool cultures.
Cross-contamination of  Coburger ham and bone ham by other raw meat prod-
ucts at the butcher’s does not appear likely. After all, the butcher was compliant 
with all Dutch hygienic requirements and Salmonella typhimurium was found, not 
only on, but also in, the Coburger ham. Also, the Coburger ham and the bone 
ham had been made from the same batch of  raw pork meat in the same brine 
solution. And the higher RR for becoming ill from the Coburger ham compared 
to the bone ham fits with the fact that Coburger ham is brined and dried for a 
shorter period than bone ham.  We moreover established that traditional salting, 
smoking and drying of  raw pork meat was not antimicrobiologically effective 
against Salmonella typhimurium phage type 20, occurring in the batch of  raw pork 
meat supplied to the butcher, from which the Coburger ham and bone ham were 
subsequently prepared.
The literature supports these conclusions. Salmonella is frequently found in the 
alimentary canal of  the pig, and in many cases – 71% - Salmonella typhimurium is 
the type involved.5 During the slaughtering process in Dutch slaughterhouses, 
30% of  all carcasses are contaminated via the content of  the gut with Salmonella 
strains, which ultimately leads to contamination of  the raw meat.6,7 In 1997, the 
main strain isolated from 14% of  the raw ground pork meat and from 8% of  
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all raw pork meat examined in the Netherlands was Salmonella typhimurium.8 The 
literature also notes that bacteria can withstand salt concentrations of  up to 4.5 M 
NaCl, that the antimicrobiological effect of  nitrate and nitrite is limited and that 
bacteria can continue to grow in dried, salted ham for at least three months.9-12
Annually, some 3% of  the Dutch population is infected mainly with Salmonella 
typhimurium and Salmonella enteritidis, which results in 400,000 episodes of  gas-
troenteritis.1,13
Since 1985, pigs have been the leading source of  infection with Salmonella typh-
imurium (W. van Pelt, Centre for Infectious Diseases Epidemiology, Diagnostics 
and Screening for Infectious Diseases, RIVM, written bulletin, 1998).5
Conclusion
In the light of  the results of  our study, we advise further investigation of  whether 
traditional salting, drying and smoking of  raw pork meat is sufficiently effective 
against Salmonella strains in raw pork meat, all the more as no data proved to be 
available in the literature on the subject. Pork meat products that undergo a less 
rigorous salting, smoking and drying process, such as bacon, salt pork, Canadian 
bacon, slab bacon, bacon square, Lachsschinken, casselerrib and pickled pork, 
are all products qualifying in this respect.14
This study underscores the importance of  good manufacturing practice (GMP) 
and quality control, according to the principles of  Hazard Analysis and Critical 
Control Points (HACCP), in all stages of  production of  pork meat.15
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Abstract
Objective. To elucidate the cause of  an epidemic of  gastroenteritis amongst the 
guests and waiting staff  of  two weddings celebrated on the same day in the 
same restaurant.
Design. Retrospective and descriptive.
Method. Following an outbreak of  gastroenteritis amongst 215 wedding guests 
and restaurant staff  in 1999, the Public Health Institute Midden-Limburg, the 
Netherlands, inventoried the demographic and clinical variables and consumed 
foods by means of  a structured written interview. Faecal samples and remaining 
food products were bacteriologically examined, and later on faeces were virologi-
cally examined for the presence of  the Norwalk-like virus (NLV). The attack 
and the incidence rates of  NLV-positive faecal specimens amongst consumers 
and non-consumers of  specific food products were calculated, as well as the 
corresponding relative risks with 95% confidence intervals.
Results. The overall attack rate was 66%. A NLV with the same genotype was 
found statistically significantly more frequently in faecal specimens of  ill per-
sons compared with non-ill individuals. Of  the 61 different dishes served, two 
showed a statistically significant relation with being ill. These food products were 
eaten by 26% of  the ill persons. No statistically significant association was found 
between NLV-positive faeces and consumption of  a specific dish. The index 
case began having symptoms of  gastroenteritis at the morning of  the wedding 
party, before food was served. The guests of  the two wedding parties used the 
same entrance and toilets.
Conclusion. The epidemic was caused by a single NLV strain. No association could 
be found between the consumption of  certain food products and being ill. The 
NLV epidemic was probably caused through direct or indirect contact between 
wedding guests and restaurant personnel. In the case of  such reports of  gastro-
enteritis epidemics, it is strongly recommended to test faecal, food product and 
environment samples for both bacteria and viruses, with an emphasis on NLV, 
to ensure early diagnosis.
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Introduction
In the Netherlands, a country with a population of  16 million (2000), annually 
some 7 million episodes of  acute gastroenteritis occur, leading to 2.3 million 
GP consultations, 3.6 million episodes of   drug treatment for an average of  2 
weeks, and 12,000 years of  work or school absenteeism.1,2 A recent prospective 
population cohort study showed a standardised incidence of  gastroenteritis of  
283 per 1000 person years, with bacteria accounting for 5% of  the incidence, 
bacterial toxins for 9%, parasites for 6% and viruses for 21%; in 11 of  the latter 
mentioned, the culprits are Norwalk-like caliciviruses (NLVs).3 Recent studies 
have moreover revealed NLVs as the leading cause of  all epidemics of  gastro-
enteritis reported to the Dutch municipal public health services, accounting for 
fully  87% of  cases.4 The exact contribution of  NLV as cause of  food-related 
outbreaks in the Netherlands is unknown. Studies in Japan, United Kingdom 
and the United States indicate that their contribution is considerable.5
Essential to efforts on collective prevention is a knowledge of  sources of  gas-
troenteritides. Active surveillance of  gastroenteritis epidemics can be used to 
establish the microbiological cause, source, transmission and spread.6 This would 
allow the direct implementation of  intervention measures and the adjustment, 
where necessary, of  procedures aimed at prevention. If  persons working in health 
care or the food industry are involved in outbreaks of  gastroenteritis, the risk 
of  infection for their patients or products respectively constitutes an additional 
reason for active surveillance (see the scenario for ‘Outbreaks of  gastroenteretis 
in institutions’, compiled by the National Coordination of  Infectious Disease 
Control (1996); www.infectieziekten.info).7
These considerations led us to investigate the cause of  an outbreak of  gastroen-
teritis. The immediate ground for the investigation was a report from a nursing 
home employee to the Public Health Service (PHS) of  Midden-Limburg in August 
1999, that after her wedding, numerous guests had become ill with symptoms 
of  nausea, vomiting and diarrhoea.
Patients and Methods
Circumstances
The bride’s report stated that the wedding had been celebrated in a restaurant 
where a dinner and a supper were served. The bride had invited co-workers 
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from the nursing home. The situation was mapped out in consultation with 
the restaurant manager. The restaurant had one kitchen and on the day of  the 
wedding, three other weddings were also celebrated with respectively a supper, 
a dinner and a dinner which was later followed by cocktail snacks. A fifth group 
held a barbecue in the evening. Guests at the second wedding and staff  that 
waited at both wedding 1 and 2 developed gastroenteritis. The staff  in ques-
tion had also eaten several of  the dishes served at weddings 1 and 2. Inquiries 
revealed that none of  the guests at wedding 3 and 4, or at the barbecue fell ill. 
The meals served to all 5 groups of  guests were partially made up of  the same 
dishes. The guests at weddings 1 and 2 made use of  the same entrance and 
sanitary facilities. These were separate from the guests at weddings 3 and 4 and 
from the barbecue group, who all used a different entrance and set of  sanitary 
facilities, and other rooms.
Retrospective cohort study
On the day the report was made, four days after the wedding, the PHS instigated 
a retrospective cohort study among the guests attending wedding 1 (n = 157) and 
wedding 2 (n = 47) and among the restaurant staff. Symptoms were recorded until 
the end of  the outbreak; with the aid of  a structured questionnaire personally 
addressed to each, all the dishes partaken from were tabulated, in order to detect 
the source of  the pathogen.
Preventive measures
As laid down in the protocol (‘Outbreaks of  gastroenteritis in institutions’, 
compiled by the National Coordination of  Infectious Disease Control (1996); 
www.infectieziekten.info), all restaurant staff  and the wedding guests employed 
in a nursing home and whose work involved either the preparation, packaging 
or treatment of  food and beverages or nursing activities, were asked not to work 
in the institutional kitchen or to perform nursing activities until their symptoms 
had disappeared and any positive bacterial culture results came back negative.
Stool tests
Faecal samples were collected both from subjects who had become ill and 
from those who had not, 5 to 10 days after the wedding; these samples were 
cultured first for Salmonella, Shigella, Campylobacter jejuni and Yersinia enterocolitica 
according to the standard methods used at the Regional Laboratory, Atrium 
Medisch Centrum, Heerlen. After the  bacterial culture results came in, 78 faecal 
samples were tested for the presence of  NLV at the Laboratory for Infectious 
Chapter 7
117
Diseases, National Institute for Public Health and the Environment, using ‘reverse 
transcription’-PCR (RT-PCR).4 NLV positive RT-PCR products subsequently 
underwent sequential analysis and the genotype of  the virus was determined 
using phylogenetic analysis. 4
Food testing
Leftovers from the food products consumed during the festive meals were exam-
ined microscopically with acridine orange stain and gram stain, and an aerobic 
colony count was performed for Bacillus cereus, Clostridium perfringens, Enterobacte-
riaceae, Salmonella, Staphylococcus aureus and yeast and moulds by the Inspectorate 
for Health Protection and Veterinary Public Health in The Hague. The food 
preparation process and location at which preparation took place were examined 
using standard methods by the same Inspectorate.
At the time of  this outbreak, the Netherlands did not yet have a microbiological 
laboratory where food products could be examined for the presence of  NLV.
Definitions and statistics
Persons were categorized as ‘ill’ if  they succumbed to nausea, vomiting, stomach 
ache, diarrhoea, chills or fever within a week after the gathering. The median 
incubation time was calculated from the start of  the wedding. 
Attack rates and incidence rates of  positive faecal specimens amongst consumers 
and non-consumers of  specific food products were calculated. 
To achieve the largest possible groups, guests and staff  were combined into 4 
risk groups, all of  whom had consumed a different combination of  dishes.8 
The corresponding relative risks with 95% confidence intervals were calculated 
with the χ2 test. 
All calculations were performed using the computer program ‘Statistical Pack-
age for the Social Sciences’ (SPSS, International BV, Gorinchem) and EpiInfo, 
version 6.02 (EpiInfo 6, Centers for Disease Control, Atlanta, VS).
Results
Attack rates
Of  the guests attending weddings 1 and 2 and of  the restaurant staff, respectively 
70% (110/157), 77% (36/47) and 82% (9/11) completed the questionnaire, a 
total response of  72% (155/215). The average age of  this more closely studied 
group of  155 persons, composed of  86 females and 69 males, was 37 years (range: 
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2-91). The overall attack rate in the study group was 66% (102/155); among the 
guests at weddings 1 and 2 and among the restaurant staff  respectively, the specific 
attack rate was 70% (77/110), 50% (18/36) and 78% (7/9) (Table). The average 
age of  the subjects who had become ill was 38 years (range: 5-91); among those 
who had not become ill this was 33 years (range: 2-64). Ill individuals reported 
nausea (n = 81; 79%), stomach ache (n = 72; 71%), diarrhoea (n = 65; 64%), 
vomiting (n = 55; 54%), headache (n = 51; 50%), chills (n = 42; 41%), fever 
(n = 35; 34%) and muscle pain (n = 33; 32%). The average duration of  the ill-
ness was 50 h (range: 12-72). None of  the ill individuals were hospitalized. The 
median incubation time was 40 h. Two people fell ill on the day of  the wedding. 
The majority became ill on the second day after the wedding, including the first 
victims among the personnel of  the restaurant (Figure).
NLV infection
Faecal specimens were obtained from 59 of  the 102 ill individuals, and from 19 of  
those who did not become ill. The 78 stool cultures were negative for Salmonella, 
Shigella, Campylobacter. jejuni and Yersinia enterocolitica. NLV-RNA was detected in 
40 of  the 59 faecal specimens from the subjects who were ill and in 4 of  the 19 
Table. Risk of  illness following exposure to Norwalk-like virus (NLV) (estimate based on a posi-
tive faecal culture) among guests at 2 weddings and staff  of  the restaurant at which the guests 
consumed a meal.
Groups studied Number Ill persons (%) Faecal culture Ill persons (%) among 
those with an NLV negative 
faecal culture
Relative risk (95%-CI) P*
NLV positive (%) Ill persons (%)
guests wedding 1 110 77 (70) 35/62 (56) 33/35 (94) 15/27 (56) 1.41 (1.07-1.87) 0.005†
guests wedding 2 36 18 (50) 6/11 (55) 4/6 (67) 3/5 (60) 1.1 (0.45-2.77) 0.82
personnel 9 7 (78) 3/5 (60) 3/3 (100) 1/2 (50) 2.00 (0.50-8.00) 0.17
total group 155 102 (66) 44/78 (56) 40/44 (91) 19/34 (56) 1.63 (1.19-2.22) 0.0003†
Risk groups‡
risk group 1 34 27 (79) 16/17 (94) 14/16 (88) 0/1 (0) 0.03†
risk group 2 91 69 (76) 30/52 (58) 29/30 (97) 15/22 (68) 1.42 (1.06-1.90) 0.005†
risk group 3 36 18 (50) 6/11 (55) 4/6 (67) 3/5 (60) 1.11 (0.45-2.77) 0.82
risk group 4 127 87 (69) 36/63 (57) 33/36 (92) 18/27 (67) 1.38 (1.03-1.83) 0.01†
*Value of  P on assessment of  the difference in the percentage of  ill individuals with a positive 
faecal culture and the percentage of  ill individuals with a negative faecal culture (X2-test)  
†Statistically significant  
‡At wedding 1, 34 guests and staff  (risk group 1) partook of  17 dishes at the dinner and 91 guests 
and staff  (risk group 2) of  37 dishes at supper. At wedding 2, 36 guests and staff  (risk group 3) 
partook of  26 dishes at the supper. Risk group 4 was formed of  the 127 guests and staff  who had 
partaken at both suppers
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faecal specimens from the healthy group (RR: 1.63; 95%-CI: 1.19-2.22; Table), 
a statistically significant difference. All NLV strains had the same genotype (GI, 
Southampton).
At wedding 1, 34 guests and restaurant staff  (risk group 1) partook of  17 dishes 
at the dinner, while 91 guests and restaurant staff  (risk group 2) consumed 37 
dishes at the supper. At wedding 2, 36 guests and restaurant staff  (risk group 3) 
partook of  26 dishes at the supper. Risk group 4 was made up of  the 127 guests 
and restaurant staff  partaking of  18 dishes from both suppers. The attack rate 
in the risk groups varied from 50-79% (Table). The index case belonged only to 
risk group 1. She was nauseated and vomited on the morning of  the wedding. 
She did not submit a faecal sample.
Risk of  illness associated with specific dishes. 
To assess whether the consumption of  specific dishes was associated with falling 
ill, dish-specific attack rates were calculated in the 4 risk group. A statistically 
significant relation was found between ‘consommé’ and becoming ill in risk 
group 1 (RR: 1.66; 95%-CI: 1.04-2.65) and in risk group 3, between the ‘grilled 
chicken breast filet’ and becoming ill (RR: 2.79; 95%-CI: 1.45-5.37). No suspi-
Table. Risk of  illness following exposure to Norwalk-like virus (NLV) (estimate based on a posi-
tive faecal culture) among guests at 2 weddings and staff  of  the restaurant at which the guests 
consumed a meal.
Groups studied Number Ill persons (%) Faecal culture Ill persons (%) among 
those with an NLV negative 
faecal culture
Relative risk (95%-CI) P*
NLV positive (%) Ill persons (%)
guests wedding 1 110 77 (70) 35/62 (56) 33/35 (94) 15/27 (56) 1.41 (1.07-1.87) 0.005†
guests wedding 2 36 18 (50) 6/11 (55) 4/6 (67) 3/5 (60) 1.1 (0.45-2.77) 0.82
personnel 9 7 (78) 3/5 (60) 3/3 (100) 1/2 (50) 2.00 (0.50-8.00) 0.17
total group 155 102 (66) 44/78 (56) 40/44 (91) 19/34 (56) 1.63 (1.19-2.22) 0.0003†
Risk groups‡
risk group 1 34 27 (79) 16/17 (94) 14/16 (88) 0/1 (0) 0.03†
risk group 2 91 69 (76) 30/52 (58) 29/30 (97) 15/22 (68) 1.42 (1.06-1.90) 0.005†
risk group 3 36 18 (50) 6/11 (55) 4/6 (67) 3/5 (60) 1.11 (0.45-2.77) 0.82
risk group 4 127 87 (69) 36/63 (57) 33/36 (92) 18/27 (67) 1.38 (1.03-1.83) 0.01†
*Value of  P on assessment of  the difference in the percentage of  ill individuals with a positive 
faecal culture and the percentage of  ill individuals with a negative faecal culture (X2-test)  
†Statistically significant  
‡At wedding 1, 34 guests and staff  (risk group 1) partook of  17 dishes at the dinner and 91 guests 
and staff  (risk group 2) of  37 dishes at supper. At wedding 2, 36 guests and staff  (risk group 3) 
partook of  26 dishes at the supper. Risk group 4 was formed of  the 127 guests and staff  who had 
partaken at both suppers
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cious dishes were found in risk groups 2 and 4. Of  the 102 ill subjects, 27 (26%) 
had partaken of  the 2 suspicious dishes. 
Dishes as source of  NLV?
To identify certain dishes as a source of  NLV, dish-specific infection percent-
ages were calculated in the 4 risk groups. The faeces of  92% (11/12) of  those 
consuming the suspicious dishes and the faeces of  67% (10/15) of  individuals, 
who had not consumed the 2 suspicious dishes, were NLV positive. This is not 
a statistically significant difference (RR: 1.38; 95%-CI: 0.92-2.04). None of  the 
other dishes consumed showed any statistically significant relation with NLV 
positive faeces. 
Thirteen leftover food products, sauces and ingredients from the wedding 
meals were collected from the restaurant and examined. None of  these prod-
ucts showed any trace of  Bacillus. cereus, Campylobacter, Campylobacter perfringens, 
Enterobacteriaceae, Salmonella, Staphylococcus aureus, yeasts or moulds. The restaurant 
was in compliance with the hygienic and architectural legal requirements and 
operated in accordance with the principles of  ‘Hazard Analysis and Critical 
Control Points’ (HACCP).9
Figure. The cases of  illness and cumulating of  cases (shown as an epidemiological curve) among 
the guests at the 2 weddings and among the staff  of  the restaurant at which the guests consumed 
a meal; day 1 is the day of  the wedding.
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Discussion
We may conclude that an outbreak of  gastroenteritis occurred among the guests 
at 2 weddings and the serving staff, caused by an identical strain of  Norwalk-like 
virus, which in all likelihood was transmitted not by food, but by person-to-person 
contact and contact with contaminated surfaces.  
Epidemic gastroenteritis caused by NLV
NLVs are the main agents to cause epidemic gastroenteritis in humans.10 The 
prototype of  this group of  caliciviruses, the Norwalk virus, was discovered in 
1972 in the faeces of  volunteers who were fed bacteria-free faecal filtrates derived 
from schoolchildren in the town of  Norwalk (Ohio, US), who had been felled 
by an outbreak of  acute gastroenteritis.11,12 Vomiting is characteristic for NLV 
infections; enabling the virus to spread via vomit and aerosol droplets of  vomit. 
NLV infections are generally mild in children, but for most adults, the onset of  
symptoms is extremely acute, usually accompanied by projectile vomiting and 
diarrhoea.
The infective dose is as small as 10-100 virus particles. Uncooked food such as 
raw oysters, cockles and mussels, and food handlers contaminated with NLV are 
regularly implicated sources of  infection. The virus spreads via the faecal-oral 
route, transmitted in contaminated water and food, although the usual route is 
person-to-person contact.12
Food unlikely the source of  NLV in this case
The high rate of  participation in our study survey, renders the outcome of  the 
investigation into whether the NLV outbreak was foodborne or not, very reliable. 
While no non-response study was performed, and a relatively higher percentage 
of  ill individuals submitted faecal samples than individuals who remained healthy, 
it is unlikely that distortion occurred at the level of  suspicious exposure factors, 
as the results of  the study were published after the questionnaires were handed 
in. Another argument against a foodborne outbreak is the fact that the kitchen 
was in compliance with HACPP standards and that no uncooked food, raw fish 
products or oysters were served. We view the fact that 26% of  those who became 
ill had partaken of  2 statistically suspicious dishes as a coincidence. After all, a 
large number – 61 in total - of  different dishes was examined. Moreover, 1 of  the 
2 suspicious dishes was also served at weddings 3 and 4, where no one became 
ill.
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Transmission of  NLV through direct contact
This outbreak may also have been caused by NLV transmission via direct or 
indirect contact between wedding guests and personnel. An argument in favour 
of  a person-to-person outbreak is the fact that one person became ill on the day 
of  the wedding itself, even before the food was served: the index person. As a key 
player in risk group 1, she participated in greeting the family before and during 
the dinner. The people in risk group 1 subsequently became part of  risk group 2 
during the rest of  the day, which group came into contact with risk group 3 in the 
shared hall and sanitary facilities. This fits well with the decreasing attack rates in 
risk groups 1, 2 and 3: respectively 79%, 76% and 50%. As a wedding guest was 
the first to succumb, with restaurant staff  becoming ill only after 2 days following 
the wedding, contamination via a member of  the serving staff  appears unlikely.
Also, the NLV outbreak described by us was characterized by vomiting in more 
than 50% of  the ill individuals, an incubation time of  between 24-28 h and illness 
duration of  between 12-60 h.12 These characteristics led to the viral diagnosis 
following analysis of  the questionnaires.
The fact that no virus was found in the faeces of  32% of  those becoming ill may 
have resulted from a disease definition that was simply not specific enough, but 
is more likely due to the tardy collection of  faecal samples (5–10 days after the 
weddings). NLV excretion reaches maximum levels during the acute phase (24-72 
h), although excretion up to minimally 10 days has been observed in volunteers. 
As NLV levels in the stool are usually low, the best chance of  actually diagnosing 
NLV infection is by ensuring that an outbreak of  gastroenteritis is reported without 
delay, directly followed by the collection of  faeces from symptomatic individuals. 
Had bacterial and viral testing been performed simultaneously during this out-
break, the viral diagnosis would have probably been determined earlier. The 
victims and restaurant owner would have been informed earlier, in particular about 
the consequences for the prevention policy to be followed. After all, recovered 
food workers and nursing staff  with a negative bacterial culture are permitted to 
return to work (‘Outbreaks of  gastroenteritides in institutions’, compiled by the 
National Coordination of  Infectious Disease Control (1996); www.infectieziek-
ten.info), whereas persons with a positive viral culture may not, in the light of  
the chance of  viral shedding, which may last for days, and transmission of  the 
low infective dose of  NLV (Protocol ‘Calicivirus’ (2002, National Coordination 
of  Infectious Disease Control (1996); www.infectieziekten.info). Workers may 
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return to work according to this protocol 24-72 hours after these symptoms 
have indeed gone and stringent adherence to hand and toilet hygiene is enforced 
(Protocol ‘Calicivirus’ (2002).
Conclusion
On the grounds of  this study we strongly advocate performing bacterial and 
viral tests simultaneously in the event of  gastroenteritis, especially if  persons 
working in the food industry or in nursing are involved. We advocate this in part 
because of  the high prevalence of  NLV in epidemics of  gastroenteritis in the 
Netherlands,3,13 the lack of  insight into the prevalence of  the symptoms during 
a gastroenteritis epidemic prior to analysis of  the questionnaires and the low 
predictive value of  symptoms regarding the cause of  an outbreak.14 
In addition, viral examination of  the surroundings and mandatory saving of  
leftover food samples from the restaurants and central kitchens may not be absent, 
enabling an implicated food product to be easily taken out of  circulation.
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Summary 
Objective. To assess the risk of  introduction of  polio virus in a Cape Verdian com-
munity of  Rotterdam, during the polio epidemic in Cape Verde in 2000.
Methods. All 225 insufficiently vaccinated 0–14-year-old children out of  all 0–14-
year-old Cape Verdian children living in Rotterdam (n = 4188) and a random 
sample of  285 Cape Verdians out of  all 15–30-year-old Cape Verdians (n = 5074) 
in Rotterdam were surveyed to assess travel behaviour and vaccination coverage. 
Faecal specimens were collected and sewage samples taken in neighbourhoods 
with a sizable Cape Verdian population for testing of  polio virus.
Results. Of  the Cape Verdian children aged 0–14 years living in Rotterdam, 
94.6% was sufficiently vaccinated, but 10% of  the 91 responding insufficiently 
vaccinated children aged 0-14 years, reported travelling to Cape Verde during the 
polio epidemic. Of  the responding adults aged 15–30 years living in Rotterdam 
(n=82), 10% was not vaccinated against polio, and 17% reported travelling to 
Cape Verde during the polio epidemic.
In the faeces of  80 insufficiently vaccinated individuals aged 0–14 years and in 
74 adults aged 15–30 years, no poliovirus was detected. 
Samples of  sewage from six sites were negative for poliovirus.
Conclusion. No evidence of  poliovirus infection was found in the Cape Verdian 
population in Rotterdam despite extensive travel to the Cape Verde during the 
outbreak.
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Introduction
In the Netherlands, the vaccination coverage with inactivated polio vaccine (IPV) 
in the national vaccination program is high (97.2% in 2000), but it is not evenly 
distributed throughout the country.1 In 2003, 37 (8%) of  all 485 municipalities 
had a coverage rate of  < 90% in 9-year-old children; nine of  these 37 achieved < 
80%.1 These municipalities are in an area that crosses the country diagonally from 
the north–east to the south–west, where they surround Rotterdam; they are home 
to an estimated 275.000 members of  Orthodox Reformed religious communities 
who decline vaccination.2 These communities have suffered polio epidemics, most 
recently in 1992–1993,3 and other vaccine preventable epidemics of  measles and 
rubella.4,5 Since 1993, the number of  new polio-susceptible children has increased 
by several tens of  thousands.2,6
The World Health Organization (WHO) is committed to eradicate poliomyelitis.7 
Unfortunately, the campaign has encountered set-backs, with introduction of  infec-
tion in previously free areas.8,9 In August 2000, an epidemic of  poliomyelitis was 
reported in Cape Verde, an archipelago in the Atlantic Ocean west of  Senegal, where 
the estimated vaccination coverage in children under 5 years was < 80%.10
In November 2000, the WHO warned of  the export of  wild poliovirus to countries 
with extensive travel contact with Cape Verde. At this time, neither clinical cases 
of  poliomyelitis nor poliovirus infections had been diagnosed in The Netherlands. 
Since Rotterdam has a large Cape Verdian community and adequate information 
was not available about the vaccine coverage of  Cape Verdians above the age of  
14 years, the possibility could not be excluded of  importation of  poliovirus into 
the Cape Verdian community in Rotterdam, from which then transmission might 
occur into the surrounding unprotected religious communities.
Therefore, the Dutch authorities decided to vaccinate all inadequately (less then 
three times) vaccinated Cape Verdians aged 0–30 years in The Netherlands with 
live oral polio vaccine (OPV). To promote the participation in the campaign, 
anonymous obtainment of  OPV was permitted.
The authorities assumed that Cape Verdians above 30 years were naturally pro-
tected through the last poliovirus type 1 epidemic in Cape Verde, as reported to 
them by the WHO to have occurred in 1970.
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To assess the risk of  introduction of  poliovirus into the Rotterdam community 
and to determine whether the virus was actually introduced before the vaccina-
tion campaign, the vaccination coverage, travel frequency to Cape Verde during 
the polio epidemic and presence of  poliovirus in the Cape Verdian community 
of  Rotterdam were studied.
Methods
Study population
In this study, a Cape Verdian was defined as a person with at least with one par-
ent born in Cape Verde, and who was registered in the Municipal Population 
Register (MPR) of  Rotterdam. The target group of  the national vaccination 
campaign against poliomyelitis was divided into two age groups 0–14 and 15–30 
years. By cross-referencing the MPR with the Provincial Vaccination Register, 
all 225 insufficiently vaccinated (< 3 doses IPV) Cape Verdian children from 0 
to 14 years were identified among the 4188 that were registered on the MPR. 
The second study group was a random sample of  285 subjects, obtained from 
the MPR from all 5074 Cape Verdians aged 15–30 years registered as resident 
in Rotterdam.
Data collection
A structured questionnaire about travel behaviour to Cape Verde and contact with 
returned travellers was mailed to both study groups with a request for a faeces 
sample. The parents of  the children < 14 years were also asked about vaccination 
status of  their children and travel to and from Cape Verde after the 1st July 2000, 
6 weeks before the first clinical case of  poliomyelitis was diagnosed on the islands. 
The place of  residence of  all Cape Verdians in Rotterdam was obtained from the 
MPR. Finally, a non-response analysis was performed to assess if  respondents 
and non-responders aged 0–30 years were evenly distributed throughout the 
neighbourhoods of  Rotterdam, and whether respondents aged 0–14 years were 
representative of  the non-responders aged 0–14 years in frequency of  vaccina-
tion.
Faeces study 
Faeces samples were examined at the National Institute of  Health and the Envi-
ronment for the presence of  virus, as recommended by the WHO.11 
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Sewage samples were tested for poliovirus in the six neighbourhoods with the 
highest number of  Cape Verdian immigrants. The locations for sewage sam-
pling were chosen to represent effluent from areas of  most dense Cape Verdian 
congregation. Six sewage samples of  1 l each were taken on a rain-free day to 
avoid dilution. The samples were collected in sterile bottles kept at 4 0C and 
transported within 24 h to the laboratory for examination for the presence of  
poliovirus according to a previously described method.12
Statistical analysis
The sample size of  group 1 (n = 225) was determined by the total number of  
the insufficiently vaccinated Cape Verdians in Rotterdam aged 0–14 year. The 
sample size of  group 2 (n = 285) was chosen in such a way that with a participa-
tion rate of  25% in the faeces study, a prevalence of  infection with polio virus 
of  at least 4% would be detected with a confidence of  95%. 
The 95% confidence interval of  the prevalence of  positive faeces samples was 
calculated assuming a binomial distribution, because only a positive or negative 
outcome was possible.13 The confidence interval in the total group of  0–30-year 
olds was calculated assuming that if  polio virus infection had occurred, it would 
have been in the insufficiently vaccinated group aged 0–14 years.
Significance was calculated by means of  the chi-square test, with Yates’ correc-
tion (Epi-InfoTM version 5.1; CDC, Atlanta, GA, USA).
Results
The response rate to the questionnaire was 40% among the 225 aged 0–14 years 
and 29% among the 285 aged 15–30 years. Of  the 91 responding 0–14-year-olds 
with insufficient vaccination against polio, 9 (10%) had visited Cape Verde during 
the polio epidemic (Table 1) and of  these 9 children, three had never received a 
vaccination against polio (Table 2).
Fourteen (17%) of  the 82 responding 15–30-year-olds had had visited Cape 
Verde during the polio epidemic.
Contact with a person who had been in Cape Verde during the epidemic was 
frequent, reported in 58% of  the group aged 0–14 years with insufficient vac-
cination and 75% of  the 15–30-year-olds.
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The percentage of  Cape Verdians in Rotterdam with sufficient vaccination against 
polio in the age groups 0–14 years was 94.6% (3963/4188). Of  the 225 insuf-
ficiently vaccinated 0–14-year-olds, 112 (50%) were vaccinated at least once and 
27/225 (24%) were too young to be vaccinated three times (Table 2). 
By using the efficacy of  polio vaccine after 1, 2 and 3 doses,14 we calculated that 
only 150 (3.6%) of  all 0–14-year-old Cape Verdian children in Rotterdam were 
susceptible to infection with poliovirus (calculation shown in Table 2). In the 
group of  15–30-year-old Cape Verdians and the travellers among them, 90% 
reported to be vaccinated.
During the observation period, Rotterdam had a population of  592 660, with 
14 449 (2.4%) Cape Verdian immigrants who lived in 70 of  the 85 city neigh-
bourhoods. However, 39% (5700) of  all Cape Verdian immigrants lived in six 
neighbourhoods from where the sewage samples were taken. The insufficiently 
vaccinated Cape Verdians were spread proportionately among the Cape Verdian 
communities.
A faeces sample was provided by 80/225 (35%) of  the participants of  the group 
aged 0–14 years and by 74/285 (26%) of  the group aged 15–30 years. None of  
the faecal samples contained poliovirus. Based on the absence of  positive findings 
of  poliovirus, it was calculated that with a 95% upper confidence limit, a possible 
prevalence of  poliovirus in the groups aged 0–14 and 15–30 years, and for the 
total group aged 0–30 years, would not be >3.7%, 4.0% and 1.1% respectively.
Table 1. Results of  the questionnaire among Cape Verdians in Rotterdam in 2000.
Group 1 Group 2
Mean age (years) 5 22
Male 40 (44) 39 (47)
Ever been to Cape Verde 34 (37) 75 (92)
Visit to Cape Verde during polio epidemic 9 (10) 14 (17)
Contact (any) with person who was on Cape Verde during 
polio epidemic
58 (64) 62 (75)
Contact at home with person who was on Cape Verde during 
polio epidemic
50 (55) 56 (68)
Group 1, Cape Verdians 0-14 year less then three times vaccinated (n=91)
Group 2, Cape Verdians 15-30 year random sample (n=82)
Values in parenthesis are percentages
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No poliovirus was detected in the six sewage samples in the six neighbourhoods 
examined. In four of  six samples other enteroviruses were detected. 
In 2000 and 2001, no poliovirus infections were reported in The Netherlands.
In an existing enterovirus surveillance programme OPV virus was found in faeces 
samples of  four hospitalized patients of  Cape Verdian origin, not admitted for 
symptoms of  poliomyelitis.
Finally, no statistically significant difference was found between respondents and 
non-respondents aged 0–14 years and 0–30 years in vaccination frequency and 
proportionate spread throughout the Cape Verdian communities, respectively.
Discussion
Although no cases of  polio infection were reported, risk factors for the introduc-
tion of  poliovirus in the Cape Verdian community in Rotterdam were certainly 
present. 
No poliovirus was detected in the faeces of  154 individuals in the combined 
study groups aged 0–30 years, indicating statistically that an infection rate of  
1.1% at most was missed in this group. This rate is much lower than the infec-
tion rate of  6% found in The Netherlands during the early phase of  the polio 
Table 2. The observed and required vaccination frequency, considering age and requirements of  
the National Vaccination Programme of  all 225 0-14 year old Rotterdam Cape Verdians who were 
not vaccinated sufficiently against polio (less then three times). The 9 children who were on Cape 
Verde during the polio-epidemic are indicated between brackets. The number of  non protected 
children is calculated according to the known efficacy of  polio vaccination.14
Required vaccination 
frequency
Observed vaccination frequency
0 1 2 ³ 3 Total
0 27 0 0 0 27
1 16 0 0 0 16
2 25 1 0 0 26
3 10 [1] 6 21 0 37
> 3 35 [2] 40 [4] 44 [2] 0 119
Total 113 47 65 0 225
Efficacy against poliomyelitis 0% 36% 89% 100%
No protection against clinical 
poliomyelitis
113 30 7 0 150
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epidemic in 1992–1993, when an average infection rate in faeces was found of  
6% in schools with both vaccinated and non-vaccinated students.15
Also in the sewage investigation, no indication was found, for circulation of  
poliovirus among Cape Verdians living in Rotterdam. 
Routine screening of  sewage samples makes the prediction of  a polio epidemic 
in its early stages possible.12,15 The sewage investigations in Rotterdam were 
conducted in neighbourhoods with the highest concentration of  Cape Verdians 
in Rotterdam (5700/14 449). With the sensitivity of  the study by Hovi et al.16 
extrapolated to the Rotterdam sewage investigation, one poliovirus secretor 
among the 5700 Cape Verdians would have been detected.
Cape Verdians in Rotterdam, aged 15–30 years reported the high vaccination 
coverage of  90%. The coverage in the age groups 0–14 years was 94.6%, which 
is comparable with the coverage in the Dutch population in general. The remain-
ing 5.4% was at least partly vaccinated. 
Also, Cape Verdians in Rotterdam live well spread over the city and do not 
constitute >15% of  any neighbourhood population. In particular, there was no 
concentration of  insufficiently vaccinated Cape Verdians in Rotterdam. 
Cape Verdians living illegally in Rotterdam were not included in the study, and 
thus could bias the results. According to key figures in the Cape Verdian com-
munity in Rotterdam however, illegal Cape Verdians add at most 10% to the 
Cape Verdian community and live concentrated in the six neighbourhoods from 
which the sewage samples were taken. 
Besides their own herd immunity, Cape Verdians were protected as well by the 
high vaccination coverage of  the general Dutch population in Rotterdam, which 
is approximately 97%.1 The minimal required vaccination coverage to prevent 
circulation of  poliovirus is 82–87%.17
Alertness regarding adequate vaccination of  travellers to polio-epidemic areas 
remains necessary. The polio epidemic in Cape Verde was only reported to the 
health authorities in Rotterdam 3 months after it started. This underlines the 
importance of  rapid communication of  outbreaks to authorities. 
This study showed that there was no need of  fear for indirect transmission to 
the Orthodox Reformed religious communities in The Netherlands through the 
Cape Verdian community in Rotterdam.
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Contacts between Cape Verdians and the Orthodox Reformed communities are 
limited anyway, because the latter attend their own schools and are unlikely to 
share hygienic facilities with Cape Verdians. Nevertheless, caution is warranted.
In retrospect and considering the extensive coverage against polio in both the 
Cape Verdian and the general Dutch population, inactivated polio vaccine (IPV) 
vaccination of  insufficiently vaccinated individual Cape Verdians would have been 
sufficient. In this way any conceivable risk of  OPV virus to become pathogenic 
would be avoided.
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This thesis focuses on outbreak management, the domain of  public health 
practice, as an opportunity to obtain knowledge, basically the domain of  
science, for communicable disease control.
In the introduction we outlined the interrelationship between science and public 
health practice.
In the field of  science, research leads to knowledge about determinants and 
interventions of  communicable diseases on the levels of  agent, transmission and 
host. In science, epidemiology is used to obtain evidence about determinants 
and interventions.
In public health practice knowledge is applied to control communicable diseases, 
and surveillance monitors the occurrence of  communicable diseases and detects 
signals of  outbreaks and combines signals to suspect an outbreak.
In outbreak management surveillance may lead to the formulation of  hypotheses 
about determinants and possible interventions, and epidemiology is used for test-
ing hypotheses for guidance towards effective control of  communicable diseases 
at hand.
Answering the research questions of  this thesis
The first research question is whether epidemiological studies during outbreak 
management are able to generate specific knowledge for the containment of  the 
communicable disease at hand, and the second question is whether these studies 
are able to generate knowledge of  more general nature than necessary for the 
immediate containment of  the communicable disease at hand.
In short, the answer to these two questions is “yes”. From my case studies, as 
described in the previous chapters of  my thesis, this becomes evident. Systematic 
outbreak management, in which surveillance and epidemiology are combined, 
generates knowledge in the same way as research does in the domain of  science.
To substantiate my confirmative answer to the two research questions, the case 
studies in my thesis and the knowledge obtained in these case studies are sum-
marized in tables 9.1 and 9.2. The tables list the motivation for the studies and 
the knowledge that I have identified during the outbreak management.
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Knowledge is differentiated into specific and general knowledge. Firstly each of  
the two types of  knowledge are differentiated into the three basic determinants of  
communicable diseases: (1) the infectious agent and its source(s); (2) the transmis-
sion of  the agent to the host, and the environment in which transmission takes 
place; and (3) the host, or a group of  hosts, including the routes of  entry into the 
host and the reactions (immunity, morbidity and mortality) of  a host or a group 
of  hosts to the infection with an agent. Secondly, the two types of  knowledge 
are differentiated into interventions to control communicable diseases that are 
directed towards the three determinants of  communicable diseases.1-3
Table 9.1 represents the pertussis studies in chapter 2-5. Chapter 2 describes an 
epidemiological study of  an outbreak of  coughing in a convent among the nuns 
and their staff  in the village of  Baexem, the Netherlands. The study started after 
the general practitioner of  the convent reported to the surveillance system that 
for 9 weeks he had tried to diagnose an outbreak of  coughing in the convent 
and to stop the outbreak with several therapies, including antibiotics. The general 
practitioner did not consider the diagnosis pertussis because the nuns were adults, 
while at that time pertussis was considered to be a children’s disease. 
The specific knowledge obtained in the course of  the outbreak management was 
that pertussis was the cause of  the outbreak. This was established in a retrospec-
tive cohort study. On the basis of  this diagnosis, measures were taken to curb 
the outbreak. 
The most important contribution to general knowledge for the control of  per-
tussis was the discovery that adults can be seriously at risk for morbidity and 
mortality due to pertussis. The hypothesis that adults are a true risk group for 
pertussis was substantiated in this study. The pertussis outbreak was followed to 
its end and serological testing was done up to one year after the outbreak. This 
follow-up of  the outbreak provided general knowledge about the practicality and 
yield of  single and paired IgA and IgG antibody titers for diagnosing pertussis 
infections among adults. 
The study described in chapter 2 served as a data base for three further studies 
of  pertussis. The outcome of  the serological testing of  the cohort of  nuns and 
their staff  was used in the successive studies described in chapters 3 and 4 to 
obtain more general knowledge about the diagnosis of  pertussis with serological 
tests. In these chapters we focused on the IgA and IgG antibody titer levels for 
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diagnosing pertussis infections and were able to contribute to general knowledge 
about the increase and decrease of  IgG antibody titers in children and adults 
with clinical pertussis, and to general knowledge about the meaning of  single 
IgA and IgG titers for laboratory confirmation of  pertussis in adults in the first 
three weeks of  pertussis.
In chapter 5 the outcome of  the study in chapter 2 was linked to the outcome 
of  a study of  the careers of  the nuns in the convent. This was done because in 
the study described in chapter 2 it was not found that within the group of  elderly 
nuns the risk for pertussis was statistically significantly increased with age. It was 
therefore hypothesised that the serious outbreak among the elderly nuns could 
be seen as a natural experiment with lack of  natural re-infections in the environ-
ment of  the isolated convent. The linking of  the data of  the two studies helped 
to establish the association between social isolation and pertussis. The study 
described in chapter 5 revealed the importance of  social isolation as a risk factor 
for pertussis. In that way general knowledge was obtained about environmental 
and host factors contributing to pertussis and leading to further insight into the 
importance of  immunity due to natural re-infections. Finally, it also led to advice 
regarding possible vaccination strategies in countries with successful national 
vaccination campaigns.
Table 9.2 represents the outbreak studies in chapter 6-8. 
The two studies on gastro-enteritis in chapter 6 and 7 revealed specific knowledge 
about the bacterial and viral cause of  epidemics of  gastro-enteritis. General 
knowledge was generated about ways to diagnose the cause of  gastro-enteritis 
in the food and health care sector in order to avoid the risk of  transmission and 
undesired prolongation of  the duration of  Norwalk-like virus outbreaks in this 
vulnerable sector. The discovery of  Salmonella typhimurium in a salted and smoked 
meat product initiated further research into this possible risk factor by the Food 
and Consumer Product Safety Authority.
Finally, in chapter 8 the study on possible introduction of  polio virus in Rotter-
dam through the resident Cape Verdian community generated knowledge about 
the risk of  introduction of  poliovirus into a migrant community in a major city 
during an outbreak of  poliomyelitis in the country of  origin. General knowledge 
was generated about the importance of  travellers being adequately protected 
to avoid any risk of  transmission of  polio virus from epidemic and endemic 
countries towards countries with large unvaccinated populations. Knowledge was 
obtained as well about the use of  inactivated polio vaccine (IPV) instead of  live 
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Table 9.1. Summary of  specific and general knowledge obtained from the pertussis study in 
Chapter 2, 3, 4 and 5.
Study Chapter 2: An epidemic of  pertussis among elderly people in a religious 
institution in The Netherlands
Chapter 3: Age-specific long-term course 
of  IgG antibodies to pertussis toxin after  
symptomatic infection with Bordetella 
pertussis
Chapter 4: Sensitivity and specificity 
of  single IgA and IgG antibodies for 
early diagnosis of  pertussis in adults: 
evaluation for outbreak management in 
public health practice
Chapter 5: A pertussis outbreak 
associated with social isolation 
among elderly nuns in a convent  
Motivation for the study Outbreak management of  a 9-week lasting epidemic of  serious coughing in 
a convent with elderly nuns, not responding to antibiotic therapy given by 
the general practitioner
Interest in improvement of  the serological 
pertussis test in children and adults, based 
on clinical pertussis among children and 
adults
Interest in improvement of  the 
serological diagnostic test for early 
diagnosis of  pertussis among adults 
in public health practice
Seeking of  an explanation of  the 
serious pertussis epidemic among 
elderly nuns and their personnel in a 
religious convent in 19924
Specific knowledge
Determinant level Agent Bordetella pertussis cause of  outbreak in convent - - -
Transmission Description of  epidemiological curve of  pertussis outbreak - - -
Host Description of  clinical signs and symptoms, frequency, and duration of  the 
Bordetella pertussis outbreak among personnel and nuns in the convent
Significant (4-fold) increasing and decreasing IgA and IgG titres used and 
accepted for confirmation of  pertussis infection to overcome difficulties 
of  confirmation due to the particular Dutch policy of  pertussis testing
Description of  single IgA and IgG titre levels of  subjects with and without 
clinical pertussis
Description and comparison of  yield of  culture, PCR significant paired 
increasing and decreasing IgA and IgG tests
Morbidity and mortality rates were significant lower among adult personnel 
than among elderly nuns
- - -
Intervention level Agent - - - -
Transmission Antibiotics, as prescribed by the general practitioner of  the convent, in the 
first 9 weeks of  the epidemic, did not stop transmission of  Bordetella pertussis 
in the convent
- - -
Host Antibiotics, as prescribed by the general practitioner of  the convent, in 
the first 9 weeks of  the epidemic, did not prevent serious morbidity and 
mortality due to Bordetella pertussis infection among nuns in the convent
- - -
General knowledge
Determinant level Agent Bordetella pertussis causes pertussis among adults and elderly - - -
Transmission - - - -
Host Comparison of  increase and decrease of  
IgG antibody titres in children and adults 
with pertussis showed no difference in 
rise, peak and decline of  IgG between 
different age groups
Low levels IgA and IgG titres are 
sensitive, specific and practical for 
laboratory confirmation of  Bordetella 
pertussis in adults in the first three weeks 
of  outbreak management
Age is not, and social isolation is a 
risk factor for pertussis
Lack of  natural re-infections with 
Bordetella pertussis suggested as cause 
of  serious pertussis epidemic
Intervention level Agent - - - -
Transmission - - - -
Host - - - Suggestion made that booster 
doses of  pertussis vaccine may be a 
valuable strategy to control pertussis 
in populations with successful 
national childhood vaccination 
campaigns
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Table 9.1. Summary of  specific and general knowledge obtained from the pertussis study in 
Chapter 2, 3, 4 and 5.
Study Chapter 2: An epidemic of  pertussis among elderly people in a religious 
institution in The Netherlands
Chapter 3: Age-specific long-term course 
of  IgG antibodies to pertussis toxin after  
symptomatic infection with Bordetella 
pertussis
Chapter 4: Sensitivity and specificity 
of  single IgA and IgG antibodies for 
early diagnosis of  pertussis in adults: 
evaluation for outbreak management in 
public health practice
Chapter 5: A pertussis outbreak 
associated with social isolation 
among elderly nuns in a convent  
Motivation for the study Outbreak management of  a 9-week lasting epidemic of  serious coughing in 
a convent with elderly nuns, not responding to antibiotic therapy given by 
the general practitioner
Interest in improvement of  the serological 
pertussis test in children and adults, based 
on clinical pertussis among children and 
adults
Interest in improvement of  the 
serological diagnostic test for early 
diagnosis of  pertussis among adults 
in public health practice
Seeking of  an explanation of  the 
serious pertussis epidemic among 
elderly nuns and their personnel in a 
religious convent in 19924
Specific knowledge
Determinant level Agent Bordetella pertussis cause of  outbreak in convent - - -
Transmission Description of  epidemiological curve of  pertussis outbreak - - -
Host Description of  clinical signs and symptoms, frequency, and duration of  the 
Bordetella pertussis outbreak among personnel and nuns in the convent
Significant (4-fold) increasing and decreasing IgA and IgG titres used and 
accepted for confirmation of  pertussis infection to overcome difficulties 
of  confirmation due to the particular Dutch policy of  pertussis testing
Description of  single IgA and IgG titre levels of  subjects with and without 
clinical pertussis
Description and comparison of  yield of  culture, PCR significant paired 
increasing and decreasing IgA and IgG tests
Morbidity and mortality rates were significant lower among adult personnel 
than among elderly nuns
- - -
Intervention level Agent - - - -
Transmission Antibiotics, as prescribed by the general practitioner of  the convent, in the 
first 9 weeks of  the epidemic, did not stop transmission of  Bordetella pertussis 
in the convent
- - -
Host Antibiotics, as prescribed by the general practitioner of  the convent, in 
the first 9 weeks of  the epidemic, did not prevent serious morbidity and 
mortality due to Bordetella pertussis infection among nuns in the convent
- - -
General knowledge
Determinant level Agent Bordetella pertussis causes pertussis among adults and elderly - - -
Transmission - - - -
Host Comparison of  increase and decrease of  
IgG antibody titres in children and adults 
with pertussis showed no difference in 
rise, peak and decline of  IgG between 
different age groups
Low levels IgA and IgG titres are 
sensitive, specific and practical for 
laboratory confirmation of  Bordetella 
pertussis in adults in the first three weeks 
of  outbreak management
Age is not, and social isolation is a 
risk factor for pertussis
Lack of  natural re-infections with 
Bordetella pertussis suggested as cause 
of  serious pertussis epidemic
Intervention level Agent - - - -
Transmission - - - -
Host - - - Suggestion made that booster 
doses of  pertussis vaccine may be a 
valuable strategy to control pertussis 
in populations with successful 
national childhood vaccination 
campaigns
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Table 9.2. Summary of  specific and general knowledge obtained from the outbreak studies in 
Chapter 6, 7 and 8.
Study Chapter 6: An epidemic of  Salmonella typhimurium associated with 
traditional salted, smoked, and dried ham
Chapter 7: A gastroenteritis epidemic caused by a 
Norwalk-like virus after two weddings in a restaurant; 
a plea for integral microbiological investigation
Chapter 8: Risk of  introduction of  poliovirus into a Dutch Cape 
Verdian community during an outbreak of  poliovirus in Cape 
Verde, 2000
Motivation for the study Outbreak management of  an epidemic of  gastro-enteritis among 
guests of  a family party
Outbreak management of  an epidemic of  gastro-
enteritis among guests after a wedding party
To assess the risk of  introduction of  polio virus in a Cape Verdian 
community in Rotterdam, during the polio epidemic in Cape 
Verde in 2000, before live oral polio vaccine (OPV) was used in 
a mass vaccination campaign in the Cape Verdian community in 
Rotterdam. The mass vaccination campaign was held to prevent 
poliomyelitis in individual cases, and to prevent transmission of  the 
poliovirus to the non-vaccinated communities in the Bible Belt in 
the Netherlands
Specific knowledge
Determinant level Agent Salmonella typhimurium fage type 20 cause of  the outbreak of  gastro-
enteritis
Norwalk-like virus cause of  outbreak of  gastro-enteritis No evidence of  polio virus infection was found in the Rotterdam 
Cape Verdian community
Transmission Salted and smoked ham was source and vehicle of  transmission of  
Salmonella typhimurium
Description of  epidemiological curve of  Norwalk-like 
virus outbreak
Unvaccinated subjects travelled between the Cape Verdian 
community in Rotterdam and the polio-epidemic Cape Verde, 
risking transmission of  poliovirus between the two countries
Important guest in the wedding party appeared to be the 
index case of  the Norwalk-like virus outbreak
Host Description of  clinical signs and symptoms, frequency, incubation 
period and duration of  a Salmonella typhimurium infection
Description of  clinical signs and symptoms, frequency, 
incubation period and duration of  a Norwalk-like virus 
infection
Intervention level Agent
Transmission
Host Distribution of  sufficiently and insufficiently vaccinated 
Cape Verdians in the general population of  Rotterdam is 
proportionately sufficient to maintain herd immunity against 
poliomyelitis
No evidence was found to justify the use of  live oral polio vaccine 
(OPV) in a an anonymous mass vaccination campaign in a 
Rotterdam Cape Verdian community with HIV-infection rates 
up to 5% in some risk groups
General knowledge
Determinant level Agent
Transmission During gatherings like parties Norwalk-like virus is being 
transmitted directly from person to person
Host
Intervention level Agent Salting and smoking appeared insufficient bactericidal to kill Salmonella 
typhimurium in pig meat
Testing of  food products, feces and the environment 
for bacterial and viral causes might increase the speed of  
diagnosing Norwalk-like virus as cause of  outbreaks of  
gastro-enteritis in the food industry and the health care.
This will accelerate the execution of  hygienic measures to 
stop the spread of  Norwalk-like virus
Transmission Alertness regarding adequate vaccination of  travellers to polio-
epidemic areas remains necessary as long as poliomyelitis is 
not eradicated, especially of  travellers between polio-endemic 
and polio-epidemic areas and the large insufficiently vaccinated 
population in the Netherlands
Host In comparable situations a mass vaccination campaign with 
inactivated polio vaccine (IPV) has to be considered seriously 
in insufficiently vaccinated subjects in communities with a high 
IPV-vaccination coverage to avoid any conceivable risk of  OPV 
virus to become pathogenic
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Table 9.2. Summary of  specific and general knowledge obtained from the outbreak studies in 
Chapter 6, 7 and 8.
Study Chapter 6: An epidemic of  Salmonella typhimurium associated with 
traditional salted, smoked, and dried ham
Chapter 7: A gastroenteritis epidemic caused by a 
Norwalk-like virus after two weddings in a restaurant; 
a plea for integral microbiological investigation
Chapter 8: Risk of  introduction of  poliovirus into a Dutch Cape 
Verdian community during an outbreak of  poliovirus in Cape 
Verde, 2000
Motivation for the study Outbreak management of  an epidemic of  gastro-enteritis among 
guests of  a family party
Outbreak management of  an epidemic of  gastro-
enteritis among guests after a wedding party
To assess the risk of  introduction of  polio virus in a Cape Verdian 
community in Rotterdam, during the polio epidemic in Cape 
Verde in 2000, before live oral polio vaccine (OPV) was used in 
a mass vaccination campaign in the Cape Verdian community in 
Rotterdam. The mass vaccination campaign was held to prevent 
poliomyelitis in individual cases, and to prevent transmission of  the 
poliovirus to the non-vaccinated communities in the Bible Belt in 
the Netherlands
Specific knowledge
Determinant level Agent Salmonella typhimurium fage type 20 cause of  the outbreak of  gastro-
enteritis
Norwalk-like virus cause of  outbreak of  gastro-enteritis No evidence of  polio virus infection was found in the Rotterdam 
Cape Verdian community
Transmission Salted and smoked ham was source and vehicle of  transmission of  
Salmonella typhimurium
Description of  epidemiological curve of  Norwalk-like 
virus outbreak
Unvaccinated subjects travelled between the Cape Verdian 
community in Rotterdam and the polio-epidemic Cape Verde, 
risking transmission of  poliovirus between the two countries
Important guest in the wedding party appeared to be the 
index case of  the Norwalk-like virus outbreak
Host Description of  clinical signs and symptoms, frequency, incubation 
period and duration of  a Salmonella typhimurium infection
Description of  clinical signs and symptoms, frequency, 
incubation period and duration of  a Norwalk-like virus 
infection
Intervention level Agent
Transmission
Host Distribution of  sufficiently and insufficiently vaccinated 
Cape Verdians in the general population of  Rotterdam is 
proportionately sufficient to maintain herd immunity against 
poliomyelitis
No evidence was found to justify the use of  live oral polio vaccine 
(OPV) in a an anonymous mass vaccination campaign in a 
Rotterdam Cape Verdian community with HIV-infection rates 
up to 5% in some risk groups
General knowledge
Determinant level Agent
Transmission During gatherings like parties Norwalk-like virus is being 
transmitted directly from person to person
Host
Intervention level Agent Salting and smoking appeared insufficient bactericidal to kill Salmonella 
typhimurium in pig meat
Testing of  food products, feces and the environment 
for bacterial and viral causes might increase the speed of  
diagnosing Norwalk-like virus as cause of  outbreaks of  
gastro-enteritis in the food industry and the health care.
This will accelerate the execution of  hygienic measures to 
stop the spread of  Norwalk-like virus
Transmission Alertness regarding adequate vaccination of  travellers to polio-
epidemic areas remains necessary as long as poliomyelitis is 
not eradicated, especially of  travellers between polio-endemic 
and polio-epidemic areas and the large insufficiently vaccinated 
population in the Netherlands
Host In comparable situations a mass vaccination campaign with 
inactivated polio vaccine (IPV) has to be considered seriously 
in insufficiently vaccinated subjects in communities with a high 
IPV-vaccination coverage to avoid any conceivable risk of  OPV 
virus to become pathogenic
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oral polio vaccine (OPV) in comparable situations to avoid any conceivable risk 
of  OPV virus to become pathogenic and to circulate as was detected in several 
countries since 1982.4-8
Limitations and strengths of  outbreak studies reported 
in this thesis as sources of  knowledge
Limitations
The most important limitation of  outbreaks as sources for knowledge in general, 
and therefore also for the studies described in this thesis, lays partly in the reac-
tion of  the public, politicians and public health authorities responsible for public 
health, and partly in the urgency and the local situation in which an outbreak takes 
place.2,3,9 These reactions may not match the circumstances that epidemiological 
studies of  outbreaks and research require. If  outbreaks cannot be investigated 
in the required circumstances, the outcome of  epidemiological studies may have 
limited value. Therefore commitment of  the responsible politicians and the public 
health authorities is required, as well as of  the medical institutions and laboratories 
involved. Also the cooperation and commitment of  the public is necessary, espe-
cially the population at risk in an outbreak study. Commitment is also needed by 
the organisation that is being investigated as a possible source of  an outbreak.  
The urgency of  the situation of  an outbreak not only requires a swift reaction 
from all persons responsible for the outbreak study, but also professionalism. 
Possible research methods which can be used in these urgent circumstances 
should be known. Also formulation of  hypotheses and knowledge about unre-
solved scientific problems that can be investigated during an outbreak requires 
professionalism. 
There is also a need for medical knowledge of  clinical signs and symptoms of  
communicable diseases. This need for professionalism is clearly recognised for 
situations in which bioterrorism is at hand. In that case syndromic surveillance 
systems are essential as “smoke detectors”, which require prompt outbreak 
investigation. For such circumstances the importance of  the availability of  well-
trained public health professionals with responsibilities beyond the resistance of  
bioterrorism is emphasised and generally accepted.10 However, the impact of  
non-bioterroristic communicable disease outbreaks on the health of  populations 
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is much larger, and therefore justifies the highest standards of  professional qual-
ity and attention towards outbreak management.
Strengths
In the introduction of  this thesis I have argued that outbreaks should be consid-
ered as natural experiments of  communicable diseases, which may reveal clues 
about the control of  such diseases. 
The major strength of  my outbreak studies was the epidemiological approach. In 
this approach the steps for seeking a common denominator and defining a popu-
lation at risk are important. Equally important is the formulation of  a hypothesis 
about the nature of  the agent causing the outbreak, its source, transmission route 
and port of  entry, possible ways of  control, and about the susceptibility of  the 
host, or the group of  hosts. Based on these steps, hypotheses can be tested by 
determining infection and illness rates in persons exposed and not exposed to 
potential source(s), by applying questionnaires, interviews and laboratory tests. 
In that way knowledge can be generated of  more general nature than strictly 
necessary for the containment of  the specific communicable disease at hand.
Surveillance is regarded to be a cornerstone of  the system to control communica-
ble diseases in a population, especially through tracking disease trends, identifying 
new disease threats, spotting serious outbreaks and monitoring control measures. 
But even in a country like England that is well known for its communicable 
disease control, the surveillance system does not meet these expectations.11 
Consequently, surveillance leads to uncertainty about the validity of  reported 
numerators and about the correctness of  chosen denominators to obtain valid 
and meaningful rates, as derived from reported diseases. This uncertainty about 
surveillance figures makes surveillance more suitable for hypotheses formulation 
than for hypothesis testing.12 
Through investigating outbreaks with epidemiological studies, hypotheses 
formulated through data derived from surveillance may be tested. In that way 
epidemiological studies of  outbreaks may compensate for the limitations of  
surveillance. 
In my epidemiological studies of  outbreaks hypotheses were tested about the 
cause of  the outbreaks,13-18 but also about risk factors like age,16,17,19 type of  
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vaccine,17 isolation from society,18 ways of  preparing food,13,14 and environmental 
risk factors,20 and about diagnostic methods.21,22
In the literature more examples are found of  epidemiologic studies of  outbreaks 
which generated specific and general of  knowledge of  determinants and interven-
tions of  communicable diseases important for the control of  communicable. A 
recent example is a study of  an observed increase in the reported incidence of  
Salmonella typhimurium by the Dutch surveillance system, which was followed by 
an epidemiological outbreak investigation.23 In this particular study the cause of  
the outbreak was found and an intervention was proposed based on a hypothesis 
that could be tested with the epidemiological study. Another example is a study in 
which the hypothesis could be rejected that the highly pathogenic avian influenza 
A virus subtype H7N7 was not infectious for humans. An unexpectedly high 
number of  transmissions of  avian influenza A virus subtype H7N7 to people who 
were directly involved in handling infected poultry was observed, and evidence 
was found for person-to-person transmission.24 The study was done during the 
outbreak of  the H7N7 avian influenza in the Netherlands in 2003. 
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Conclusions and recommendations
1. Outbreaks should be considered as natural experiments of  communicable 
diseases, which may reveal clues for the control of  such diseases. Every 
outbreak should be considered for epidemiological investigation to test 
hypotheses, including any hypothesis that has been formulated as result 
of  surveillance data. Any specific or general knowledge resulting from 
such outbreak management studies may be deployed in future primary and 
secondary prevention activities, including early diagnosis, detection, and 
containment of  the communicable disease. 
 It is therefore recommended to follow the steps given in Table 1 of  this thesis 
for decision making about the epidemiological study of  an outbreak.
2. Data gathered in an epidemiological outbreak study can serve as a data base 
for further investigation of  the communicable diseases at hand. It creates the 
opportunity to combine these data with other data obtained about the com-
municable disease at hand, in order to obtain more general knowledge.
 It is therefore recommended to consider every outbreak as a potential data 
base for further investigation of  the communicable disease.
3. Communicable disease control and particularly outbreak management 
deserves highly-trained medical and epidemiological professionals. These 
professionals deserve an environment in which public health practice and sci-
ence can be integrated for the benefit of  communicable disease control. 
 Therefore an academic workplace, which combines the medical and academic 
surrounding of  a university hospital and the surrounding of  a public health 
service which is responsible for public health practice, is recommended as an 
ideal environment to combine the art and science of  communicable disease 
control in populations.
General discussion
152
Literature
 1. Benenson AS. Control of  Communicable Diseases in Man. 13 ed. Washington: 
American Public Health Association, 1981.
 2. Evans HS, Feldman HA. Bacterial Infection of  Humans, Epidemiology and 
Control. New York: Plenum Publishing Corporation, 1982.
 3. Heymann DL, ed. Control of  Communicable Diseases Manuel. 18th edition ed. 
Washington: American Public Health Association, 2004.
 4. Nathanson N, Fine P. Virology. Poliomyelitis eradication--a dangerous endgame. 
Science 2002;296(5566):269-70.
 5. Nomoto A, Arita I. Eradication of  poliomyelitis. Nat Immunol 2002;3(3):205-8.
 6. Kew OM, Wright PF, Agol VI, et al. Circulating vaccine-derived polioviruses: 
current state of  knowledge. Bull World Health Organ 2004;82(1):16-23.
 7. Katz SL. Polio new challenges in 2006. J Clin Virol 2006;36(3):163-5.
 8. Resurgence of  wild poliovirus type 1 transmission and consequences of  importation-
-21 countries, 2002-2005. MMWR Morb Mortal Wkly Rep 2006;55(6):145-50.
 9. Evans AS. Viral Infections of  Humans, Epidemiology and Control. New York 
and London: Plenium Publishing Corporation, 1984.
 10. Heffernan R, Mostashari F, Das D, Karpati A, Kulldorff  M, Weiss D. Syndromic 
surveillance in public health practice, New York City. Emerg Infect Dis 
2004;10(5):858-64.
 11. Getting Ahead of  the Curve – A strategy for infectious diseases. In: London DoH, 
ed: © Crown Copyright, 2002.
 12. Meriwether R. Blueprint for a National Public Health Surveillance System for the 
21st Century. In: Press NA, ed. The Future of  Public Health. Washington, DC: 
Institute of  Medicine, 1988.
 13. Mertens PL, Willemsen F, Houben AW, van Boven CP. [Bavaroise and an epidemic 
of  Salmonella enteritidis]. Ned Tijdschr Geneeskd 1990;134(26):1258-61.
 14. Mertens PL, Thissen JF, Houben AW, Sturmans F. [An epidemic of  Salmonella 
typhimurium associated with traditional salted, smoked, and dried ham]. Ned 
Tijdschr Geneeskd 1999;143(20):1046-9.
 15. Mertens PL, Thijs C, Vinjé J, Sturmans F. [A gastroenteritis epidemic caused 
by a Norwalk-like virus after 2 weddings in a restaurant; a plea for integral 
microbiological investigation]. Ned Tijdschr Geneeskd 2002;146(50):2420-4.
 16. Mertens PL, Stals FS, Schellekens JF, Houben AW, Huisman J. An epidemic of  
pertussis among elderly people in a religious institution in The Netherlands. Eur J 
Clin Microbiol Infect Dis 1999;18(4):242-7.
Chapter 9
153
 17. Mertens PL, Nijhuis HGJ. [A pertussis epidemic investigated] Epidemiologisch 
Bulletin ‘s-Gravenhage 1986;November 1986:12-20.
 18. Mertens PL, Borsboom GJ, Richardus JH. A pertussis outbreak associated with 
social isolation among elderly nuns in a convent. Clin Infect Dis 2007;44(2):266-8.
 19.  Mertens PL, M.A. Widdowson MA, Van De Avoort HG and Richardus JH. Risk 
of  introduction of  poliovirus into a Dutch Cape Verdian community during an 
outbreak of  poliovirus in Cape Verde, 2000. Trop Med Int Health 2006;11(5):746-
750.
 20. van den Bogaard AE, Mertens P, London NH, Stobberingh EE. High prevalence 
of  colonization with vancomycin- and pristinamycin-resistant enterococci in 
healthy humans and pigs in The Netherlands: is the addition of  antibiotics to 
animal feeds to blame? J Antimicrob Chemother 1997;40(3):454-6.
 21. Versteegh FG, Mertens PL, de Melker HE, Roord JJ, Schellekens JF, Teunis PF. Age-
specific long-term course of  IgG antibodies to pertussis toxin after symptomatic 
infection with Bordetella pertussis. Epidemiol Infect 2005;133(4):737-48.
 22. Mertens P, Stals FS, Steyerberg E, Richardus JH. Sensitivity and specificity of  
single IgA and IgG antibodies for early diagnosis of  pertussis in adults: evaluation 
for outbreak management in public health practice. BMC Infectious Diseases 
2007, 7:53 doi.1186/1471-2334-7-53.
 23. Kivi M, Hofhuis A, Notermans DW, et al. A beef-associated outbreak of  
Salmonella typhimurium DT104 in The Netherlands with implications for national 
and international policy. Epidemiol Infect 2007:1-10.
 24. Koopmans M, Wilbrink B, Conyn M, et al. Transmission of  H7N7 avian influenza 
A virus to human beings during a large outbreak in commercial poultry farms in 
the Netherlands. Lancet 2004;363(9409):587-93.
General discussion

Summary

Chapter 10
157
This thesis is about outbreaks of  communicable diseases as natural 
experiments and as unique opportunities for obtaining knowledge, not 
only specific knowledge for the control of  communicable diseases at hand, 
but also more general knowledge for future control of  communicable 
diseases.
In chapter 1, the general introduction, we introduce communicable disease 
control as an important issue in public health. 
We describe earlier experiences with epidemiological investigations of  outbreaks 
of  communicable diseases as source of  inspiration for this thesis. 
Subsequently we introduce the three basic determinants of  communicable 
diseases (infectious agent, transmission and host) and explain how knowledge 
about these determinants will lead to the development of  successful preventive 
interventions. 
We present research of  determinants of  communicable diseases and the 
development of  interventions as the domain of  science, and the implemen-
tation of  interventions (control) as the domain of  public health practice.
Unsuccessful control may lead to outbreaks of  communicable diseases, which 
are usually detected through surveillance systems. Outbreaks of  communicable 
diseases are introduced as unique opportunities for research and as potential 
sources of  knowledge. In this perspective we establish the need for an etiologic 
diagnosis to reach the goal of  containment of  an outbreak, argue that epide-
miological evidence is necessary, and describe the systematic steps in outbreak 
management to be followed to reach this goal. 
We introduce surveillance as a tool in the control of  communicable diseases. 
The purpose of  surveillance is to watch over the occurrence of  communicable 
diseases. Surveillance is defined as the permanent process of  systematic collec-
tion, orderly consolidation, analysis, interpretation and evaluation of  pertinent 
data with prompt dissemination of  the results and processed information to 
those who need to know, particularly those who are in a position to take action in 
cases of  outbreaks to control a communicable diseases. We indicate the concern 
about the quality of  data obtained in surveillance suffering from the “garbage in, 
garbage out” principle. Ways to improve surveillance are described. We state that 
surveillance data may be used to monitor health events and determinants, and 
Summary
158
to formulate hypotheses, but not to test hypotheses. So surveillance should lead 
to, but not be confused with research.
We depict in a model the various aspects of  communicable disease control and 
how the domains of  science (research and the body of  knowledge about deter-
minants and interventions) and public health practice (surveillance, application 
of  interventions and outbreak management) interrelate. 
The general introduction ends with the research questions:
1. Are epidemiological studies during outbreak management able to generate 
specific knowledge for the containment of  the communicable disease at 
hand?
2. Are epidemiological studies during outbreaks management able to generate 
knowledge of  more general nature than necessary for the immediate contain-
ment of  the communicable disease at hand?
In chapter 2 we describe an outbreak of  pertussis among elderly people in a 
religious institution in the Netherlands. 
The study was started because an epidemic of  serious coughing with a duration 
of  9 weeks, was not explained by the general practitioner of  the institution. 
Antibiotics had not stopped the epidemic. In a first clinical evaluation of  a 
group of  coughing nuns the working diagnosis pertussis was made because the 
type of  coughing was very similar to the typical pertussis coughing which can 
be observed in the tropics in unvaccinated children. 
In the retro- and prospective epidemiological study of  the outbreak, the subjects 
were evaluated for their vaccination status and for history and presence of  respira-
tory symptoms. Specimens were collected from the 75 nuns and 24 staff  members 
for the laboratory investigation cultures, polymerase chain reactions, and changes 
in antibody titers in reaction on an infection with agents likely to have caused the 
outbreak. Special attention was given to pertussis as cause of  the epidemic because 
of  the characteristic clinical symptoms of  nuns in the convent. 
None of  the 75 residents and 19 of  24 non-resident personnel had been vac-
cinated against pertussis. The overall attack rate of  clinical pertussis, defined as 
persistent cough lasting at least 2 weeks, was 49%. In five subjects with clinical 
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pertussis, either culture or polymerase chain reaction or both were positive for 
Bordetella pertussis. A significant (at least 4-fold) change in specific antibody titre 
was observed in 85% (41/48) and 20% (10/49) of  subjects with and without 
clinical pertussis, respectively (P<0.0001, chi-square 41.1). The attack rate of  
laboratory-confirmed pertussis was 42% (41/98). This rate was 5% (1/19), 20% 
(1/5), and 53% (39/74) in vaccinated personnel, non-vaccinated personnel, and 
non-vaccinated residents, respectively (not significant). Among residents aged 
between 55–74 years and 75–94 years, the attack rates were 47% (17/36) and 
58% (22/38), respectively (relative risk = 0.8; 95% confidence interval 0.5–1.3). 
Four of  75 residents (5%) died while they were symptomatic for pertussis.
It was concluded that the attack rate of  pertussis was high among non-vaccinated 
elderly and that pertussis tended to increase with age and that there may be a 
considerable risk of  mortality from pertussis in this population. Physicians were 
advised to be alert to the diagnosis of  pertussis in the elderly with nocturnal and 
prolonged periods of  coughing.
In chapter 3 we describe a study in which we investigated whether and how 
the rate of  decline of  IgG antibodies to pertussis toxin (IgG-PT) after natural 
infection with Bordetella pertussis is dependent on age.
Therefore we measured IgG-PT in follow-up sera of  121 patients aged 0–94 
years, obtained after 123 episodes of  Bordetella pertussis infection. 
For analysis we applied a dynamic model for the inactivation of  Bordetella pertussis 
by the immune system. 
There were no significant differences in rise, peak and decline of  IgG-PT between 
different age groups, although there was a tendency for a more rapid increase, a 
higher peak and a faster decline with increasing age. 
The IgG-PT cut-off  of  100 U/ml for serodiagnosis of  pertussis appeared valid in 
all age groups. A decline of  IgG-PT to <10 U/ml was associated with increased 
risk of  re-infection with Bordetella pertussis.
In chapter 4 we state that an accurate and practical laboratory test is needed to 
confirm clinical diagnosis of  pertussis in adults during the first 3 symptomatic 
weeks, when treatment is effective and transmission can be interrupted. 
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Therefore we focussed on the rise of  IgA and IgG antibodies to pertussis in the 
earliest clinical stages of  pertussis. We assessed the sensitivity and specificity of  
single IgA and IgG levels in the cohort study of  a pertussis epidemic in the 99 
adults in the closed religious community studied is chapter 2 and 3 as well. Sen-
sitivities were assessed in the sera of  46 laboratory confirmed clinical pertussis 
cases during the first 3 weeks. Specificities were calculated in sera of  35 asymp-
tomatic controls without clinical symptoms or laboratory confirmed infections 
from the same community (internal controls). We compared these specificities 
with the specificities of  single IgA and IgG levels in 4275 external controls from 
a cross-section of  the general Dutch population aged 21-79 years who had not 
coughed for more than 2 weeks in the past year, and without pertussis diagnoses. 
The study was done in the Netherlands when whole-cell pertussis vaccine was 
used in the national vaccination programme. 
Levels of  24 U/ml for IgA and 27 U/ml for IgG gave sensitivities of  100% and 
75%, respectively, in the first 2 weeks, 100% in the third week, and 97% after 
the fourth week. The levels were reached within 2 days after onset of  increase, 
and remained above these levels for roughly 7.2 and 5.1 months, respectively. 
Specificity was 82% for IgA and 89% for IgG in the internal controls and 90% 
in the external controls, respectively. 
We suggested levels of  24 U/ml for IgA and 27 U/ml (= 27 International Units 
(IU)/ml) for IgG as sensitive, specific, and practical for laboratory confirmation 
of  clinical pertussis in adults in the first 3 weeks of  outbreak management.
In chapter 5 we describe a study attempting to reveal the explanation for the 
serious pertussis outbreak in the convent in the Netherlands in 1992, described 
in Chapter 2.
We showed that the pertussis incidence during the outbreak was higher among 
75 retired (unvaccinated) nuns living in the convent (60%) than among 24 staff  
members (8%) living in the open society. We also showed that the pertussis 
incidence during the outbreak was higher among 9 nuns with only a convent 
career (100%) than among 66 nuns who had a career outside of  the convent 
(55%) before retirement in the convent. The pertussis incidence increased with 
duration of  social isolation but not with age. We concluded that natural infection 
with Bordetella pertussis contracted in society effectively protected nuns against 
pertussis. Indeed, in the Netherlands in 1995–1996, the estimated incidence of  
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infection was 6.6% per year among individuals 3–79 years of  age, up to 10.8% 
among individuals 20–24 years of  age, and much higher than the reported 
pertussis incidence of  0.01% in the Dutch population per year in the national 
surveillance system. 
Because both infection-acquired immunity and vaccine-acquired immunity 
wane over time, we concluded that booster doses of  pertussis vaccines may be 
a valuable strategy to control pertussis in populations with national childhood 
vaccination programs.
In chapter 6 we describe an epidemic of  gastroenteritis after a family party 
caused by Salmonella typhimurium and associate the epidemic with traditional salt-
ing, drying and smoking of  raw pork meat.
To discover the cause of  the epidemic of  gastroenteritis we used a retrospective 
cohort study. All 109 party-goers were asked to complete a written questionnaire 
about consumed food products and demographic and clinical variables and to 
hand in a faeces sample. The data were collected at the Public Health Institute 
Midden-Limburg, the Netherlands. Faeces and the remaining food products 
were examined microbiologically. The attack rates and the incidence rates of  
positive faeces culture among consumers and non-consumers of  specific food 
products were calculated as well as the corresponding relative risks (RR) with 
95% confidence intervals (95% CI).
The overall attack rate among the participants in the study was 35% (30/86). Twen-
ty-eight different food products were served. Only consumption of  ‘Coburger 
ham’ and of  ‘bone ham’ was statistically significantly related to being ill (RR: 2.4; 
95% CI: 1.5-4.0 and RR: 1.4; 95% CI: 1.1-1.9, respectively). Salmonella typhimurium 
phage type 20 was statistically significantly more frequently found in faeces of  
ill compared with non-ill party-goers (RR: 6.4; 95% CI: 2.5-16.1). Salmonella typh-
imurium phage type 20 was found in ‘Coburger ham’. Consumption of  ‘Coburger 
ham’ only, was statistically significantly related to a positive faeces culture (RR: 
4.1; 95% CI: 2.0-8.5). ‘Coburger ham’ and ‘bone ham’ originated from the same 
batch of  raw meat and were prepared in the same manner in the same salt bath. 
The shorter duration of  salting and drying of  ‘Coburger ham’ compared with 
‘bone ham’ corresponded with a higher relative risk of  becoming ill. 
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We concluded that consumption of  ‘bone ham’ and ‘Coburger ham’ infected 
with Salmonella typhimurium phage type 20 caused the outbreak. Traditional salting, 
drying and smoking of  raw pork meat was not antimicrobiologically effective 
against Salmonella typhimurium.
We recommended investigation of  the antimicrobiological effect of  the traditional 
preparation of  meat and underlined the importance of  Good Manufacturing 
Practices and quality control in all stages of  production of  pork meat, according 
to the principles of  Hazard Analysis and Critical Control Points.
Chapter 7 describes a gastroenteritis epidemic caused by a Norwalk-like virus 
after two weddings in a restaurant and provides a plea for integral microbiologi-
cal investigation.
To elucidate the cause of  the epidemic of  gastroenteritis amongst the guests 
and waiting staff  of  two weddings celebrated on the same day in the same res-
taurant, we used a retrospective and descriptive epidemiological study. After an 
outbreak of  gastroenteritis amongst 215 wedding guests and restaurant staff  in 
1999, we inventoried in the Public Health Service Midden-Limburg, the Neth-
erlands, the demographic and clinical variables and consumed foods by means 
of  a structured written interview. Faecal samples and remaining food products 
were bacteriologically examined, and later on faeces were virologically examined 
for the presence of  the Norwalk-like virus (NLV). The attack and the incidence 
rates of  NLV-positive faecal specimens amongst consumers and non-consumers 
of  specific food products were calculated, as well as the corresponding relative 
risks with 95% confidence intervals.
The overall attack rate was among the weddings guests and personnel who par-
ticipated in the study was 66% (102/155). Of  the 61 different dishes served, two 
showed a statistically significant relation with being ill. These food products were 
eaten by 26% of  the ill persons. An NLV with the same genotype was found 
statistically significantly more frequently in faecal specimens of  ill persons com-
pared with non-ill individuals. No statistically significant association was found 
between NLV-positive faeces and consumption of  a specific dish. The index 
case began having symptoms of  gastroenteritis at the morning of  the wedding 
party, before food was served. The guests of  the two wedding parties used the 
same entrance and toilets. 
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We concluded that the epidemic was caused by a single NLV strain. No association 
could be found between the consumption of  certain food products and being 
ill. The NLV epidemic was probably caused through direct or indirect contact 
between wedding guests and restaurant personnel.
We recommended that in the case of  such reports of  gastroenteritis epidem-
ics, to test faecal, food product and environment samples for both bacteria and 
viruses, with an emphasis on NLV, to ensure early diagnosis.
In chapter 8 we describe the risk of  introduction of  poliovirus into the largest 
Cape Verdian community in the Netherlands during an outbreak of  poliovirus 
in Cape Verde in 2000. 
The study was carried out in the week before all against poliomyelitis insuffi-
ciently vaccinated 0-30 year old Cape Verdians in the Netherlands, were called 
upon, possibly anonymous, to be vaccinated with life oral polio vaccine (OPV). 
In the Dutch national vaccination program inactivated polio vaccine (IPV) is 
being used.
The purpose of  the campaign was to protect Cape Verdians in The Netherlands 
against poliomyelitis and to combat transmission of  polio virus to the Orthodox 
Reformed communities in the Netherlands.
We surveyed all 225 insufficiently vaccinated 0–14-year-old among all Cape 
Verdian children in Rotterdam (n = 4188) and a random sample of  285 out 
of  all 15–30-year-old Cape Verdians (n = 5074) in Rotterdam, to assess travel 
behaviour and vaccination coverage. Faecal specimens were collected and sew-
age samples taken in neighbourhoods with a sizable Cape Verdian population 
for testing of  polio virus.
Of  the Cape Verdian children aged 0–14 years living in Rotterdam, 94.6% was 
sufficiently vaccinated, but 10% of  the 91 responding insufficiently vaccinated 
children aged 0-14 years, reported travelling to Cape Verde during the polio epi-
demic. Of  the responding adults aged 15–30 years living in Rotterdam (n=82), 
10% was not vaccinated against polio, and 17% reported travelling to Cape Verde 
during the polio epidemic.
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In the faeces of  80 insufficiently vaccinated individuals aged 0–14 years and in 
74 adults aged 15–30 years, no poliovirus was detected. Samples of  sewage from 
six sites were negative for poliovirus.
We concluded that, although risk factors for the introduction of  polio virus were 
present, there was no evidence of  poliovirus infection found in the Cape Verdian 
population in Rotterdam despite extensive travel to the Cape Verde during the 
outbreak.
We stated that, in retrospect and considering the extensive coverage against polio 
in both the Cape Verdian and the general Dutch population, inactivated polio 
vaccine (IPV) vaccination of  insufficiently vaccinated individual Cape Verdians 
would have been sufficient. In this way any conceivable risk of  OPV virus to 
become pathogenic would be avoided.
We underlined that alertness regarding adequate vaccination of  travellers to 
polio-epidemic areas remains necessary and that in this perspective caution is 
warranted, especially regarding the ten of  thousands members of  the Orthodox 
Reformed communities in the Netherlands, not being protected against polio, as 
long as poliomyelitis is not eradicated completely from the world.
Finally, in chapter 9, the general discussion, the research questions are answered 
and the limitations and strengths are discussed in the context of  literature. 
We state that through investigating outbreaks with epidemiological studies, 
hypotheses, including hypotheses formulated through data derived from sur-
veillance, may be tested. In that way epidemiological studies of  outbreaks may 
compensate for the limitations of  surveillance.
 
The conclusions and recommendations derived are:
1. Outbreaks should be considered as natural experiments of  communicable dis-
eases, which may reveal clues for the control of  such diseases. Every outbreak 
should be considered for epidemiological investigation to test hypotheses, 
including any hypothesis that has been formulated as result of  surveillance 
data. Any specific or general knowledge resulting from such outbreak manage-
ment studies may be deployed in future primary and secondary prevention 
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activities, including early diagnosis, detection, and containment of  the com-
municable disease. 
 It is therefore recommended to follow a set of  steps given in the first table 
of  this thesis for decision making about the epidemiological study of  an 
outbreak.
2. Data gathered in an epidemiological outbreak study may serve as a data base 
for further investigation of  the communicable diseases at hand. It creates 
the opportunity to combine these data with other data obtained about the 
communicable disease at hand, in order to obtain more general knowledge.
 It is therefore recommended to consider every outbreak as a potential data 
base for further investigation of  the communicable disease.
3. Communicable disease control and particularly outbreak management deserves 
highly-trained medical and epidemiological professionals. These professionals 
deserve an environment in which public health practice and science can be 
integrated for the benefit of  communicable disease control.
 Therefore an academic workplace, which combines the medical and academic 
surrounding of  a university hospital and the surrounding of  a public health 
service which is responsible for public health practice, is recommended as an 
ideal environment to combine the art and science of  communicable disease 
control in populations.
Summary
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In dit proefschrift worden uitbraken van overdraagbare ziekten beschouwd 
als natuurlijke experimenten en als unieke kansen om kennis te verkrijgen, 
niet alleen kennis voor de directe bestrijding van overdraagbare ziekten, 
maar ook kennis van meer algemene aard voor toekomstige bestrijding 
van overdraagbare ziekten.
In hoofdstuk 1, de algemene inleiding, wordt de bestrijding van overdraag-
bare ziekten gepresenteerd als een belangrijk onderdeel van de maatschappelijke 
gezondheidszorg. 
Eerdere ervaringen met epidemiologisch onderzoek van overdraagbare ziekten 
worden beschreven als bronnen van inspiratie voor dit proefschrift. 
Daarna worden de drie basale determinanten (bepalende factoren) van over-
draagbare ziekten gepresenteerd: het agens, de transmissie en de gastheer. We 
leggen uit hoe kennis over deze determinanten kan leiden tot de ontwikkeling 
van succesvolle preventieve interventies.
We presenteren onderzoek naar determinanten en interventies van overdraagbare 
ziekten als het domein van de wetenschap en het toepassen van interventies als 
het domein van de maatschappelijke gezondheidszorg. 
Niet succesvolle beheersing van overdraagbare ziekten kan leiden tot uitbraken, 
die meestal worden opgespoord in surveillancesystemen. Uitbraken worden 
gepresenteerd als unieke kansen voor onderzoek en als potentiële bronnen van 
kennis. Vanuit dit perspectief  stellen we de noodzaak vast voor het vinden van 
een oorzaak om een uitbraak te kunnen beheersen en beredeneren we dat hier-
voor epidemiologisch bewijs nodig is. We beschrijven de stappen die stelselmatig 
zouden moeten worden gevolgd om epidemiologisch bewijs te verkrijgen en 
uitbraken te beheersen.
Vervolgens presenteren we surveillance als een hulpmiddel bij het bewaken en 
beheersen van overdraagbare ziekten. Surveillance wordt gedefinieerd als “het 
voortdurend en stelselmatig verzamelen, rangschikken, ontleden, schatten en 
uitleggen van relevante cijfers, onmiddellijk gevolgd door verspreiding van de 
verkregen resultaten onder degenen die erover moeten weten, en in het bijzon-
der onder degenen die bij machte zijn om actie te ondernemen in geval van een 
uitbraak, om de overdraagbare ziekte te beheersen”. 
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We wijzen dan op de bezorgdheid die bestaat over de kwaliteit van de cijfers 
verkregen in surveillance, waardoor surveillance lijdt aan het “garbage in, garbage 
out”-principe. Manieren om surveillance te verbeteren worden beschreven. We 
stellen dat gegevens verkregen uit surveillance wel gebruikt mogen worden om 
toezicht te houden op gebeurtenissen met betrekking tot gezondheid en ziekte 
en hun determinanten en voor de formulering van hypothesen, maar niet om 
hypothesen te toetsen. Dus surveillance kan wel leiden tot wetenschap, maar 
moet er niet mee worden verwisseld.
Vervolgens presenteren we een model met de verschillende aspecten van de 
beheersing van overdraagbare ziekten. In het model is weergegeven hoe weten-
schap (onderzoek en het geheel aan kennis over determinanten en interventies) 
en daadwerkelijke maatschappelijke gezondheidszorg (surveillance, uitvoeren van 
interventies en het beheersen van uitbraken) samenhangen.
De algemene inleiding eindigt met de onderzoeksvragen:
1. Kan met behulp van epidemiologische studies bij het beheersen van een 
uitbraak specifieke kennis worden verkregen voor de directe beheersing van 
een overdraagbare ziekte?
2. Kan met behulp van epidemiologische studies bij het beheersen van een uit-
braak, kennis worden verkregen, die van algemenere aard is dan nodig voor 
de directe beheersing van een overdraagbare ziekte?
In hoofdstuk 2 beschrijven we een studie van een uitbraak van kinkhoest in een 
groep van ouderen in een klooster in Nederland.
De studie werd opgezet omdat de oorzaak van een al 9 weken durende epide-
mie van ernstig hoesten niet achterhaald was door de huisarts van het klooster. 
Antibiotica hadden de epidemie niet beëindigd.
Tijdens een eerste klinische evaluatie van een groep hoestende nonnen werd 
de werkdiagnose kinkhoest gesteld omdat het hoesten veel leek op het typische 
hoesten dat in de tropen kan worden waargenomen bij niet-gevaccineerde kin-
deren.
In een retro- en prospectieve studie van de uitbraak, werd de vaccinatiestatus en 
de aanwezigheid van en het verloop van hoesten onderzocht bij de 99 personen 
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in het klooster. Van deze 75 nonnen en 24 personeelsleden werden ook monsters 
verzameld voor laboratoriumonderzoek van kweken, polymerase-kettingreacties, 
en veranderingen in antistoftiters ten gevolge van besmetting met mogelijke 
oorzaken van de epidemie. Speciale aandacht werd gegeven aan kinkhoest als 
oorzaak, vanwege de karakteristieke klinische symptomen van de nonnen in het 
klooster.
Geen van de 75 nonnen en 19 van de 24 personeelsleden waren gevaccineerd 
tegen kinkhoest. Het percentage personen met klinische kinkhoest, gedefinieerd 
als een aanhoudende hoest van minstens 2 weken, was 49%. Van hen had 10% een 
positieve kweek, een positieve polymerase kettingreactie of  beide. Bij 85% (41/48) 
van de personen met klinische kinkhoest en bij 20% (10/49) van de personen 
zonder klinische kinkhoest werd een significante (minstens 4-voudige stijging) 
van specifieke antistoftiters tegen kinkhoest waargenomen (P<0.0001, Chi-
kwadraat 41.1). Het percentage personen met laboratorium bevestigde kinhoest 
bedroeg 42% (41/98). Dit percentage bedroeg respectievelijk 5% (1/19), 20% 
(1/5), en 53% (39/74) bij gevaccineerd personeel, niet-gevaccineerd personeel 
en de niet-gevaccineerde bewoners van het klooster (statistisch niet-significant). 
Dit percentage bedroeg bij de kloosterbewoners in de leeftijdscategorieën 55-74 
jaar en 75-94 jaar respectievelijk 47% (17/36) en 58% (22/38), (relatieve risico 
= 0.8; 95% betrouwbaarheidsinterval 0.5–1.3). Vier van de 75 kloosterbewoners 
(5%) stierven toen zij leden aan de symptomen van kinkhoest.
We concludeerden dat het kinkhoestpercentage hoog was onder de niet-gevac-
cineerde oudere kloosterbewoners, dat kinkhoest neigde toe te nemen met 
de leeftijd en dat kinkhoest een aanzienlijk sterfterisico zou kunnen zijn in de 
populatie ouderen.
We adviseerden artsen om alert te zijn op het stellen van de diagnose kinkhoest 
bij ouderen met nachtelijk en langdurig hoesten.
In hoofdstuk 3 beschrijven we een studie waarin we onderzochten of  en hoe 
de antistof  IgG pertussis toxine (IgG-PT) tegen kinkhoest afhankelijk van de 
leeftijd daalt, na een natuurlijke infectie met de Bordetella pertussis bacterie.
Daarvoor maten we het verloop van IgG-PT in de sera van 121 patiënten in de 
leeftijd van 0-94 jaar, die samen 123 episoden van een besmetting met Bordetella 
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pertussis doormaakten. Voor de analyse gebruikten we een dynamisch model voor 
de inactivatie van Bordetella pertussis door het immuunsysteem.
In de verschillende leeftijdgroepen werd er geen significant verschil gevonden 
in de stijging, piekhoogte en daling van IgG-PT, hoewel IgG-PT er toe neigde 
om met toename van de leeftijd sneller te stijgen naar hogere pieken en sneller 
te dalen. 
Het IgG-PT afkappunt van 100 U/ml leek valide voor de sero-diagnose kinkhoest 
in alle leeftijdscategorieën.
Een daling van IgG-PT beneden 10 U/ml werd in verband gebracht met een 
toename van het risico op een re-infectie met Bordetella pertussis.
In hoofdstuk 4 stellen we dat een nauwkeurige en praktische laboratorium-
test nodig is om bij volwassenen de klinische diagnose kinkhoest serologisch 
te kunnen bevestigen in de eerste drie symptomatische weken. Immers dan is 
behandeling effectief  en dan kan transmissie van de Bordetella pertussis bacterie 
worden doorbroken. 
Daarvoor spitsten we ons toe op de stijging en daling van IgA en IgG antistoffen 
in de vroegste klinische dagen van kinkhoest. Wij beoordeelden de sensitiviteit 
en specificiteit van enkelvoudige IgA en IgG niveaus in de cohortstudie van de 
kinkhoestepidemie onder de 99 volwassenen in de gesloten religieuze gemeen-
schap, die eveneens werd bestudeerd in hoofdstuk 2.
De sensitiviteit van IgA en IgG in de eerste 3 klinische weken van kinkhoest werd 
bepaald in de 46 personen met laboratorium bevestigde kinkhoest met klinische 
verschijnselen. De specificiteit van IgA en IgG werd berekend in de sera van de 
interne controle groep, de 35 personen zonder klinische symptomen van kink-
hoest en zonder een laboratorium bevestigen infectie met Bordetella pertussis. We 
vergeleken deze specificiteiten met de specificiteiten van enkelvoudige IgA en IgG 
niveaus in de externe controlegroep, een dwarsdoorsnede van 4275 personen uit 
de algemene Nederlandse bevolking in dezelfde leeftijdscategorie van 21-79 jaar. 
Deze groep gaf  aan, in het jaar voorafgaande aan het dwarsdoorsnedeonderzoek, 
niet langer dan 2 weken gehoest te hebben en geen diagnose kinkhoest te heb-
ben gekregen. Het onderzoek werd uitgevoerd in Nederland toen het cellulaire 
vaccin tegen kinkhoest werd gebruikt.
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Niveaus van 24 U/ml IgA en 27 U/ml IgG gaven een sensitiviteit van respec-
tievelijk 100% en 75% in de eerste twee klinische weken van kinhoest, 100% in 
de derde week en 97% vanaf  de vierde week. Deze IgA en IgG niveaus werden 
binnen 2 dagen na het begin van hun stijging bereikt, en ze bleven boven deze 
niveaus gedurende respectievelijk 7.2 en 5.1 maanden. De specificiteit van 24 
U/ml IgA en 27 U/ml IgG was respectievelijk 82% en 89% in de interne con-
trolegroep en 90% in de externe controlegroep.
We stelden een IgA niveau van 24 U/ml en een IgG niveau van 27 U/ml (= 27 
Internationale Units (IU)/ml) voor als sensitieve, specifieke en praktische tests 
voor de laboratoriumbevestiging van klinische kinkhoest in de eerste 3 weken 
bij uitbraak management.
In hoofdstuk 5 beschrijven we een onderzoek waarin wordt getracht een ver-
klaring te vinden voor de ernstige uitbraak van kinkhoest in het klooster in 
Nederland in 1992, beschreven in hoofdstuk 2. 
We toonden aan, dat de incidentie van kinkhoest hoger was bij de 75 gepensio-
neerde (ongevaccineerde) nonnen, die woonden in het klooster (60%), dan bij 
de 24 personeelsleden (8%), die woonden in de open samenleving. Ook toonden 
we aan, dat tijdens de uitbraak de incidentie van kinkhoest hoger was onder de 
9 nonnen die hun hele carrière in het klooster verbleven (100%), dan onder de 
nonnen die een carrière buiten het klooster hadden, voordat ze met pensioen 
in het klooster terugkeerden (55%). De incidentie van kinkhoest nam statistisch 
significant toe met de duur van de sociale isolatie in het klooster en niet met de 
leeftijd van de nonnen.
Wij concludeerden dat natuurlijke infectie met Bordetella pertussis opgelopen in de 
samenleving de nonnen effectief  beschermde tegen kinkhoest. Dit paste bij de 
geschatte incidentie van natuurlijke infecties met Bordetella pertussis in Nederland 
in 1995-1996 van 6.6% per jaar in de populatie in de leeftijdscategorie 3-79 jaar. 
Deze incidentie liep zelfs op tot 10.8% onder 20-24 jarigen. Deze infectie-inci-
dentie was veel hoger dan de incidentie van 0.01% van de jaarlijks aangegeven 
gevallen van kinkhoest uit de algemene Nederlandse bevolking.
Omdat zowel immuniteit na infectie als na vaccinatie afneemt in de tijd, conclu-
deerden we, dat het boosteren met pertussis vaccinatie mogelijk een waardevolle 
Samenvatting
174
strategie zou kunnen zijn in populaties met succesvolle vaccinatieprogramma’s 
onder kinderen.
In hoofdstuk 6 beschrijven we een onderzoek van een uitbraak van Salmonella 
typhimurium na een familiefeest. We brengen de uitbraak in verband met traditi-
oneel gezouten, gerookte en gedroogde ham.
Om de oorzaak van de epidemie van gastro-enteritis te achterhalen voerden we 
een retrospectief  cohortonderzoek uit vanuit de Gewestelijke Gezondheids-
dienst Midden-Limburg. Daartoe inventariseerden we met een gestructureerde 
schriftelijke vragenlijst onder alle 109 feestgangers de demografische gegevens, 
klinische verschijnselen en genuttigde voedselsoorten. Feces en voedselrestanten 
werden microbiologisch onderzocht. Vervolgens werden de ziektefrequenties en 
de frequenties van positieve feceskweken onder gebruikers en niet-gebruikers 
van specifieke voedselsoorten en de relatieve risico’s (RR’s) met 95%-betrouw-
baarheidsinterval (95%-BI) berekend.
Het ziektepercentage in de groep die deelnam aan het onderzoek bedroeg 35% 
(30/86). Er werden 28 voedselsoorten geserveerd. Alleen het nuttigen van Cobur-
ger ham en van beenham was statistisch significant gerelateerd aan ziek worden 
(RR: 2,4; 95%-BI: 1,5-4,0 respectievelijk RR: 1,4; 95%-BI: 1,1-1,9). Salmonella 
typhimurium faagtype 20 werd statistisch significant vaker in feces van zieken 
dan van niet-zieken gevonden. (RR: 6,4; 95%-BI: 2,5-16,1). Alleen het nuttigen 
van Coburger ham vertoonde een statistisch significante relatie met het hebben 
van een positieve feceskweek (RR: 4,1; 95%-BI: 2,0-8,5). Salmonella typhimurium 
faagtype 20 werd in de Coburger ham aangetroffen. Coburger ham en beenham 
werden op dezelfde wijze bereid van dezelfde partij rauw varkensvlees in het-
zelfde pekelbad. De kortere duur dat Coburger ham werd gepekeld en gedroogd 
vergeleken met beenham paste bij het hogere relatieve risico op ziek worden.
We concludeerden dat de oorzaak van de uitbraak het consumeren van met Sal-
monella typhimurium faagtype 20 besmette beenham en Coburger ham was. Het 
ambachtelijk zouten, drogen en roken had onvoldoende antimicrobiologisch effect 
tegen reeds in het rauwe varkensvlees voorkomende Salmonella typhimurium. 
We adviseerden om nader onderzoek te doen naar het antimicrobiologische effect 
van het ambachtelijke procédé en onderstreepten het belang van de kwaliteits-
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controle volgens de principes van ‘hazard analysis and critical control points’ in 
alle stappen van de productie van varkensvlees.
In hoofdstuk 7 beschrijven we een uitbraak van maag- en darmstoornissen, ver-
oorzaakt door een Norwalk Like virus (NLV) na twee bruiloften in een restaurant, 
en houden we een pleidooi voor integraal microbiologisch onderzoek.
Om de oorzaak te achterhalen werd vanuit de Gewestelijke Gezondheidsdienst 
Midden-Limburg een retrospectief  en beschrijvend onderzoek uitgevoerd onder 
de 215 bruiloftsgasten en het restaurantpersoneel. Met een gestructureerde 
schriftelijke vragenlijst werden demografische gegevens, klinische verschijnselen 
en genuttigde voedselsoorten geïnventariseerd. Feces en voedselrestanten werden 
eerst bacteriologisch onderzocht; later werd de feces op de aanwezigheid van 
NLV onderzocht. De ziektepercentages en de frequenties van NLV-positieve 
uitslagen onder gebruikers en niet-gebruikers van specifieke voedselsoorten, en 
de RR met 95%-BI werden berekend.
Het ziektepercentage onder de bruiloftsgasten en het personeel die deelnamen 
aan het onderzoek bedroeg 66% (102/155). Er werden 61 verschillende gerechten 
geserveerd, waarvan 2 een statistisch significante relatie vertoonden met ziekte. 
Van deze 2 gerechten werd door 26% van de zieken gegeten. Een NLV met 
hetzelfde genotype werd statistisch significant vaker in feces van zieken dan in 
feces van niet-zieken aangetroffen. Er werd geen significant verband gevonden 
tussen het nuttigen van een specifiek gerecht en NLV-positieve feces. 
De indexpersoon kreeg gastro-enteritis op de ochtend van de bruiloft vóórdat 
het voedsel werd geserveerd. De twee groepen bruiloftsgasten maakten gebruik 
van dezelfde ingang en toiletgroep.
We concludeerden dat de epidemie werd veroorzaakt door dezelfde NLV-stam. 
Omdat er geen verband werd gevonden tussen bepaalde typen voedsel en ziek 
worden, concludeerden we dat het virus waarschijnlijk verspreid werd door 
direct of  indirect onderling contact tussen de bruiloftsgasten en het restaurant-
personeel. 
We adviseerden om bij dit soort meldingen van epidemieën van gastro-enteritis 
fecesmonsters, voedselmonsters en omgevingsmonsters tegelijkertijd bacteriolo-
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gisch en virologisch te onderzoeken, in het bijzonder op NLV, om de diagnose 
zo snel mogelijk te kunnen stellen.
In hoofdstuk 8 beschrijven we het risico van import van het poliovirus in de 
grootste Kaapverdische gemeenschap in Nederland, tijdens de uitbraak van 
poliomyelitis (kinderverlamming) in Kaap Verdië in 2000. Het onderzoek werd 
uitgevoerd in de week voordat alle onvoldoende tegen poliomyelitis gevaccineerde 
0-30 jarige Kaapverdiërs in Nederland werden opgeroepen om zich in een mas-
savaccinatiecampagne, eventueel anoniem te laten vaccineren met het levende 
orale poliovaccin (OPV). In het Nederlandse Rijksvaccinatieprogramma wordt 
gevaccineerd met geïnactiveerd poliovaccin (IPV).
Het doel van deze campagne was om Kaapverdiërs in Nederland te beschermen 
tegen poliomyelitis en overdracht van het poliovirus naar de niet gevaccineerde 
Orthodox Gereformeerde gemeenschappen in Nederland tegen te gaan.
We onderzochten alle 225 onvoldoende gevaccineerde 0-14 jarige onder alle 
Kaapverdische kinderen (n=4188) in Rotterdam, en een willekeurige steekproef  
van 285 verkregen uit alle 15-30 jarige Kaapverdiërs (n=5074) in Rotterdam. 
We onderzochten het reisgedrag en de vaccinatiestatus en vroegen om een 
fecesmomster aan de onderzochte personen. In de buurten met een omvangrijke 
Kaapverdische bevolking werden rioolmonsters genomen.
Van de Kaapverdische 0-14 jarige kinderen in Rotterdam, was 94.6% voldoende 
gevaccineerd, echter 10% van de 91 responderende onvoldoende gevaccineerde 
0-14 jarige kinderen rapporteerde een reis naar Kaap Verdië tijdens de polio-
epidemie. Van de responderende 15-30 jarige Kaapverdische volwassenen in 
Rotterdam (n=82), rapporteerde 10% niet tegen polio te zijn gevaccineerd en 
17% rapporteerde een reis naar Kaap Verdië tijdens de polio-epidemie.
In de feces van 80 onvoldoende gevaccineerde kinderen in de leeftijd van 0-14 jaar 
en van 74 volwassenen in de leeftijd van 15-30 jaar werd geen poliovirus gevonden. 
In de rioolmonsters van de 6 buurten werd geen poliovirus gevonden.
We concludeerden dat er wel risicofactoren aanwezig waren voor de import van 
poliovirus, maar dat er ondanks intensief  reizen naar Kaap Verdië tijdens de 
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polio-epidemie, geen bewijs werd gevonden voor infectie van de Rotterdamse 
Kaapverdische gemeenschap met het poliovirus.
We stelden dat achteraf  beschouwd en gezien de hoge vaccinatiegraad in zowel 
de Kaapverdische als de algemene Nederlandse bevolking met geïnactiveerd 
poliovaccin, het vaccineren van onvoldoende gevaccineerde Kaapverdiërs met 
geïnactiveerd poliovaccin, afdoende zou zijn geweest. Op die manier zou ieder 
denkbaar risico op het pathogeen worden van het levende OPV zijn vermeden. 
We onderstreepten dat alertheid op afdoende vaccinatie van reizigers naar 
polio-endemische gebieden noodzakelijk blijft. We onderstreepten ook, dat in 
dit perspectief  voorzichtigheid is geboden zolang tienduizenden leden van de 
Orthodox Gereformeerde gemeenschappen in Nederland niet beschermd zijn 
tegen kinderverlamming, en zolang kinderverlamming niet compleet is uitgeroeid 
op aarde.
Ten slotte worden in hoofdstuk 9, de algemene discussie, de onderzoeksvragen 
beantwoord en de sterke en zwakke kanten van het onderzoek besproken in de 
context van de literatuur.
We stellen, dat met epidemiologisch onderzoek van uitbraken hypothesen, inclu-
sief  hypothesen die zijn gebaseerd op data verkregen in surveillance, kunnen 
worden getoetst. 
Op die manier kunnen epidemiologische studies van uitbraken compenseren 
voor de beperkingen van surveillance.
De conclusies en aanbevelingen zijn:
1. Uitbraken zouden moeten worden beschouwd als natuurlijke experimenten 
van overdraagbare ziekten, die aanwijzingen voor de beheersing van zulke 
ziekten kunnen onthullen.
 Bij iedere uitbraak zou daarom moeten worden overwogen of  de uitbraak 
epidemiologische wordt onderzocht om wetenschappelijke hypothesen te 
toetsen, inclusief  hypothesen die zijn gebaseerd op cijfers verkregen in surveil-
lance. Specifieke of  algemene kennis die voortkomt uit zulk onderzoek kan 
eventueel worden ingezet bij toekomstige primaire en secundaire preventie-
activiteiten, met inbegrip van opsporing, vroege diagnostiek en de beheersing 
van de overdraagbare ziekte.
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 Daarom wordt aanbevolen om bij het nemen van een besluit over een epide-
miologische studie van een uitbraak, de stappen te volgen die zijn weergegeven 
in de eerste tabel in dit proefschrift.
2. Gegevens die verzameld zijn in een epidemiologische studie van een uitbraak 
kunnen mogelijk dienen als gegevensbestand voor verder onderzoek van de 
overdraagbare ziekte. Zulk een gegevensbestand schept de mogelijkheid om 
het te combineren met andere gegevens verkregen over de overdraagbare 
ziekte, om zodoende meer algemene kennis te verkrijgen.
 Daarom wordt aanbevolen om iedere uitbraak te beschouwen als een poten-
tieel gegevensbestand voor nader onderzoek van de overdraagbare ziekte.
3. De beheersing van overdraagbare ziekten en vooral het beheersen van uitbraken 
verdient bekwame medische en epidemiologische geschoolde vakmensen.
 Deze vakmensen verdienen een omgeving, waarin de praktijk van de maat-
schappelijke gezondheidszorg en de wetenschap kunnen worden verenigd, in 
het belang van de beheersing van overdraagbare ziekten.
 Daarom wordt een academische werkplaats, waarin zowel de medische als de 
academische omgeving van een universiteitsziekenhuis wordt gecombineerd 
met de omgeving van een dienst die verantwoordelijk is voor de uitoefening 
van de maatschappelijke gezondheidszorg, aanbevolen als een ideale omge-
ving om de kunst en de kunde van de beheersing van overdraagbare ziekten 
te combineren.
Dankwoord  
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